Gene Symbol | Gene ID | Gene Info |
---|---|---|
Hoxc4
|
ENSMUSG00000075394.3 | homeobox C4 |
Arx
|
ENSMUSG00000035277.9 | aristaless related homeobox |
Otp
|
ENSMUSG00000021685.10 | orthopedia homeobox |
Esx1
|
ENSMUSG00000023443.7 | extraembryonic, spermatogenesis, homeobox 1 |
Phox2b
|
ENSMUSG00000012520.8 | paired-like homeobox 2b |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chrX_93377714_93377865 | Arx | 91279 | 0.075632 | -0.82 | 2.4e-14 | Click! |
chrX_93310384_93310605 | Arx | 23984 | 0.210849 | -0.82 | 3.1e-14 | Click! |
chrX_93300120_93300496 | Arx | 13798 | 0.229512 | -0.81 | 4.4e-14 | Click! |
chrX_93310672_93310849 | Arx | 24250 | 0.210285 | -0.81 | 4.5e-14 | Click! |
chrX_93301856_93302148 | Arx | 15492 | 0.226745 | -0.81 | 5.9e-14 | Click! |
chrX_137118164_137118315 | Esx1 | 1932 | 0.129490 | -0.38 | 4.4e-03 | Click! |
chr15_103018773_103018952 | Hoxc4 | 72 | 0.932598 | 0.23 | 9.0e-02 | Click! |
chr15_103034517_103034688 | Hoxc4 | 207 | 0.868651 | 0.13 | 3.3e-01 | Click! |
chr15_103033145_103033336 | Hoxc4 | 1155 | 0.289062 | 0.12 | 3.7e-01 | Click! |
chr15_103030186_103030337 | Hoxc4 | 4134 | 0.104728 | -0.11 | 4.3e-01 | Click! |
chr15_103035846_103035997 | Hoxc4 | 1526 | 0.217402 | 0.11 | 4.3e-01 | Click! |
chr13_94875414_94875568 | Otp | 111 | 0.969955 | -0.73 | 2.0e-10 | Click! |
chr13_94868641_94869006 | Otp | 6779 | 0.208778 | -0.64 | 1.9e-07 | Click! |
chr13_94882766_94882917 | Otp | 241 | 0.934683 | -0.60 | 1.5e-06 | Click! |
chr13_94883034_94883185 | Otp | 509 | 0.810518 | -0.59 | 1.8e-06 | Click! |
chr13_94883241_94883651 | Otp | 846 | 0.641455 | -0.48 | 2.3e-04 | Click! |
chr5_67101894_67102059 | Phox2b | 2675 | 0.232967 | -0.47 | 2.6e-04 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr17_47909349_47909983 | 120.26 |
Gm15556 |
predicted gene 15556 |
12712 |
0.13 |
chr15_79690079_79691459 | 105.19 |
Gtpbp1 |
GTP binding protein 1 |
76 |
0.92 |
chr7_109191268_109192295 | 85.81 |
Lmo1 |
LIM domain only 1 |
16574 |
0.17 |
chr3_144198270_144199266 | 74.81 |
Gm43445 |
predicted gene 43445 |
494 |
0.79 |
chr6_138582721_138582913 | 62.77 |
Lmo3 |
LIM domain only 3 |
849 |
0.56 |
chr3_55075221_55075624 | 57.47 |
Gm43555 |
predicted gene 43555 |
17766 |
0.13 |
chr3_144174293_144174609 | 54.40 |
Lmo4 |
LIM domain only 4 |
20367 |
0.17 |
chr1_80408527_80409167 | 50.84 |
Gm6189 |
predicted gene 6189 |
23662 |
0.13 |
chr16_72699156_72700074 | 49.63 |
Robo1 |
roundabout guidance receptor 1 |
36411 |
0.24 |
chr6_138424907_138425582 | 44.55 |
Lmo3 |
LIM domain only 3 |
629 |
0.69 |
chr1_86479174_86479713 | 44.14 |
Rpl30-ps6 |
ribosomal protein L30, pseudogene 6 |
5784 |
0.15 |
chr1_12409934_12410455 | 43.57 |
Mir6341 |
microRNA 6341 |
15792 |
0.23 |
chr19_43767999_43768210 | 43.53 |
Cutc |
cutC copper transporter |
3231 |
0.18 |
chr7_109174643_109175577 | 41.40 |
Lmo1 |
LIM domain only 1 |
97 |
0.97 |
chr1_84960126_84960364 | 39.55 |
AC167036.1 |
novel protein |
1263 |
0.35 |
chr5_139681780_139682442 | 37.98 |
Gm42424 |
predicted gene 42424 |
19536 |
0.16 |
chr19_4387351_4387502 | 37.01 |
Kdm2a |
lysine (K)-specific demethylase 2A |
9491 |
0.13 |
chr13_43480925_43481874 | 36.92 |
Ranbp9 |
RAN binding protein 9 |
117 |
0.95 |
chr8_94898997_94899206 | 36.74 |
Ccdc102a |
coiled-coil domain containing 102A |
18420 |
0.1 |
chr2_154765762_154765945 | 36.45 |
Gm14214 |
predicted gene 14214 |
4079 |
0.16 |
chr4_116720426_116721428 | 35.02 |
Tesk2 |
testis-specific kinase 2 |
21 |
0.96 |
chr9_88483752_88484150 | 34.89 |
Syncrip |
synaptotagmin binding, cytoplasmic RNA interacting protein |
1377 |
0.28 |
chr5_66337123_66338408 | 34.50 |
Apbb2 |
amyloid beta (A4) precursor protein-binding, family B, member 2 |
83 |
0.96 |
chr15_82794220_82794587 | 34.33 |
Cyp2d26 |
cytochrome P450, family 2, subfamily d, polypeptide 26 |
109 |
0.93 |
chr6_122590057_122590215 | 34.18 |
Apobec1 |
apolipoprotein B mRNA editing enzyme, catalytic polypeptide 1 |
9991 |
0.1 |
chr19_7605885_7606822 | 33.79 |
Lgals12 |
lectin, galactose binding, soluble 12 |
750 |
0.59 |
chr5_111836465_111837021 | 33.77 |
Gm36535 |
predicted gene, 36535 |
43356 |
0.15 |
chr5_112001700_112002600 | 33.69 |
Gm42488 |
predicted gene 42488 |
57915 |
0.13 |
chr17_21473484_21473684 | 33.24 |
Zfp53 |
zinc finger protein 53 |
15414 |
0.1 |
chr1_184290010_184290162 | 33.17 |
Gm37223 |
predicted gene, 37223 |
68243 |
0.11 |
chr10_61413342_61413765 | 33.03 |
Nodal |
nodal |
4419 |
0.13 |
chr13_23533504_23534327 | 32.77 |
H2ac10 |
H2A clustered histone 10 |
9 |
0.78 |
chr1_21660699_21661216 | 32.71 |
Gm7658 |
predicted gene 7658 |
147901 |
0.04 |
chr8_108703603_108704102 | 32.31 |
Zfhx3 |
zinc finger homeobox 3 |
752 |
0.73 |
chr17_47914586_47915244 | 32.13 |
Gm15556 |
predicted gene 15556 |
7463 |
0.14 |
chr7_4739300_4740219 | 31.32 |
Kmt5c |
lysine methyltransferase 5C |
356 |
0.63 |
chr7_126975552_126976438 | 30.20 |
Cdiptos |
CDIP transferase, opposite strand |
57 |
0.51 |
chr5_60042722_60043044 | 30.17 |
Gm43393 |
predicted gene 43393 |
17000 |
0.17 |
chr11_4094091_4094832 | 29.46 |
Mtfp1 |
mitochondrial fission process 1 |
679 |
0.5 |
chr11_30648868_30649937 | 29.22 |
Acyp2 |
acylphosphatase 2, muscle type |
185 |
0.95 |
chr1_78203643_78204022 | 29.20 |
Pax3 |
paired box 3 |
6698 |
0.23 |
chr8_111312693_111312982 | 28.82 |
Mlkl |
mixed lineage kinase domain-like |
3282 |
0.18 |
chr2_155604522_155604830 | 28.50 |
Myh7b |
myosin, heavy chain 7B, cardiac muscle, beta |
6536 |
0.08 |
chr5_33542035_33542598 | 28.32 |
Fam53a |
family with sequence similarity 53, member A |
86596 |
0.05 |
chr6_73014411_73015031 | 27.65 |
Gm20560 |
predicted gene, 20560 |
2678 |
0.26 |
chr3_122635255_122635465 | 27.65 |
Gm5981 |
predicted gene 5981 |
2089 |
0.24 |
chr11_60537440_60537820 | 27.17 |
Alkbh5 |
alkB homolog 5, RNA demethylase |
348 |
0.76 |
chr11_87056483_87056634 | 27.01 |
Gdpd1 |
glycerophosphodiester phosphodiesterase domain containing 1 |
17504 |
0.1 |
chr14_69007423_69007574 | 26.48 |
Stc1 |
stanniocalcin 1 |
21740 |
0.18 |
chr5_107251776_107252288 | 26.47 |
Gm42900 |
predicted gene 42900 |
4472 |
0.17 |
chr3_52938291_52938546 | 26.43 |
Gm20750 |
predicted gene, 20750 |
10752 |
0.18 |
chr5_115436438_115437458 | 26.20 |
4930430O22Rik |
RIKEN cDNA 4930430O22 gene |
304 |
0.74 |
chr10_13240589_13240802 | 26.11 |
Gm47402 |
predicted gene, 47402 |
35469 |
0.15 |
chr4_97777645_97778418 | 25.88 |
E130114P18Rik |
RIKEN cDNA E130114P18 gene |
17 |
0.72 |
chr16_76319178_76320114 | 25.70 |
Nrip1 |
nuclear receptor interacting protein 1 |
4012 |
0.29 |
chr15_98608664_98610204 | 25.67 |
Adcy6 |
adenylate cyclase 6 |
598 |
0.55 |
chr7_45103031_45103408 | 25.66 |
Fcgrt |
Fc receptor, IgG, alpha chain transporter |
133 |
0.83 |
chr8_41787037_41787444 | 25.56 |
2810404M03Rik |
RIKEN cDNA 2810404M03 gene |
40027 |
0.2 |
chr9_61370339_61371660 | 25.32 |
Gm10655 |
predicted gene 10655 |
628 |
0.63 |
chr11_62978995_62979146 | 25.20 |
Cdrt4os1 |
CMT1A duplicated region transcript 4, opposite strand 1 |
25058 |
0.12 |
chr10_39169764_39170498 | 25.12 |
D030034A15Rik |
RIKEN cDNA D030034A15 gene |
3121 |
0.19 |
chr3_82809967_82810130 | 25.11 |
Gm43348 |
predicted gene 43348 |
2186 |
0.32 |
chr9_108338578_108339700 | 24.92 |
Gpx1 |
glutathione peroxidase 1 |
85 |
0.89 |
chr13_63496923_63497254 | 24.87 |
Fancc |
Fanconi anemia, complementation group C |
190 |
0.93 |
chr7_70331281_70331985 | 24.84 |
Gm29683 |
predicted gene, 29683 |
6189 |
0.14 |
chr8_27058344_27058703 | 24.83 |
Plpbp |
pyridoxal phosphate binding protein |
7749 |
0.11 |
chr19_45208051_45208464 | 24.76 |
Lbx1 |
ladybird homeobox 1 |
27555 |
0.14 |
chr13_62952253_62952404 | 24.74 |
Gm48812 |
predicted gene, 48812 |
2886 |
0.22 |
chr10_94574788_94575101 | 24.70 |
Tmcc3 |
transmembrane and coiled coil domains 3 |
313 |
0.87 |
chr2_170158021_170158172 | 24.67 |
Zfp217 |
zinc finger protein 217 |
9993 |
0.28 |
chr11_35750522_35750899 | 24.65 |
Pank3 |
pantothenate kinase 3 |
18774 |
0.16 |
chr3_150650247_150650464 | 24.58 |
Gm43470 |
predicted gene 43470 |
61537 |
0.15 |
chr13_63230595_63230746 | 24.48 |
Aopep |
aminopeptidase O |
9359 |
0.1 |
chr5_67572619_67572866 | 24.47 |
1700025A08Rik |
RIKEN cDNA 1700025A08 gene |
35084 |
0.11 |
chr6_42363179_42363495 | 24.36 |
2010310C07Rik |
RIKEN cDNA 2010310C07 gene |
7334 |
0.09 |
chr19_38038262_38038413 | 24.26 |
Myof |
myoferlin |
5014 |
0.16 |
chr1_167802317_167803268 | 24.23 |
Lmx1a |
LIM homeobox transcription factor 1 alpha |
113235 |
0.07 |
chr9_71663389_71664022 | 24.20 |
Cgnl1 |
cingulin-like 1 |
15355 |
0.21 |
chr3_127930721_127931028 | 24.19 |
9830132P13Rik |
RIKEN cDNA 9830132P13 gene |
14702 |
0.14 |
chr3_34504199_34504577 | 24.08 |
Gm29135 |
predicted gene 29135 |
22181 |
0.16 |
chr5_67400952_67401103 | 24.07 |
Bend4 |
BEN domain containing 4 |
26303 |
0.11 |
chr1_171438341_171438492 | 24.06 |
F11r |
F11 receptor |
837 |
0.41 |
chr17_56036249_56036917 | 24.05 |
Sh3gl1 |
SH3-domain GRB2-like 1 |
7 |
0.94 |
chr6_72552548_72553107 | 23.97 |
Capg |
capping protein (actin filament), gelsolin-like |
111 |
0.94 |
chr2_170147589_170148059 | 23.65 |
Zfp217 |
zinc finger protein 217 |
279 |
0.95 |
chr12_79674954_79675872 | 23.64 |
9430078K24Rik |
RIKEN cDNA 9430078K24 gene |
249320 |
0.02 |
chr10_80960659_80960810 | 23.55 |
Gm3828 |
predicted gene 3828 |
6024 |
0.1 |
chr12_29698179_29698919 | 23.50 |
C630031E19Rik |
RIKEN cDNA C630031E19 gene |
12104 |
0.29 |
chr17_73014151_73014450 | 23.50 |
Gm30420 |
predicted gene, 30420 |
14778 |
0.2 |
chr6_146981244_146981874 | 23.49 |
Ppfibp1 |
PTPRF interacting protein, binding protein 1 (liprin beta 1) |
5076 |
0.15 |
chr13_63039019_63039172 | 23.44 |
Aopep |
aminopeptidase O |
23602 |
0.15 |
chr15_103086389_103086877 | 23.43 |
Gm28876 |
predicted gene 28876 |
15478 |
0.09 |
chr12_80055509_80055682 | 23.34 |
Gm36660 |
predicted gene, 36660 |
25839 |
0.13 |
chr18_74294664_74294815 | 23.25 |
Cfap53 |
cilia and flagella associated protein 53 |
219 |
0.92 |
chr14_65375154_65375567 | 23.04 |
Zfp395 |
zinc finger protein 395 |
33 |
0.97 |
chr10_125785483_125786054 | 22.96 |
Lrig3 |
leucine-rich repeats and immunoglobulin-like domains 3 |
180400 |
0.03 |
chr16_28419987_28420138 | 22.95 |
Fgf12 |
fibroblast growth factor 12 |
26013 |
0.27 |
chr13_91890302_91890496 | 22.94 |
Ckmt2 |
creatine kinase, mitochondrial 2 |
13514 |
0.2 |
chr8_33672832_33673070 | 22.89 |
Gsr |
glutathione reductase |
3949 |
0.18 |
chr1_184675628_184676155 | 22.81 |
Gm38358 |
predicted gene, 38358 |
19143 |
0.14 |
chr13_80695725_80695888 | 22.80 |
Arrdc3 |
arrestin domain containing 3 |
187578 |
0.03 |
chr5_149152427_149152589 | 22.79 |
Gm8615 |
predicted pseudogene 8615 |
3511 |
0.12 |
chr12_84590377_84590778 | 22.74 |
Abcd4 |
ATP-binding cassette, sub-family D (ALD), member 4 |
13475 |
0.15 |
chr15_56685520_56686076 | 22.66 |
Has2os |
hyaluronan synthase 2, opposite strand |
4146 |
0.27 |
chr5_115977292_115977636 | 22.62 |
Cit |
citron |
9439 |
0.15 |
chr11_17768900_17769081 | 22.52 |
Gm12016 |
predicted gene 12016 |
129807 |
0.05 |
chr1_64087943_64089121 | 22.46 |
Gm13748 |
predicted gene 13748 |
9878 |
0.19 |
chr2_160619427_160619728 | 22.36 |
Gm14221 |
predicted gene 14221 |
394 |
0.83 |
chr15_25498410_25498830 | 22.30 |
Gm48957 |
predicted gene, 48957 |
40131 |
0.14 |
chr17_86301671_86301829 | 22.29 |
2010106C02Rik |
RIKEN cDNA 2010106C02 gene |
14572 |
0.27 |
chr18_87921786_87922162 | 22.27 |
Gm24987 |
predicted gene, 24987 |
3590 |
0.34 |
chr18_56871340_56871513 | 22.06 |
Gm18087 |
predicted gene, 18087 |
44662 |
0.14 |
chr10_21295422_21295685 | 21.94 |
Hbs1l |
Hbs1-like (S. cerevisiae) |
426 |
0.79 |
chr12_108445055_108445500 | 21.87 |
Gm15636 |
predicted gene 15636 |
4007 |
0.23 |
chr3_115660838_115661123 | 21.80 |
S1pr1 |
sphingosine-1-phosphate receptor 1 |
54092 |
0.13 |
chr6_9834968_9835442 | 21.79 |
Gm5110 |
predicted gene 5110 |
337649 |
0.01 |
chr2_167713774_167713925 | 21.68 |
A530013C23Rik |
RIKEN cDNA A530013C23 gene |
22668 |
0.1 |
chr2_169724085_169724254 | 21.68 |
Tshz2 |
teashirt zinc finger family member 2 |
90493 |
0.08 |
chr3_141952957_141953255 | 21.55 |
Bmpr1b |
bone morphogenetic protein receptor, type 1B |
21583 |
0.27 |
chr8_104602539_104603204 | 21.53 |
Cdh16 |
cadherin 16 |
10393 |
0.09 |
chr6_49150791_49151235 | 21.51 |
Gm18010 |
predicted gene, 18010 |
21746 |
0.13 |
chr4_19926174_19926326 | 21.46 |
Atp6v0d2 |
ATPase, H+ transporting, lysosomal V0 subunit D2 |
3645 |
0.26 |
chr11_115833007_115833489 | 21.32 |
Llgl2 |
LLGL2 scribble cell polarity complex component |
677 |
0.52 |
chr5_96162084_96163134 | 21.14 |
Cnot6l |
CCR4-NOT transcription complex, subunit 6-like |
619 |
0.75 |
chr5_134932998_134933165 | 21.08 |
Mettl27 |
methyltransferase like 27 |
297 |
0.75 |
chr2_174291748_174291899 | 21.04 |
Gnasas1 |
GNAS antisense RNA 1 |
3566 |
0.16 |
chr13_43231981_43232458 | 20.92 |
Tbc1d7 |
TBC1 domain family, member 7 |
60718 |
0.11 |
chr16_25293836_25294037 | 20.70 |
Tprg |
transformation related protein 63 regulated |
7115 |
0.32 |
chr3_9573631_9573906 | 20.41 |
Zfp704 |
zinc finger protein 704 |
8469 |
0.25 |
chr18_64182836_64182987 | 20.39 |
St8sia3os |
ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 3, opposite strand |
14107 |
0.15 |
chr8_121127592_121127785 | 20.34 |
Foxl1 |
forkhead box L1 |
252 |
0.88 |
chr2_93008105_93008300 | 20.30 |
Prdm11 |
PR domain containing 11 |
5708 |
0.22 |
chr17_47973531_47974497 | 20.29 |
Gm14871 |
predicted gene 14871 |
29558 |
0.11 |
chr15_76545778_76546051 | 20.27 |
Slc52a2 |
solute carrier protein 52, member 2 |
6950 |
0.07 |
chr18_74810351_74810502 | 20.18 |
Acaa2 |
acetyl-Coenzyme A acyltransferase 2 (mitochondrial 3-oxoacyl-Coenzyme A thiolase) |
17043 |
0.15 |
chr8_109436759_109437295 | 20.02 |
Gm23163 |
predicted gene, 23163 |
11283 |
0.22 |
chr8_79372394_79372598 | 20.02 |
Smad1 |
SMAD family member 1 |
15818 |
0.17 |
chr4_154121558_154121709 | 20.01 |
Trp73 |
transformation related protein 73 |
5028 |
0.13 |
chr5_145635834_145635985 | 19.94 |
Cyp3a63-ps |
cytochrome P450, family 3, subfamily a, member 63, pseudogene |
1916 |
0.29 |
chr2_105769867_105770156 | 19.94 |
Elp4 |
elongator acetyltransferase complex subunit 4 |
44311 |
0.13 |
chr10_13521965_13522177 | 19.92 |
Pex3 |
peroxisomal biogenesis factor 3 |
13890 |
0.17 |
chr4_117682587_117682738 | 19.82 |
Dmap1 |
DNA methyltransferase 1-associated protein 1 |
389 |
0.81 |
chr8_34622313_34622510 | 19.77 |
Gm34096 |
predicted gene, 34096 |
14106 |
0.17 |
chr14_25768987_25769661 | 19.71 |
Zcchc24 |
zinc finger, CCHC domain containing 24 |
285 |
0.88 |
chr4_75212425_75212866 | 19.67 |
Gm12912 |
predicted gene 12912 |
65036 |
0.1 |
chr16_57569043_57569375 | 19.63 |
Filip1l |
filamin A interacting protein 1-like |
19967 |
0.21 |
chr10_4433482_4433825 | 19.63 |
Armt1 |
acidic residue methyltransferase 1 |
928 |
0.39 |
chr3_96875239_96875430 | 19.48 |
Gpr89 |
G protein-coupled receptor 89 |
874 |
0.48 |
chr4_141729612_141729763 | 19.47 |
Ddi2 |
DNA-damage inducible protein 2 |
6268 |
0.13 |
chr4_148085353_148085504 | 19.46 |
Agtrap |
angiotensin II, type I receptor-associated protein |
652 |
0.52 |
chr3_60124259_60124607 | 19.40 |
Gm24382 |
predicted gene, 24382 |
3314 |
0.28 |
chr11_49713043_49713524 | 19.27 |
Cnot6 |
CCR4-NOT transcription complex, subunit 6 |
560 |
0.67 |
chr6_131411592_131411743 | 19.26 |
Gm18688 |
predicted gene, 18688 |
22244 |
0.12 |
chr2_85172390_85172701 | 19.26 |
Gm13713 |
predicted gene 13713 |
11767 |
0.11 |
chr4_132075006_132075723 | 19.19 |
Epb41 |
erythrocyte membrane protein band 4.1 |
43 |
0.91 |
chr11_31830043_31830943 | 19.17 |
Gm12107 |
predicted gene 12107 |
2167 |
0.31 |
chr10_120387024_120387466 | 19.12 |
9230105E05Rik |
RIKEN cDNA 9230105E05 gene |
2278 |
0.28 |
chr1_177475904_177476057 | 19.12 |
Gm37306 |
predicted gene, 37306 |
8602 |
0.17 |
chr6_67161663_67162061 | 19.07 |
A430010J10Rik |
RIKEN cDNA A430010J10 gene |
3062 |
0.22 |
chr3_6887007_6887616 | 19.07 |
Gm22074 |
predicted gene, 22074 |
89957 |
0.09 |
chr12_54985296_54986516 | 19.04 |
Baz1a |
bromodomain adjacent to zinc finger domain 1A |
30 |
0.91 |
chr3_29136074_29136608 | 18.99 |
Gm38029 |
predicted gene, 38029 |
38497 |
0.17 |
chr5_86910820_86911040 | 18.97 |
Ugt2b34 |
UDP glucuronosyltransferase 2 family, polypeptide B34 |
3993 |
0.12 |
chr14_20116064_20116365 | 18.88 |
Saysd1 |
SAYSVFN motif domain containing 1 |
22320 |
0.14 |
chr17_71290525_71291000 | 18.87 |
Emilin2 |
elastin microfibril interfacer 2 |
6485 |
0.15 |
chr8_35996791_35996947 | 18.86 |
Gm22030 |
predicted gene, 22030 |
19291 |
0.18 |
chr11_101791110_101791279 | 18.82 |
Etv4 |
ets variant 4 |
5823 |
0.17 |
chr5_62765571_62765753 | 18.78 |
Arap2 |
ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2 |
458 |
0.87 |
chr1_66862302_66862580 | 18.74 |
Acadl |
acyl-Coenzyme A dehydrogenase, long-chain |
836 |
0.42 |
chr7_114149112_114149263 | 18.72 |
Rras2 |
related RAS viral (r-ras) oncogene 2 |
31406 |
0.17 |
chr4_71306835_71307025 | 18.71 |
Gm11229 |
predicted gene 11229 |
20988 |
0.25 |
chr9_65217162_65217313 | 18.57 |
Parp16 |
poly (ADP-ribose) polymerase family, member 16 |
2083 |
0.21 |
chr2_134350455_134350845 | 18.56 |
Hao1 |
hydroxyacid oxidase 1, liver |
203657 |
0.03 |
chr4_134773043_134773241 | 18.52 |
Ldlrap1 |
low density lipoprotein receptor adaptor protein 1 |
5118 |
0.21 |
chr8_20817574_20818579 | 18.41 |
Gm20946 |
predicted gene, 20946 |
10277 |
0.15 |
chr8_57331592_57331743 | 18.37 |
5033428I22Rik |
RIKEN cDNA 5033428I22 gene |
451 |
0.73 |
chrX_114816403_114816592 | 18.32 |
Gm14897 |
predicted gene 14897 |
41390 |
0.14 |
chr18_38524125_38524316 | 18.28 |
Gm50349 |
predicted gene, 50349 |
42917 |
0.11 |
chr8_128688109_128688260 | 18.26 |
Itgb1 |
integrin beta 1 (fibronectin receptor beta) |
2314 |
0.29 |
chr7_145179623_145180137 | 18.25 |
Gm45181 |
predicted gene 45181 |
16884 |
0.2 |
chr9_70935136_70935406 | 18.24 |
Lipc |
lipase, hepatic |
463 |
0.83 |
chr19_38356392_38356694 | 18.21 |
Gm50150 |
predicted gene, 50150 |
13929 |
0.14 |
chr5_115854472_115854630 | 18.12 |
Cit |
citron |
3573 |
0.2 |
chr4_84637418_84637684 | 18.11 |
Bnc2 |
basonuclin 2 |
37445 |
0.19 |
chr2_167721600_167721763 | 18.07 |
A530013C23Rik |
RIKEN cDNA A530013C23 gene |
30500 |
0.1 |
chr7_90059784_90060230 | 18.06 |
Gm44861 |
predicted gene 44861 |
17310 |
0.12 |
chr6_90360055_90360850 | 18.01 |
Zxdc |
ZXD family zinc finger C |
9040 |
0.11 |
chr4_56831175_56831326 | 18.00 |
Ctnnal1 |
catenin (cadherin associated protein), alpha-like 1 |
1397 |
0.35 |
chr12_91383684_91384259 | 17.97 |
Cep128 |
centrosomal protein 128 |
382 |
0.63 |
chr17_46104525_46104933 | 17.97 |
Mrps18a |
mitochondrial ribosomal protein S18A |
6257 |
0.12 |
chr6_135276607_135276767 | 17.95 |
Gm36640 |
predicted gene, 36640 |
12672 |
0.12 |
chr18_56870554_56870904 | 17.91 |
Gm18087 |
predicted gene, 18087 |
45359 |
0.14 |
chr18_3005171_3005609 | 17.87 |
Gm50072 |
predicted gene, 50072 |
10518 |
0.21 |
chr1_162020499_162020732 | 17.79 |
2810442N19Rik |
RIKEN cDNA 2810442N19 gene |
15443 |
0.14 |
chr16_95382153_95382455 | 17.79 |
Gm31641 |
predicted gene, 31641 |
26628 |
0.2 |
chr10_69253249_69253618 | 17.73 |
Rhobtb1 |
Rho-related BTB domain containing 1 |
12204 |
0.19 |
chr5_132074744_132075423 | 17.73 |
Auts2 |
autism susceptibility candidate 2 |
24674 |
0.16 |
chr4_128695309_128695460 | 17.70 |
Phc2 |
polyhomeotic 2 |
6589 |
0.2 |
chr8_128350517_128350668 | 17.64 |
Nrp1 |
neuropilin 1 |
8012 |
0.23 |
chr3_157732464_157732921 | 17.59 |
Gm33466 |
predicted gene, 33466 |
6284 |
0.26 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
13.8 | 55.2 | GO:0046013 | regulation of T cell homeostatic proliferation(GO:0046013) |
8.5 | 25.6 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
7.7 | 23.1 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
7.0 | 21.1 | GO:0035513 | oxidative RNA demethylation(GO:0035513) oxidative single-stranded RNA demethylation(GO:0035553) |
6.1 | 18.3 | GO:0061146 | Peyer's patch morphogenesis(GO:0061146) |
5.9 | 29.5 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
5.4 | 16.1 | GO:2000828 | regulation of parathyroid hormone secretion(GO:2000828) |
5.2 | 10.3 | GO:0021823 | cerebral cortex tangential migration using cell-cell interactions(GO:0021823) postnatal olfactory bulb interneuron migration(GO:0021827) |
4.9 | 24.5 | GO:0060480 | lung goblet cell differentiation(GO:0060480) |
4.6 | 106.1 | GO:0061014 | positive regulation of mRNA catabolic process(GO:0061014) |
4.5 | 13.6 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
4.4 | 13.3 | GO:0090365 | regulation of mRNA modification(GO:0090365) |
3.9 | 11.6 | GO:0003347 | epicardial cell to mesenchymal cell transition(GO:0003347) |
3.8 | 15.3 | GO:0034627 | 'de novo' NAD biosynthetic process(GO:0034627) |
3.7 | 22.4 | GO:0034382 | chylomicron remnant clearance(GO:0034382) triglyceride-rich lipoprotein particle clearance(GO:0071830) |
3.7 | 11.1 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
3.7 | 11.0 | GO:1900095 | regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
3.7 | 14.6 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
3.6 | 14.4 | GO:0032417 | positive regulation of sodium:proton antiporter activity(GO:0032417) |
3.2 | 9.7 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
3.2 | 12.7 | GO:0021569 | rhombomere 3 development(GO:0021569) |
3.1 | 22.0 | GO:0060613 | fat pad development(GO:0060613) |
3.1 | 18.6 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
3.0 | 15.2 | GO:1903689 | regulation of wound healing, spreading of epidermal cells(GO:1903689) |
3.0 | 9.0 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
3.0 | 3.0 | GO:0050883 | musculoskeletal movement, spinal reflex action(GO:0050883) |
2.9 | 8.7 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
2.8 | 5.7 | GO:0014873 | response to muscle activity involved in regulation of muscle adaptation(GO:0014873) |
2.8 | 19.4 | GO:0032790 | ribosome disassembly(GO:0032790) |
2.8 | 8.3 | GO:0019254 | carnitine metabolic process, CoA-linked(GO:0019254) |
2.8 | 11.0 | GO:0065001 | specification of axis polarity(GO:0065001) |
2.7 | 5.5 | GO:0090259 | regulation of retinal ganglion cell axon guidance(GO:0090259) |
2.7 | 8.2 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
2.7 | 8.2 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
2.7 | 8.1 | GO:2000834 | androgen secretion(GO:0035935) regulation of androgen secretion(GO:2000834) positive regulation of androgen secretion(GO:2000836) |
2.7 | 40.2 | GO:0043968 | histone H2A acetylation(GO:0043968) |
2.6 | 7.9 | GO:0008050 | female courtship behavior(GO:0008050) |
2.6 | 5.2 | GO:0002840 | T cell mediated immune response to tumor cell(GO:0002424) regulation of T cell mediated immune response to tumor cell(GO:0002840) |
2.6 | 7.7 | GO:0045226 | extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
2.6 | 10.2 | GO:0031999 | negative regulation of fatty acid beta-oxidation(GO:0031999) |
2.5 | 10.2 | GO:0007296 | vitellogenesis(GO:0007296) |
2.5 | 5.1 | GO:1900135 | positive regulation of renin secretion into blood stream(GO:1900135) |
2.5 | 7.5 | GO:0045626 | negative regulation of T-helper 1 cell differentiation(GO:0045626) |
2.5 | 7.5 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
2.5 | 9.9 | GO:0006987 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
2.4 | 9.8 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
2.4 | 2.4 | GO:1904259 | regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904259) positive regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904261) basement membrane assembly involved in embryonic body morphogenesis(GO:2001197) |
2.4 | 12.2 | GO:0072656 | maintenance of protein location in mitochondrion(GO:0072656) |
2.4 | 9.6 | GO:0051031 | tRNA transport(GO:0051031) |
2.4 | 7.1 | GO:0010908 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
2.3 | 16.0 | GO:0035811 | negative regulation of urine volume(GO:0035811) |
2.3 | 6.8 | GO:0060160 | negative regulation of dopamine receptor signaling pathway(GO:0060160) |
2.3 | 6.8 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
2.3 | 4.5 | GO:2000646 | positive regulation of receptor catabolic process(GO:2000646) |
2.2 | 4.5 | GO:0030423 | targeting of mRNA for destruction involved in RNA interference(GO:0030423) siRNA loading onto RISC involved in RNA interference(GO:0035087) |
2.2 | 11.2 | GO:0071918 | urea transmembrane transport(GO:0071918) |
2.2 | 4.4 | GO:0097051 | establishment of protein localization to endoplasmic reticulum membrane(GO:0097051) |
2.2 | 10.9 | GO:2001268 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001268) |
2.2 | 8.7 | GO:0060397 | JAK-STAT cascade involved in growth hormone signaling pathway(GO:0060397) |
2.1 | 4.3 | GO:1900106 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
2.1 | 4.2 | GO:0006578 | amino-acid betaine biosynthetic process(GO:0006578) |
2.1 | 8.5 | GO:0046499 | S-adenosylmethioninamine metabolic process(GO:0046499) |
2.1 | 8.4 | GO:0060696 | regulation of phospholipid catabolic process(GO:0060696) |
2.1 | 6.3 | GO:0090210 | regulation of establishment of blood-brain barrier(GO:0090210) |
2.1 | 6.2 | GO:0072092 | ureteric bud invasion(GO:0072092) |
2.1 | 8.2 | GO:2000562 | negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
2.1 | 10.3 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
2.1 | 6.2 | GO:0070827 | chromatin maintenance(GO:0070827) |
2.0 | 10.2 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
2.0 | 8.2 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
2.0 | 8.1 | GO:0061030 | epithelial cell differentiation involved in mammary gland alveolus development(GO:0061030) |
2.0 | 4.1 | GO:0035054 | embryonic heart tube anterior/posterior pattern specification(GO:0035054) |
2.0 | 6.1 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
2.0 | 8.1 | GO:0032971 | regulation of muscle filament sliding(GO:0032971) |
2.0 | 6.1 | GO:0019676 | ammonia assimilation cycle(GO:0019676) |
2.0 | 30.2 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
2.0 | 6.0 | GO:1990928 | response to amino acid starvation(GO:1990928) |
2.0 | 5.9 | GO:0061626 | pharyngeal arch artery morphogenesis(GO:0061626) |
2.0 | 5.9 | GO:0002432 | granuloma formation(GO:0002432) |
2.0 | 3.9 | GO:0042427 | serotonin biosynthetic process(GO:0042427) primary amino compound biosynthetic process(GO:1901162) |
1.9 | 30.8 | GO:0019430 | removal of superoxide radicals(GO:0019430) |
1.9 | 1.9 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
1.9 | 7.6 | GO:0071286 | cellular response to magnesium ion(GO:0071286) |
1.9 | 47.3 | GO:0030866 | cortical actin cytoskeleton organization(GO:0030866) |
1.9 | 5.7 | GO:0021943 | formation of radial glial scaffolds(GO:0021943) |
1.9 | 5.6 | GO:0048696 | regulation of collateral sprouting in absence of injury(GO:0048696) |
1.9 | 5.6 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
1.8 | 7.4 | GO:0030917 | midbrain-hindbrain boundary development(GO:0030917) |
1.8 | 23.9 | GO:0097286 | iron ion import(GO:0097286) |
1.8 | 5.5 | GO:0060319 | primitive erythrocyte differentiation(GO:0060319) |
1.8 | 5.5 | GO:0021555 | midbrain-hindbrain boundary morphogenesis(GO:0021555) |
1.8 | 20.0 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
1.8 | 9.0 | GO:0010626 | negative regulation of Schwann cell proliferation(GO:0010626) |
1.8 | 7.2 | GO:0061158 | 3'-UTR-mediated mRNA destabilization(GO:0061158) |
1.8 | 7.2 | GO:0051365 | cellular response to potassium ion starvation(GO:0051365) |
1.8 | 12.4 | GO:0031848 | protection from non-homologous end joining at telomere(GO:0031848) |
1.8 | 10.5 | GO:0090336 | positive regulation of brown fat cell differentiation(GO:0090336) |
1.7 | 5.2 | GO:0061535 | glutamate secretion, neurotransmission(GO:0061535) |
1.7 | 10.4 | GO:0060836 | lymphatic endothelial cell differentiation(GO:0060836) |
1.7 | 5.2 | GO:0071635 | negative regulation of transforming growth factor beta production(GO:0071635) |
1.7 | 1.7 | GO:0010643 | cell communication by chemical coupling(GO:0010643) |
1.7 | 74.0 | GO:0045600 | positive regulation of fat cell differentiation(GO:0045600) |
1.7 | 6.9 | GO:0010510 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) |
1.7 | 8.6 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
1.7 | 6.8 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
1.7 | 8.4 | GO:0045964 | positive regulation of catecholamine metabolic process(GO:0045915) positive regulation of dopamine metabolic process(GO:0045964) |
1.7 | 21.5 | GO:0021527 | spinal cord association neuron differentiation(GO:0021527) |
1.6 | 14.4 | GO:0046415 | urate metabolic process(GO:0046415) |
1.6 | 3.2 | GO:0051295 | establishment of meiotic spindle localization(GO:0051295) |
1.6 | 8.0 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
1.6 | 6.4 | GO:0051890 | regulation of cardioblast differentiation(GO:0051890) |
1.6 | 12.7 | GO:0006012 | galactose metabolic process(GO:0006012) |
1.6 | 7.9 | GO:0051987 | positive regulation of attachment of spindle microtubules to kinetochore(GO:0051987) |
1.6 | 6.3 | GO:2000741 | positive regulation of mesenchymal stem cell differentiation(GO:2000741) |
1.6 | 3.1 | GO:0018992 | germ-line sex determination(GO:0018992) |
1.6 | 10.9 | GO:0051764 | actin crosslink formation(GO:0051764) |
1.5 | 1.5 | GO:0032907 | transforming growth factor beta3 production(GO:0032907) regulation of transforming growth factor beta3 production(GO:0032910) |
1.5 | 9.0 | GO:0015871 | choline transport(GO:0015871) |
1.5 | 12.0 | GO:0040016 | embryonic cleavage(GO:0040016) |
1.5 | 1.5 | GO:0016078 | tRNA catabolic process(GO:0016078) |
1.5 | 8.9 | GO:2000675 | negative regulation of type B pancreatic cell apoptotic process(GO:2000675) |
1.5 | 7.4 | GO:0052805 | histidine catabolic process(GO:0006548) imidazole-containing compound catabolic process(GO:0052805) |
1.5 | 7.3 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
1.5 | 2.9 | GO:0090310 | negative regulation of methylation-dependent chromatin silencing(GO:0090310) |
1.5 | 2.9 | GO:0042536 | negative regulation of tumor necrosis factor biosynthetic process(GO:0042536) |
1.5 | 7.3 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
1.4 | 2.9 | GO:0046439 | cysteine catabolic process(GO:0009093) L-cysteine catabolic process(GO:0019448) L-cysteine metabolic process(GO:0046439) |
1.4 | 2.9 | GO:0030865 | cortical cytoskeleton organization(GO:0030865) |
1.4 | 7.1 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) |
1.4 | 7.1 | GO:0042663 | regulation of endodermal cell fate specification(GO:0042663) |
1.4 | 5.7 | GO:0018243 | protein O-linked glycosylation via threonine(GO:0018243) |
1.4 | 5.6 | GO:0060083 | smooth muscle contraction involved in micturition(GO:0060083) |
1.4 | 4.2 | GO:0032485 | regulation of Ral protein signal transduction(GO:0032485) |
1.4 | 4.2 | GO:0045541 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
1.4 | 8.3 | GO:1902916 | positive regulation of protein polyubiquitination(GO:1902916) |
1.3 | 2.7 | GO:0014010 | Schwann cell proliferation(GO:0014010) |
1.3 | 20.1 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
1.3 | 6.7 | GO:0033184 | positive regulation of histone ubiquitination(GO:0033184) |
1.3 | 6.7 | GO:1903242 | regulation of cardiac muscle adaptation(GO:0010612) regulation of cardiac muscle hypertrophy in response to stress(GO:1903242) |
1.3 | 1.3 | GO:2000338 | chemokine (C-X-C motif) ligand 1 production(GO:0072566) regulation of chemokine (C-X-C motif) ligand 1 production(GO:2000338) |
1.3 | 4.0 | GO:0046340 | diacylglycerol catabolic process(GO:0046340) |
1.3 | 13.2 | GO:0032060 | bleb assembly(GO:0032060) |
1.3 | 18.3 | GO:0001502 | cartilage condensation(GO:0001502) cell aggregation(GO:0098743) |
1.3 | 1.3 | GO:0071332 | response to fructose(GO:0009750) cellular response to fructose stimulus(GO:0071332) |
1.3 | 5.2 | GO:1904528 | regulation of microtubule binding(GO:1904526) positive regulation of microtubule binding(GO:1904528) |
1.3 | 7.7 | GO:1902035 | positive regulation of hematopoietic stem cell proliferation(GO:1902035) |
1.3 | 3.9 | GO:0051081 | membrane disassembly(GO:0030397) nuclear envelope disassembly(GO:0051081) |
1.3 | 1.3 | GO:0034140 | negative regulation of toll-like receptor 3 signaling pathway(GO:0034140) |
1.3 | 1.3 | GO:0060576 | intestinal epithelial cell development(GO:0060576) |
1.3 | 3.8 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
1.2 | 6.2 | GO:0034227 | tRNA thio-modification(GO:0034227) |
1.2 | 6.2 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
1.2 | 3.7 | GO:1902255 | positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902255) |
1.2 | 3.7 | GO:1900108 | negative regulation of nodal signaling pathway(GO:1900108) |
1.2 | 6.1 | GO:2000535 | entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
1.2 | 6.1 | GO:1904948 | midbrain dopaminergic neuron differentiation(GO:1904948) |
1.2 | 2.4 | GO:1990705 | cholangiocyte proliferation(GO:1990705) |
1.2 | 2.4 | GO:0051898 | negative regulation of protein kinase B signaling(GO:0051898) |
1.2 | 3.6 | GO:0048859 | formation of anatomical boundary(GO:0048859) |
1.2 | 21.6 | GO:0015986 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
1.2 | 5.9 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
1.2 | 4.7 | GO:0044828 | negative regulation by host of viral genome replication(GO:0044828) |
1.2 | 7.0 | GO:0048012 | hepatocyte growth factor receptor signaling pathway(GO:0048012) |
1.2 | 4.7 | GO:0051790 | short-chain fatty acid biosynthetic process(GO:0051790) |
1.2 | 3.5 | GO:0015772 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
1.2 | 5.8 | GO:0036089 | cleavage furrow formation(GO:0036089) |
1.2 | 3.5 | GO:0061356 | Wnt protein secretion(GO:0061355) regulation of Wnt protein secretion(GO:0061356) |
1.1 | 1.1 | GO:0072205 | metanephric collecting duct development(GO:0072205) |
1.1 | 6.9 | GO:0075522 | IRES-dependent viral translational initiation(GO:0075522) |
1.1 | 4.6 | GO:0072675 | osteoclast fusion(GO:0072675) |
1.1 | 4.5 | GO:2000504 | positive regulation of blood vessel remodeling(GO:2000504) |
1.1 | 1.1 | GO:0048566 | embryonic digestive tract development(GO:0048566) |
1.1 | 4.5 | GO:0045630 | positive regulation of T-helper 2 cell differentiation(GO:0045630) |
1.1 | 1.1 | GO:0003179 | heart valve morphogenesis(GO:0003179) |
1.1 | 8.9 | GO:0001778 | plasma membrane repair(GO:0001778) |
1.1 | 5.6 | GO:0006545 | glycine biosynthetic process(GO:0006545) |
1.1 | 3.3 | GO:0035795 | negative regulation of mitochondrial membrane permeability(GO:0035795) |
1.1 | 8.7 | GO:0051895 | negative regulation of focal adhesion assembly(GO:0051895) |
1.1 | 3.3 | GO:0008054 | negative regulation of cyclin-dependent protein serine/threonine kinase by cyclin degradation(GO:0008054) |
1.1 | 1.1 | GO:0072191 | ureter smooth muscle development(GO:0072191) ureter smooth muscle cell differentiation(GO:0072193) |
1.1 | 3.2 | GO:0032439 | endosome localization(GO:0032439) |
1.1 | 4.3 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
1.1 | 3.2 | GO:0003383 | apical constriction(GO:0003383) |
1.1 | 3.2 | GO:0051771 | negative regulation of nitric-oxide synthase biosynthetic process(GO:0051771) |
1.1 | 1.1 | GO:0055118 | negative regulation of cardiac muscle contraction(GO:0055118) |
1.1 | 2.1 | GO:0051572 | negative regulation of histone H3-K4 methylation(GO:0051572) |
1.1 | 6.4 | GO:0002441 | histamine production involved in inflammatory response(GO:0002349) histamine secretion involved in inflammatory response(GO:0002441) histamine secretion by mast cell(GO:0002553) |
1.1 | 6.3 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
1.1 | 5.3 | GO:2000389 | regulation of neutrophil extravasation(GO:2000389) positive regulation of neutrophil extravasation(GO:2000391) |
1.1 | 3.2 | GO:0017187 | peptidyl-glutamic acid carboxylation(GO:0017187) |
1.0 | 12.5 | GO:0097320 | membrane tubulation(GO:0097320) |
1.0 | 2.1 | GO:0031296 | B cell costimulation(GO:0031296) |
1.0 | 1.0 | GO:0086011 | membrane repolarization during action potential(GO:0086011) regulation of membrane repolarization during action potential(GO:0098903) |
1.0 | 2.1 | GO:0014057 | positive regulation of acetylcholine secretion, neurotransmission(GO:0014057) |
1.0 | 4.1 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
1.0 | 15.5 | GO:0070328 | acylglycerol homeostasis(GO:0055090) triglyceride homeostasis(GO:0070328) |
1.0 | 2.1 | GO:1901078 | negative regulation of relaxation of muscle(GO:1901078) |
1.0 | 11.3 | GO:0038166 | angiotensin-activated signaling pathway(GO:0038166) |
1.0 | 49.2 | GO:0070373 | negative regulation of ERK1 and ERK2 cascade(GO:0070373) |
1.0 | 3.1 | GO:0016237 | lysosomal microautophagy(GO:0016237) piecemeal microautophagy of nucleus(GO:0034727) late nucleophagy(GO:0044805) |
1.0 | 6.1 | GO:0033689 | negative regulation of osteoblast proliferation(GO:0033689) |
1.0 | 3.0 | GO:0032474 | otolith morphogenesis(GO:0032474) |
1.0 | 4.0 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
1.0 | 3.0 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
1.0 | 4.0 | GO:0072592 | oxygen metabolic process(GO:0072592) |
1.0 | 8.0 | GO:0070131 | positive regulation of mitochondrial translation(GO:0070131) |
1.0 | 4.9 | GO:0015879 | carnitine transport(GO:0015879) |
1.0 | 3.9 | GO:0006742 | NADP catabolic process(GO:0006742) |
1.0 | 3.0 | GO:0006393 | termination of mitochondrial transcription(GO:0006393) |
1.0 | 5.9 | GO:0070327 | thyroid hormone transport(GO:0070327) |
1.0 | 7.8 | GO:0048199 | vesicle targeting, to, from or within Golgi(GO:0048199) |
1.0 | 2.9 | GO:0034436 | glycoprotein transport(GO:0034436) |
1.0 | 9.8 | GO:0010867 | positive regulation of triglyceride biosynthetic process(GO:0010867) |
1.0 | 1.0 | GO:0032847 | regulation of cellular pH reduction(GO:0032847) |
1.0 | 1.0 | GO:0003419 | growth plate cartilage chondrocyte proliferation(GO:0003419) |
1.0 | 3.9 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
1.0 | 13.6 | GO:0043486 | histone exchange(GO:0043486) |
1.0 | 9.7 | GO:0035278 | miRNA mediated inhibition of translation(GO:0035278) |
1.0 | 11.5 | GO:0014733 | regulation of skeletal muscle adaptation(GO:0014733) |
1.0 | 3.8 | GO:0051639 | actin filament network formation(GO:0051639) |
1.0 | 1.9 | GO:0050955 | thermoception(GO:0050955) |
1.0 | 5.7 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.9 | 16.1 | GO:0042572 | retinol metabolic process(GO:0042572) |
0.9 | 1.9 | GO:0009756 | carbohydrate mediated signaling(GO:0009756) hexose mediated signaling(GO:0009757) sugar mediated signaling pathway(GO:0010182) glucose mediated signaling pathway(GO:0010255) |
0.9 | 5.7 | GO:0015671 | oxygen transport(GO:0015671) |
0.9 | 9.4 | GO:0006107 | oxaloacetate metabolic process(GO:0006107) |
0.9 | 2.8 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
0.9 | 2.8 | GO:2000525 | regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
0.9 | 5.6 | GO:0030718 | germ-line stem cell population maintenance(GO:0030718) |
0.9 | 7.4 | GO:0006000 | fructose metabolic process(GO:0006000) |
0.9 | 4.6 | GO:0009446 | putrescine biosynthetic process(GO:0009446) |
0.9 | 6.4 | GO:0035999 | tetrahydrofolate interconversion(GO:0035999) |
0.9 | 1.8 | GO:0060926 | cardiac pacemaker cell differentiation(GO:0060920) cardiac pacemaker cell development(GO:0060926) |
0.9 | 7.3 | GO:0033623 | regulation of integrin activation(GO:0033623) |
0.9 | 2.7 | GO:1902219 | intrinsic apoptotic signaling pathway in response to osmotic stress(GO:0008627) regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902218) negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
0.9 | 0.9 | GO:0072050 | S-shaped body morphogenesis(GO:0072050) |
0.9 | 2.7 | GO:0060268 | negative regulation of respiratory burst involved in inflammatory response(GO:0060266) negative regulation of respiratory burst(GO:0060268) |
0.9 | 1.8 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.9 | 3.6 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.9 | 0.9 | GO:0060318 | definitive erythrocyte differentiation(GO:0060318) |
0.9 | 25.9 | GO:0050994 | regulation of lipid catabolic process(GO:0050994) |
0.9 | 7.1 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.9 | 1.8 | GO:0030576 | Cajal body organization(GO:0030576) |
0.9 | 0.9 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
0.9 | 0.9 | GO:1902075 | cellular response to salt(GO:1902075) |
0.9 | 5.3 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
0.9 | 1.8 | GO:0042759 | long-chain fatty acid biosynthetic process(GO:0042759) |
0.9 | 3.5 | GO:0043097 | pyrimidine-containing compound salvage(GO:0008655) pyrimidine nucleoside salvage(GO:0043097) |
0.9 | 0.9 | GO:0006059 | hexitol metabolic process(GO:0006059) |
0.9 | 1.8 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
0.9 | 3.5 | GO:0010991 | negative regulation of SMAD protein complex assembly(GO:0010991) |
0.9 | 1.8 | GO:0030953 | astral microtubule organization(GO:0030953) |
0.9 | 7.0 | GO:0042574 | retinal metabolic process(GO:0042574) |
0.9 | 0.9 | GO:0038180 | nerve growth factor signaling pathway(GO:0038180) |
0.9 | 11.3 | GO:0051446 | positive regulation of meiotic cell cycle(GO:0051446) |
0.9 | 0.9 | GO:0006549 | isoleucine metabolic process(GO:0006549) |
0.9 | 4.3 | GO:0071313 | cellular response to caffeine(GO:0071313) cellular response to purine-containing compound(GO:0071415) |
0.9 | 0.9 | GO:0060978 | angiogenesis involved in coronary vascular morphogenesis(GO:0060978) |
0.9 | 2.6 | GO:0021699 | cerebellar cortex maturation(GO:0021699) |
0.9 | 3.4 | GO:1900194 | negative regulation of oocyte maturation(GO:1900194) |
0.9 | 4.3 | GO:1900025 | negative regulation of substrate adhesion-dependent cell spreading(GO:1900025) |
0.9 | 2.6 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
0.9 | 0.9 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
0.8 | 1.7 | GO:0032696 | negative regulation of interleukin-13 production(GO:0032696) |
0.8 | 1.7 | GO:0035787 | cell migration involved in kidney development(GO:0035787) |
0.8 | 1.7 | GO:0015838 | amino-acid betaine transport(GO:0015838) |
0.8 | 3.3 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
0.8 | 0.8 | GO:0071033 | nuclear retention of pre-mRNA at the site of transcription(GO:0071033) |
0.8 | 1.7 | GO:2000587 | regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000586) negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
0.8 | 2.5 | GO:0048295 | positive regulation of isotype switching to IgE isotypes(GO:0048295) |
0.8 | 1.7 | GO:0000966 | RNA 5'-end processing(GO:0000966) |
0.8 | 1.7 | GO:2001271 | negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
0.8 | 4.1 | GO:0006207 | 'de novo' pyrimidine nucleobase biosynthetic process(GO:0006207) pyrimidine nucleobase biosynthetic process(GO:0019856) |
0.8 | 1.6 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) |
0.8 | 0.8 | GO:0098902 | regulation of membrane depolarization during action potential(GO:0098902) |
0.8 | 3.3 | GO:0033632 | regulation of cell-cell adhesion mediated by integrin(GO:0033632) |
0.8 | 8.2 | GO:1900745 | positive regulation of p38MAPK cascade(GO:1900745) |
0.8 | 2.4 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.8 | 4.9 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
0.8 | 0.8 | GO:0003278 | apoptotic process involved in heart morphogenesis(GO:0003278) |
0.8 | 4.0 | GO:2001260 | regulation of semaphorin-plexin signaling pathway(GO:2001260) |
0.8 | 7.3 | GO:0008535 | respiratory chain complex IV assembly(GO:0008535) |
0.8 | 2.4 | GO:0045654 | positive regulation of megakaryocyte differentiation(GO:0045654) |
0.8 | 3.2 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
0.8 | 4.8 | GO:0045656 | negative regulation of monocyte differentiation(GO:0045656) |
0.8 | 1.6 | GO:0031049 | programmed DNA elimination(GO:0031049) chromosome breakage(GO:0031052) |
0.8 | 3.2 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.8 | 3.2 | GO:0006729 | tetrahydrobiopterin biosynthetic process(GO:0006729) |
0.8 | 6.4 | GO:0061154 | endothelial tube morphogenesis(GO:0061154) |
0.8 | 1.6 | GO:0032792 | negative regulation of CREB transcription factor activity(GO:0032792) |
0.8 | 2.4 | GO:0086046 | membrane depolarization during SA node cell action potential(GO:0086046) |
0.8 | 3.2 | GO:0046322 | negative regulation of fatty acid oxidation(GO:0046322) |
0.8 | 5.5 | GO:0035584 | calcium-mediated signaling using intracellular calcium source(GO:0035584) |
0.8 | 2.4 | GO:0090069 | regulation of ribosome biogenesis(GO:0090069) |
0.8 | 7.1 | GO:0019432 | triglyceride biosynthetic process(GO:0019432) |
0.8 | 3.2 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.8 | 2.4 | GO:0060596 | mammary placode formation(GO:0060596) |
0.8 | 0.8 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
0.8 | 0.8 | GO:0035509 | negative regulation of myosin-light-chain-phosphatase activity(GO:0035509) |
0.8 | 3.1 | GO:0080154 | regulation of fertilization(GO:0080154) |
0.8 | 3.1 | GO:0031508 | chromatin remodeling at centromere(GO:0031055) pericentric heterochromatin assembly(GO:0031508) |
0.8 | 2.3 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
0.8 | 1.6 | GO:0061684 | chaperone-mediated autophagy(GO:0061684) |
0.8 | 6.2 | GO:0008343 | adult feeding behavior(GO:0008343) |
0.8 | 3.9 | GO:0002183 | cytoplasmic translational initiation(GO:0002183) |
0.8 | 19.4 | GO:1902186 | regulation of viral release from host cell(GO:1902186) |
0.8 | 4.7 | GO:0060710 | chorio-allantoic fusion(GO:0060710) |
0.8 | 1.5 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
0.8 | 1.5 | GO:0042222 | interleukin-1 biosynthetic process(GO:0042222) |
0.8 | 3.9 | GO:1904970 | brush border assembly(GO:1904970) |
0.8 | 3.1 | GO:0010761 | fibroblast migration(GO:0010761) |
0.8 | 6.9 | GO:0014912 | negative regulation of smooth muscle cell migration(GO:0014912) |
0.8 | 2.3 | GO:0009169 | ribonucleoside monophosphate catabolic process(GO:0009158) purine ribonucleoside monophosphate catabolic process(GO:0009169) |
0.8 | 1.5 | GO:0072044 | collecting duct development(GO:0072044) |
0.8 | 2.3 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
0.8 | 1.5 | GO:0061055 | myotome development(GO:0061055) |
0.8 | 2.3 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
0.8 | 4.6 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.8 | 1.5 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
0.8 | 3.8 | GO:0032933 | response to sterol depletion(GO:0006991) SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
0.8 | 0.8 | GO:0010572 | positive regulation of platelet activation(GO:0010572) |
0.8 | 2.3 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
0.8 | 0.8 | GO:0060331 | negative regulation of response to interferon-gamma(GO:0060331) negative regulation of interferon-gamma-mediated signaling pathway(GO:0060336) |
0.8 | 1.5 | GO:0051661 | maintenance of centrosome location(GO:0051661) |
0.8 | 2.3 | GO:0019086 | late viral transcription(GO:0019086) |
0.8 | 0.8 | GO:0032898 | neurotrophin production(GO:0032898) |
0.8 | 6.8 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
0.7 | 3.7 | GO:0060391 | positive regulation of SMAD protein import into nucleus(GO:0060391) |
0.7 | 10.4 | GO:0055070 | copper ion homeostasis(GO:0055070) |
0.7 | 1.5 | GO:1903800 | positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
0.7 | 19.3 | GO:0000266 | mitochondrial fission(GO:0000266) |
0.7 | 3.0 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.7 | 7.4 | GO:0045947 | negative regulation of translational initiation(GO:0045947) |
0.7 | 2.2 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
0.7 | 2.9 | GO:0032713 | negative regulation of interleukin-4 production(GO:0032713) |
0.7 | 1.5 | GO:0045041 | protein import into mitochondrial intermembrane space(GO:0045041) |
0.7 | 2.2 | GO:0072386 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.7 | 1.4 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
0.7 | 2.2 | GO:0019346 | homoserine metabolic process(GO:0009092) transsulfuration(GO:0019346) |
0.7 | 1.4 | GO:0045658 | regulation of neutrophil differentiation(GO:0045658) |
0.7 | 1.4 | GO:1990036 | calcium ion import into sarcoplasmic reticulum(GO:1990036) |
0.7 | 2.2 | GO:0001539 | cilium or flagellum-dependent cell motility(GO:0001539) cilium-dependent cell motility(GO:0060285) |
0.7 | 1.4 | GO:0007228 | positive regulation of hh target transcription factor activity(GO:0007228) |
0.7 | 0.7 | GO:0010159 | specification of organ position(GO:0010159) |
0.7 | 1.4 | GO:0070100 | negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
0.7 | 38.7 | GO:0007569 | cell aging(GO:0007569) |
0.7 | 3.6 | GO:0060044 | negative regulation of cardiac muscle cell proliferation(GO:0060044) |
0.7 | 2.1 | GO:0061000 | negative regulation of dendritic spine development(GO:0061000) |
0.7 | 8.6 | GO:0090190 | positive regulation of branching involved in ureteric bud morphogenesis(GO:0090190) |
0.7 | 0.7 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
0.7 | 1.4 | GO:0009786 | regulation of asymmetric cell division(GO:0009786) |
0.7 | 1.4 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
0.7 | 2.1 | GO:0040031 | snRNA modification(GO:0040031) |
0.7 | 2.8 | GO:0046292 | formaldehyde metabolic process(GO:0046292) |
0.7 | 5.0 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
0.7 | 1.4 | GO:0000820 | regulation of glutamine family amino acid metabolic process(GO:0000820) |
0.7 | 0.7 | GO:0003164 | His-Purkinje system development(GO:0003164) |
0.7 | 3.5 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
0.7 | 2.8 | GO:0015886 | heme transport(GO:0015886) |
0.7 | 3.5 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.7 | 1.4 | GO:0036091 | positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
0.7 | 2.1 | GO:0045896 | regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
0.7 | 5.6 | GO:0045943 | positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
0.7 | 3.5 | GO:1900454 | positive regulation of long term synaptic depression(GO:1900454) |
0.7 | 7.0 | GO:0009950 | dorsal/ventral axis specification(GO:0009950) |
0.7 | 0.7 | GO:0061511 | centriole elongation(GO:0061511) |
0.7 | 1.4 | GO:0046813 | receptor-mediated virion attachment to host cell(GO:0046813) |
0.7 | 1.4 | GO:0042754 | negative regulation of circadian rhythm(GO:0042754) |
0.7 | 6.3 | GO:0070269 | pyroptosis(GO:0070269) |
0.7 | 1.4 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
0.7 | 1.4 | GO:0002905 | mature B cell apoptotic process(GO:0002901) regulation of mature B cell apoptotic process(GO:0002905) negative regulation of mature B cell apoptotic process(GO:0002906) |
0.7 | 4.8 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
0.7 | 7.6 | GO:0019985 | translesion synthesis(GO:0019985) |
0.7 | 2.1 | GO:0009794 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
0.7 | 2.8 | GO:0070475 | rRNA base methylation(GO:0070475) |
0.7 | 2.1 | GO:0031947 | negative regulation of glucocorticoid metabolic process(GO:0031944) negative regulation of glucocorticoid biosynthetic process(GO:0031947) |
0.7 | 4.1 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
0.7 | 1.4 | GO:0010566 | regulation of ketone biosynthetic process(GO:0010566) |
0.7 | 2.1 | GO:0045542 | positive regulation of cholesterol biosynthetic process(GO:0045542) positive regulation of cholesterol metabolic process(GO:0090205) |
0.7 | 0.7 | GO:2000860 | positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
0.7 | 0.7 | GO:0002018 | renin-angiotensin regulation of aldosterone production(GO:0002018) |
0.7 | 0.7 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
0.7 | 5.4 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.7 | 3.4 | GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
0.7 | 8.8 | GO:1902624 | positive regulation of neutrophil migration(GO:1902624) |
0.7 | 1.4 | GO:0033210 | leptin-mediated signaling pathway(GO:0033210) |
0.7 | 1.3 | GO:0046104 | thymidine metabolic process(GO:0046104) |
0.7 | 5.4 | GO:0035988 | chondrocyte proliferation(GO:0035988) |
0.7 | 2.0 | GO:0006407 | rRNA export from nucleus(GO:0006407) |
0.7 | 1.3 | GO:0021873 | forebrain neuroblast division(GO:0021873) |
0.7 | 1.3 | GO:0010535 | positive regulation of activation of JAK2 kinase activity(GO:0010535) |
0.7 | 2.0 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
0.7 | 2.6 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
0.7 | 2.6 | GO:0038089 | positive regulation of cell migration by vascular endothelial growth factor signaling pathway(GO:0038089) |
0.7 | 2.0 | GO:2000653 | regulation of genetic imprinting(GO:2000653) |
0.7 | 0.7 | GO:0030539 | male genitalia development(GO:0030539) |
0.7 | 2.6 | GO:1900619 | acetylcholine metabolic process(GO:0008291) acetate ester metabolic process(GO:1900619) |
0.7 | 5.9 | GO:0006670 | sphingosine metabolic process(GO:0006670) |
0.7 | 2.6 | GO:0090274 | positive regulation of somatostatin secretion(GO:0090274) |
0.6 | 0.6 | GO:0071169 | establishment of protein localization to chromatin(GO:0071169) |
0.6 | 4.5 | GO:0071364 | cellular response to epidermal growth factor stimulus(GO:0071364) |
0.6 | 0.6 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
0.6 | 0.6 | GO:0048743 | positive regulation of skeletal muscle fiber development(GO:0048743) |
0.6 | 1.9 | GO:0043578 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
0.6 | 1.9 | GO:0061370 | testosterone biosynthetic process(GO:0061370) |
0.6 | 5.2 | GO:0035563 | positive regulation of chromatin binding(GO:0035563) |
0.6 | 37.4 | GO:0019369 | arachidonic acid metabolic process(GO:0019369) |
0.6 | 1.9 | GO:0018879 | biphenyl metabolic process(GO:0018879) |
0.6 | 25.7 | GO:0061077 | chaperone-mediated protein folding(GO:0061077) |
0.6 | 1.9 | GO:0046490 | isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) isopentenyl diphosphate metabolic process(GO:0046490) |
0.6 | 0.6 | GO:0000375 | RNA splicing, via transesterification reactions(GO:0000375) |
0.6 | 0.6 | GO:2000347 | positive regulation of hepatocyte proliferation(GO:2000347) |
0.6 | 1.9 | GO:0034499 | late endosome to Golgi transport(GO:0034499) |
0.6 | 1.9 | GO:0060390 | regulation of SMAD protein import into nucleus(GO:0060390) |
0.6 | 5.7 | GO:0007288 | sperm axoneme assembly(GO:0007288) |
0.6 | 0.6 | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
0.6 | 3.8 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
0.6 | 1.3 | GO:0090306 | spindle assembly involved in meiosis(GO:0090306) |
0.6 | 3.1 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
0.6 | 1.3 | GO:0072277 | glomerulus vasculature morphogenesis(GO:0072103) glomerular capillary formation(GO:0072104) metanephric glomerulus morphogenesis(GO:0072275) metanephric glomerulus vasculature morphogenesis(GO:0072276) metanephric glomerular capillary formation(GO:0072277) |
0.6 | 13.8 | GO:0090004 | positive regulation of establishment of protein localization to plasma membrane(GO:0090004) |
0.6 | 1.3 | GO:0072672 | neutrophil extravasation(GO:0072672) |
0.6 | 1.9 | GO:2000705 | regulation of dense core granule biogenesis(GO:2000705) |
0.6 | 3.1 | GO:0032367 | intracellular cholesterol transport(GO:0032367) |
0.6 | 0.6 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
0.6 | 1.9 | GO:0006573 | valine metabolic process(GO:0006573) |
0.6 | 5.0 | GO:0031440 | regulation of mRNA 3'-end processing(GO:0031440) |
0.6 | 1.2 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
0.6 | 4.3 | GO:0010801 | negative regulation of peptidyl-threonine phosphorylation(GO:0010801) |
0.6 | 2.5 | GO:0045053 | protein retention in Golgi apparatus(GO:0045053) |
0.6 | 2.5 | GO:0045628 | regulation of T-helper 2 cell differentiation(GO:0045628) |
0.6 | 0.6 | GO:0033159 | negative regulation of protein import into nucleus, translocation(GO:0033159) |
0.6 | 3.1 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.6 | 1.8 | GO:0070989 | oxidative demethylation(GO:0070989) |
0.6 | 1.2 | GO:0006458 | 'de novo' protein folding(GO:0006458) 'de novo' posttranslational protein folding(GO:0051084) |
0.6 | 3.1 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
0.6 | 3.1 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
0.6 | 0.6 | GO:0002314 | germinal center B cell differentiation(GO:0002314) |
0.6 | 1.2 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
0.6 | 9.1 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
0.6 | 3.6 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.6 | 2.4 | GO:0038094 | Fc-gamma receptor signaling pathway(GO:0038094) |
0.6 | 7.3 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
0.6 | 8.5 | GO:0032011 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.6 | 6.0 | GO:0090231 | regulation of spindle checkpoint(GO:0090231) |
0.6 | 4.2 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
0.6 | 0.6 | GO:0009080 | alanine catabolic process(GO:0006524) pyruvate family amino acid catabolic process(GO:0009080) |
0.6 | 17.9 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
0.6 | 0.6 | GO:0035672 | oligopeptide transmembrane transport(GO:0035672) |
0.6 | 0.6 | GO:0030916 | otic vesicle formation(GO:0030916) |
0.6 | 0.6 | GO:1903599 | positive regulation of mitophagy(GO:1903599) |
0.6 | 2.4 | GO:0070286 | axonemal dynein complex assembly(GO:0070286) |
0.6 | 1.8 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
0.6 | 2.9 | GO:0014043 | negative regulation of neuron maturation(GO:0014043) |
0.6 | 0.6 | GO:0071360 | cellular response to exogenous dsRNA(GO:0071360) |
0.6 | 2.3 | GO:0051919 | positive regulation of fibrinolysis(GO:0051919) |
0.6 | 1.2 | GO:0043321 | regulation of natural killer cell degranulation(GO:0043321) |
0.6 | 25.8 | GO:0003341 | cilium movement(GO:0003341) |
0.6 | 1.8 | GO:0035166 | post-embryonic hemopoiesis(GO:0035166) |
0.6 | 0.6 | GO:1903371 | regulation of endoplasmic reticulum tubular network organization(GO:1903371) |
0.6 | 3.5 | GO:0006621 | protein retention in ER lumen(GO:0006621) |
0.6 | 1.2 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
0.6 | 0.6 | GO:0051775 | response to redox state(GO:0051775) |
0.6 | 0.6 | GO:0030260 | entry into host cell(GO:0030260) entry into host(GO:0044409) entry into cell of other organism involved in symbiotic interaction(GO:0051806) entry into other organism involved in symbiotic interaction(GO:0051828) |
0.6 | 1.2 | GO:0060591 | chondroblast differentiation(GO:0060591) |
0.6 | 5.7 | GO:0031954 | positive regulation of protein autophosphorylation(GO:0031954) |
0.6 | 17.8 | GO:0007052 | mitotic spindle organization(GO:0007052) |
0.6 | 4.0 | GO:0043489 | RNA stabilization(GO:0043489) |
0.6 | 1.1 | GO:0002741 | positive regulation of cytokine secretion involved in immune response(GO:0002741) |
0.6 | 1.1 | GO:2000402 | negative regulation of lymphocyte migration(GO:2000402) |
0.6 | 2.3 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
0.6 | 0.6 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
0.6 | 2.3 | GO:0010528 | regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
0.6 | 1.7 | GO:0090031 | positive regulation of steroid hormone biosynthetic process(GO:0090031) |
0.6 | 0.6 | GO:0009157 | deoxyribonucleoside monophosphate biosynthetic process(GO:0009157) pyrimidine deoxyribonucleoside monophosphate biosynthetic process(GO:0009177) |
0.6 | 1.7 | GO:0018158 | protein oxidation(GO:0018158) |
0.6 | 0.6 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
0.6 | 1.1 | GO:0070669 | response to interleukin-2(GO:0070669) |
0.6 | 3.4 | GO:0007097 | nuclear migration(GO:0007097) |
0.6 | 5.6 | GO:0006301 | postreplication repair(GO:0006301) |
0.6 | 4.5 | GO:0035025 | positive regulation of Rho protein signal transduction(GO:0035025) |
0.6 | 0.6 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
0.6 | 7.8 | GO:0010824 | regulation of centrosome duplication(GO:0010824) |
0.6 | 1.1 | GO:0042832 | defense response to protozoan(GO:0042832) |
0.6 | 3.9 | GO:0045955 | negative regulation of calcium ion-dependent exocytosis(GO:0045955) |
0.6 | 1.7 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
0.5 | 15.4 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
0.5 | 1.1 | GO:0007525 | somatic muscle development(GO:0007525) |
0.5 | 2.7 | GO:0009052 | pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
0.5 | 3.8 | GO:0030575 | nuclear body organization(GO:0030575) |
0.5 | 7.6 | GO:0006693 | prostanoid metabolic process(GO:0006692) prostaglandin metabolic process(GO:0006693) |
0.5 | 1.1 | GO:0032927 | positive regulation of activin receptor signaling pathway(GO:0032927) |
0.5 | 2.2 | GO:0051255 | spindle midzone assembly(GO:0051255) |
0.5 | 0.5 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
0.5 | 2.7 | GO:0051013 | microtubule severing(GO:0051013) |
0.5 | 6.5 | GO:0060261 | positive regulation of transcription initiation from RNA polymerase II promoter(GO:0060261) |
0.5 | 0.5 | GO:1902894 | negative regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902894) |
0.5 | 2.7 | GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
0.5 | 1.1 | GO:0010603 | regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
0.5 | 2.7 | GO:0002097 | tRNA wobble base modification(GO:0002097) |
0.5 | 2.1 | GO:1901660 | calcium ion export(GO:1901660) |
0.5 | 1.6 | GO:0001712 | ectodermal cell fate commitment(GO:0001712) |
0.5 | 2.6 | GO:0001842 | neural fold formation(GO:0001842) |
0.5 | 1.1 | GO:0061144 | alveolar secondary septum development(GO:0061144) |
0.5 | 2.6 | GO:0035372 | protein localization to microtubule(GO:0035372) |
0.5 | 3.7 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
0.5 | 2.6 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.5 | 0.5 | GO:0001705 | ectoderm formation(GO:0001705) |
0.5 | 2.1 | GO:0045653 | negative regulation of megakaryocyte differentiation(GO:0045653) |
0.5 | 3.1 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
0.5 | 1.0 | GO:0061091 | regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
0.5 | 3.7 | GO:0002591 | positive regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002591) |
0.5 | 1.0 | GO:2001025 | positive regulation of response to drug(GO:2001025) |
0.5 | 1.0 | GO:0042637 | catagen(GO:0042637) |
0.5 | 2.1 | GO:0060351 | cartilage development involved in endochondral bone morphogenesis(GO:0060351) |
0.5 | 1.6 | GO:0060502 | epithelial cell proliferation involved in lung morphogenesis(GO:0060502) |
0.5 | 1.6 | GO:0045901 | positive regulation of translational elongation(GO:0045901) |
0.5 | 11.4 | GO:0006688 | glycosphingolipid biosynthetic process(GO:0006688) |
0.5 | 1.6 | GO:0046600 | negative regulation of centriole replication(GO:0046600) |
0.5 | 1.0 | GO:0038027 | apolipoprotein A-I-mediated signaling pathway(GO:0038027) |
0.5 | 0.5 | GO:0060535 | trachea cartilage morphogenesis(GO:0060535) |
0.5 | 1.5 | GO:0099558 | maintenance of synapse structure(GO:0099558) |
0.5 | 2.0 | GO:0060405 | regulation of penile erection(GO:0060405) |
0.5 | 1.0 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
0.5 | 9.7 | GO:0051452 | intracellular pH reduction(GO:0051452) |
0.5 | 1.0 | GO:2001245 | regulation of phosphatidylcholine biosynthetic process(GO:2001245) |
0.5 | 0.5 | GO:1902969 | mitotic DNA replication(GO:1902969) |
0.5 | 6.1 | GO:0050774 | negative regulation of dendrite morphogenesis(GO:0050774) |
0.5 | 1.0 | GO:0051315 | attachment of mitotic spindle microtubules to kinetochore(GO:0051315) |
0.5 | 6.1 | GO:0045736 | negative regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045736) negative regulation of cyclin-dependent protein kinase activity(GO:1904030) |
0.5 | 0.5 | GO:0045875 | negative regulation of sister chromatid cohesion(GO:0045875) |
0.5 | 2.5 | GO:0036010 | protein localization to endosome(GO:0036010) |
0.5 | 4.1 | GO:0006855 | drug transmembrane transport(GO:0006855) |
0.5 | 6.1 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
0.5 | 1.0 | GO:0003241 | growth involved in heart morphogenesis(GO:0003241) |
0.5 | 5.1 | GO:2000257 | regulation of complement activation(GO:0030449) regulation of protein activation cascade(GO:2000257) |
0.5 | 1.0 | GO:0045046 | peroxisomal membrane transport(GO:0015919) protein import into peroxisome membrane(GO:0045046) |
0.5 | 2.5 | GO:0038083 | peptidyl-tyrosine autophosphorylation(GO:0038083) |
0.5 | 0.5 | GO:0071926 | cannabinoid signaling pathway(GO:0038171) endocannabinoid signaling pathway(GO:0071926) |
0.5 | 1.5 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.5 | 2.0 | GO:0000237 | leptotene(GO:0000237) |
0.5 | 8.0 | GO:0070207 | protein homotrimerization(GO:0070207) |
0.5 | 2.0 | GO:0002225 | positive regulation of antimicrobial peptide production(GO:0002225) positive regulation of antibacterial peptide production(GO:0002803) |
0.5 | 1.0 | GO:0044650 | virion attachment to host cell(GO:0019062) adhesion of symbiont to host cell(GO:0044650) |
0.5 | 1.0 | GO:2000686 | regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
0.5 | 0.5 | GO:1901836 | regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901836) |
0.5 | 6.0 | GO:0060612 | adipose tissue development(GO:0060612) |
0.5 | 1.0 | GO:0006591 | ornithine metabolic process(GO:0006591) |
0.5 | 10.4 | GO:0051298 | centrosome duplication(GO:0051298) |
0.5 | 2.5 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
0.5 | 3.0 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
0.5 | 1.5 | GO:0006768 | biotin metabolic process(GO:0006768) |
0.5 | 0.5 | GO:1901534 | positive regulation of hematopoietic progenitor cell differentiation(GO:1901534) |
0.5 | 1.5 | GO:0031468 | nuclear envelope reassembly(GO:0031468) |
0.5 | 2.0 | GO:0042487 | regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
0.5 | 1.5 | GO:0019230 | proprioception(GO:0019230) |
0.5 | 1.5 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.5 | 1.5 | GO:0051657 | maintenance of organelle location(GO:0051657) |
0.5 | 0.5 | GO:0002019 | regulation of renal output by angiotensin(GO:0002019) |
0.5 | 5.9 | GO:0006465 | signal peptide processing(GO:0006465) |
0.5 | 2.4 | GO:0051894 | positive regulation of focal adhesion assembly(GO:0051894) positive regulation of cell junction assembly(GO:1901890) |
0.5 | 1.9 | GO:0044827 | modulation by host of viral genome replication(GO:0044827) |
0.5 | 3.9 | GO:0070897 | DNA-templated transcriptional preinitiation complex assembly(GO:0070897) |
0.5 | 4.4 | GO:2000649 | regulation of sodium ion transmembrane transporter activity(GO:2000649) |
0.5 | 1.0 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
0.5 | 14.0 | GO:0000462 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) |
0.5 | 0.5 | GO:2000384 | regulation of ectoderm development(GO:2000383) negative regulation of ectoderm development(GO:2000384) |
0.5 | 3.9 | GO:0046686 | response to cadmium ion(GO:0046686) |
0.5 | 2.4 | GO:0090043 | regulation of tubulin deacetylation(GO:0090043) |
0.5 | 1.0 | GO:0002215 | defense response to nematode(GO:0002215) |
0.5 | 3.9 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.5 | 1.0 | GO:0070459 | prolactin secretion(GO:0070459) |
0.5 | 1.9 | GO:0044845 | cell wall mannoprotein biosynthetic process(GO:0000032) mannoprotein metabolic process(GO:0006056) mannoprotein biosynthetic process(GO:0006057) cell wall glycoprotein biosynthetic process(GO:0031506) cell wall biogenesis(GO:0042546) cell wall macromolecule biosynthetic process(GO:0044038) chain elongation of O-linked mannose residue(GO:0044845) cellular component macromolecule biosynthetic process(GO:0070589) |
0.5 | 0.5 | GO:0045348 | positive regulation of MHC class II biosynthetic process(GO:0045348) |
0.5 | 0.5 | GO:0060300 | regulation of cytokine activity(GO:0060300) |
0.5 | 0.5 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
0.5 | 1.0 | GO:0042737 | drug catabolic process(GO:0042737) |
0.5 | 8.1 | GO:1903861 | regulation of dendrite extension(GO:1903859) positive regulation of dendrite extension(GO:1903861) |
0.5 | 0.5 | GO:0033598 | mammary gland epithelial cell proliferation(GO:0033598) |
0.5 | 1.0 | GO:0042160 | lipoprotein modification(GO:0042160) lipoprotein oxidation(GO:0042161) |
0.5 | 1.4 | GO:0040034 | regulation of development, heterochronic(GO:0040034) |
0.5 | 0.9 | GO:0051799 | negative regulation of hair follicle development(GO:0051799) |
0.5 | 1.9 | GO:0043415 | positive regulation of skeletal muscle tissue regeneration(GO:0043415) |
0.5 | 0.9 | GO:0000710 | meiotic mismatch repair(GO:0000710) |
0.5 | 0.5 | GO:0042525 | tyrosine phosphorylation of Stat6 protein(GO:0042505) regulation of tyrosine phosphorylation of Stat6 protein(GO:0042525) |
0.5 | 0.5 | GO:0043084 | penile erection(GO:0043084) |
0.5 | 9.4 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
0.5 | 3.8 | GO:0000467 | exonucleolytic trimming involved in rRNA processing(GO:0000459) exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000467) |
0.5 | 1.4 | GO:0045636 | positive regulation of melanocyte differentiation(GO:0045636) |
0.5 | 0.9 | GO:0001921 | positive regulation of receptor recycling(GO:0001921) |
0.5 | 0.9 | GO:0045409 | negative regulation of interleukin-6 biosynthetic process(GO:0045409) |
0.5 | 23.0 | GO:0030048 | actin filament-based movement(GO:0030048) |
0.5 | 2.3 | GO:0021702 | cerebellar Purkinje cell differentiation(GO:0021702) |
0.5 | 0.5 | GO:1900368 | regulation of RNA interference(GO:1900368) |
0.5 | 5.1 | GO:0035873 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
0.5 | 1.4 | GO:1904995 | negative regulation of leukocyte tethering or rolling(GO:1903237) negative regulation of leukocyte adhesion to vascular endothelial cell(GO:1904995) |
0.5 | 2.3 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
0.5 | 2.3 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.5 | 6.5 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
0.5 | 6.5 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
0.5 | 1.4 | GO:0046543 | development of secondary female sexual characteristics(GO:0046543) |
0.5 | 1.4 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.5 | 7.8 | GO:0070830 | bicellular tight junction assembly(GO:0070830) |
0.5 | 1.4 | GO:2000643 | positive regulation of early endosome to late endosome transport(GO:2000643) |
0.5 | 0.9 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.5 | 5.5 | GO:0070166 | enamel mineralization(GO:0070166) |
0.5 | 2.8 | GO:0045648 | positive regulation of erythrocyte differentiation(GO:0045648) |
0.5 | 25.2 | GO:0035023 | regulation of Rho protein signal transduction(GO:0035023) |
0.5 | 0.9 | GO:0035358 | regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035358) |
0.5 | 2.3 | GO:0009048 | dosage compensation(GO:0007549) dosage compensation by inactivation of X chromosome(GO:0009048) |
0.5 | 0.9 | GO:0033686 | positive regulation of luteinizing hormone secretion(GO:0033686) |
0.5 | 1.4 | GO:0060087 | relaxation of vascular smooth muscle(GO:0060087) |
0.5 | 18.6 | GO:0031338 | regulation of vesicle fusion(GO:0031338) |
0.5 | 1.4 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
0.5 | 2.3 | GO:0071378 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
0.4 | 9.9 | GO:0046580 | negative regulation of Ras protein signal transduction(GO:0046580) negative regulation of small GTPase mediated signal transduction(GO:0051058) |
0.4 | 0.4 | GO:0050819 | negative regulation of coagulation(GO:0050819) |
0.4 | 0.4 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.4 | 0.4 | GO:0014016 | neuroblast differentiation(GO:0014016) response to folic acid(GO:0051593) |
0.4 | 1.8 | GO:0034434 | steroid esterification(GO:0034433) sterol esterification(GO:0034434) cholesterol esterification(GO:0034435) |
0.4 | 0.9 | GO:1904058 | positive regulation of sensory perception of pain(GO:1904058) |
0.4 | 2.7 | GO:0060628 | regulation of ER to Golgi vesicle-mediated transport(GO:0060628) |
0.4 | 2.2 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
0.4 | 1.8 | GO:0043173 | nucleotide salvage(GO:0043173) |
0.4 | 0.4 | GO:2000767 | positive regulation of cytoplasmic translation(GO:2000767) |
0.4 | 0.9 | GO:0001880 | Mullerian duct regression(GO:0001880) |
0.4 | 0.4 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
0.4 | 5.3 | GO:0071353 | response to interleukin-4(GO:0070670) cellular response to interleukin-4(GO:0071353) |
0.4 | 0.4 | GO:0072553 | terminal button organization(GO:0072553) |
0.4 | 0.4 | GO:0006868 | glutamine transport(GO:0006868) |
0.4 | 0.9 | GO:0032202 | telomere assembly(GO:0032202) |
0.4 | 0.9 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
0.4 | 1.3 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
0.4 | 0.9 | GO:0071280 | cellular response to copper ion(GO:0071280) |
0.4 | 3.9 | GO:0009954 | proximal/distal pattern formation(GO:0009954) |
0.4 | 0.9 | GO:1903071 | positive regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903071) |
0.4 | 2.2 | GO:0038092 | nodal signaling pathway(GO:0038092) |
0.4 | 0.4 | GO:0006290 | pyrimidine dimer repair(GO:0006290) |
0.4 | 1.3 | GO:0015888 | thiamine transport(GO:0015888) |
0.4 | 1.7 | GO:1905208 | negative regulation of cardiocyte differentiation(GO:1905208) |
0.4 | 2.6 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
0.4 | 0.4 | GO:0030279 | negative regulation of ossification(GO:0030279) |
0.4 | 0.9 | GO:0033567 | DNA replication, Okazaki fragment processing(GO:0033567) |
0.4 | 0.4 | GO:0006114 | glycerol biosynthetic process(GO:0006114) |
0.4 | 3.4 | GO:0030490 | maturation of SSU-rRNA(GO:0030490) |
0.4 | 0.9 | GO:0035990 | tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
0.4 | 2.1 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.4 | 0.9 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
0.4 | 1.3 | GO:0048541 | mucosal-associated lymphoid tissue development(GO:0048537) Peyer's patch development(GO:0048541) |
0.4 | 1.7 | GO:0006622 | protein targeting to lysosome(GO:0006622) |
0.4 | 0.8 | GO:0070849 | response to epidermal growth factor(GO:0070849) |
0.4 | 4.2 | GO:0007143 | female meiotic division(GO:0007143) |
0.4 | 0.8 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
0.4 | 0.8 | GO:2001032 | regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
0.4 | 3.4 | GO:0033120 | positive regulation of RNA splicing(GO:0033120) |
0.4 | 0.8 | GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
0.4 | 0.8 | GO:0014827 | intestine smooth muscle contraction(GO:0014827) |
0.4 | 0.4 | GO:0002238 | response to molecule of fungal origin(GO:0002238) |
0.4 | 1.3 | GO:0042095 | interferon-gamma biosynthetic process(GO:0042095) |
0.4 | 1.3 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.4 | 0.8 | GO:0001692 | histamine metabolic process(GO:0001692) |
0.4 | 1.3 | GO:1900451 | positive regulation of glutamate receptor signaling pathway(GO:1900451) positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
0.4 | 0.4 | GO:2000823 | regulation of androgen receptor activity(GO:2000823) |
0.4 | 1.7 | GO:1904424 | regulation of GTP binding(GO:1904424) |
0.4 | 4.2 | GO:1901663 | ubiquinone biosynthetic process(GO:0006744) quinone biosynthetic process(GO:1901663) |
0.4 | 23.6 | GO:0006338 | chromatin remodeling(GO:0006338) |
0.4 | 4.6 | GO:0070527 | platelet aggregation(GO:0070527) |
0.4 | 2.9 | GO:0031272 | regulation of pseudopodium assembly(GO:0031272) |
0.4 | 0.4 | GO:0003093 | regulation of glomerular filtration(GO:0003093) |
0.4 | 0.8 | GO:0051454 | pH elevation(GO:0045852) intracellular pH elevation(GO:0051454) |
0.4 | 0.8 | GO:0039689 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
0.4 | 2.9 | GO:1902751 | positive regulation of G2/M transition of mitotic cell cycle(GO:0010971) positive regulation of cell cycle G2/M phase transition(GO:1902751) |
0.4 | 3.3 | GO:0030502 | negative regulation of bone mineralization(GO:0030502) |
0.4 | 1.2 | GO:0033132 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
0.4 | 0.4 | GO:0070366 | regulation of hepatocyte differentiation(GO:0070366) |
0.4 | 1.2 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
0.4 | 0.8 | GO:0060297 | regulation of sarcomere organization(GO:0060297) |
0.4 | 12.6 | GO:0006418 | tRNA aminoacylation for protein translation(GO:0006418) |
0.4 | 1.2 | GO:0070314 | G1 to G0 transition(GO:0070314) |
0.4 | 3.7 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
0.4 | 5.6 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
0.4 | 0.4 | GO:0055119 | relaxation of cardiac muscle(GO:0055119) |
0.4 | 2.0 | GO:0035162 | embryonic hemopoiesis(GO:0035162) |
0.4 | 1.2 | GO:0009188 | ADP biosynthetic process(GO:0006172) ribonucleoside diphosphate biosynthetic process(GO:0009188) |
0.4 | 0.4 | GO:0034377 | plasma lipoprotein particle assembly(GO:0034377) |
0.4 | 0.4 | GO:1903423 | positive regulation of synaptic vesicle recycling(GO:1903423) |
0.4 | 1.6 | GO:0046488 | phosphatidylinositol metabolic process(GO:0046488) |
0.4 | 0.4 | GO:0048808 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
0.4 | 0.4 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
0.4 | 1.6 | GO:0098763 | mitotic cell cycle phase(GO:0098763) |
0.4 | 2.4 | GO:0001759 | organ induction(GO:0001759) |
0.4 | 2.0 | GO:0048563 | post-embryonic organ morphogenesis(GO:0048563) |
0.4 | 0.8 | GO:0032988 | ribonucleoprotein complex disassembly(GO:0032988) |
0.4 | 5.5 | GO:0071514 | genetic imprinting(GO:0071514) |
0.4 | 1.2 | GO:0010587 | miRNA catabolic process(GO:0010587) |
0.4 | 1.6 | GO:0043031 | negative regulation of macrophage activation(GO:0043031) |
0.4 | 1.2 | GO:0045908 | negative regulation of vasodilation(GO:0045908) |
0.4 | 0.8 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
0.4 | 2.0 | GO:0006004 | fucose metabolic process(GO:0006004) |
0.4 | 0.4 | GO:0010458 | exit from mitosis(GO:0010458) |
0.4 | 4.3 | GO:0009648 | photoperiodism(GO:0009648) |
0.4 | 1.2 | GO:0035590 | purinergic nucleotide receptor signaling pathway(GO:0035590) |
0.4 | 0.4 | GO:2001055 | positive regulation of mesenchymal cell apoptotic process(GO:2001055) |
0.4 | 1.2 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
0.4 | 2.3 | GO:0002756 | MyD88-independent toll-like receptor signaling pathway(GO:0002756) |
0.4 | 0.8 | GO:0070537 | histone H2A K63-linked deubiquitination(GO:0070537) |
0.4 | 1.9 | GO:0010838 | positive regulation of keratinocyte proliferation(GO:0010838) |
0.4 | 1.2 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
0.4 | 1.5 | GO:0046838 | phosphorylated carbohydrate dephosphorylation(GO:0046838) inositol phosphate dephosphorylation(GO:0046855) |
0.4 | 1.5 | GO:0046416 | D-amino acid metabolic process(GO:0046416) |
0.4 | 3.4 | GO:0002026 | regulation of the force of heart contraction(GO:0002026) |
0.4 | 0.8 | GO:1902914 | regulation of protein polyubiquitination(GO:1902914) |
0.4 | 0.4 | GO:0043308 | eosinophil activation involved in immune response(GO:0002278) eosinophil mediated immunity(GO:0002447) eosinophil degranulation(GO:0043308) |
0.4 | 0.8 | GO:0019853 | L-ascorbic acid biosynthetic process(GO:0019853) |
0.4 | 0.8 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
0.4 | 0.4 | GO:0000414 | regulation of histone H3-K36 methylation(GO:0000414) |
0.4 | 0.4 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
0.4 | 0.4 | GO:0006532 | aspartate biosynthetic process(GO:0006532) |
0.4 | 1.1 | GO:0009629 | response to gravity(GO:0009629) |
0.4 | 3.0 | GO:0071786 | endoplasmic reticulum tubular network organization(GO:0071786) |
0.4 | 19.0 | GO:0010923 | negative regulation of phosphatase activity(GO:0010923) |
0.4 | 0.8 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
0.4 | 1.1 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.4 | 1.5 | GO:0006527 | arginine catabolic process(GO:0006527) |
0.4 | 0.8 | GO:1905048 | regulation of metallopeptidase activity(GO:1905048) |
0.4 | 1.1 | GO:0098795 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
0.4 | 0.4 | GO:1900739 | regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
0.4 | 0.7 | GO:0045655 | regulation of monocyte differentiation(GO:0045655) |
0.4 | 2.6 | GO:0042744 | hydrogen peroxide catabolic process(GO:0042744) |
0.4 | 1.9 | GO:0060039 | pericardium development(GO:0060039) |
0.4 | 1.9 | GO:0016266 | O-glycan processing(GO:0016266) |
0.4 | 0.4 | GO:0070831 | basement membrane assembly(GO:0070831) |
0.4 | 0.4 | GO:0035357 | peroxisome proliferator activated receptor signaling pathway(GO:0035357) |
0.4 | 3.0 | GO:0006283 | transcription-coupled nucleotide-excision repair(GO:0006283) |
0.4 | 1.9 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
0.4 | 4.1 | GO:0006817 | phosphate ion transport(GO:0006817) |
0.4 | 1.1 | GO:1990414 | replication-born double-strand break repair via sister chromatid exchange(GO:1990414) |
0.4 | 2.2 | GO:0051546 | keratinocyte migration(GO:0051546) |
0.4 | 0.7 | GO:0061687 | detoxification of copper ion(GO:0010273) detoxification of inorganic compound(GO:0061687) stress response to copper ion(GO:1990169) |
0.4 | 2.9 | GO:0002053 | positive regulation of mesenchymal cell proliferation(GO:0002053) |
0.4 | 3.7 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
0.4 | 1.1 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.4 | 1.8 | GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest(GO:0006977) |
0.4 | 4.8 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
0.4 | 0.7 | GO:0001555 | oocyte growth(GO:0001555) |
0.4 | 1.1 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.4 | 2.9 | GO:0090312 | positive regulation of protein deacetylation(GO:0090312) |
0.4 | 0.7 | GO:0006499 | N-terminal protein myristoylation(GO:0006499) |
0.4 | 0.7 | GO:1904667 | negative regulation of ubiquitin protein ligase activity(GO:1904667) |
0.4 | 2.9 | GO:0045603 | positive regulation of endothelial cell differentiation(GO:0045603) |
0.4 | 0.7 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
0.4 | 2.2 | GO:0019321 | pentose metabolic process(GO:0019321) |
0.4 | 1.4 | GO:0033688 | regulation of osteoblast proliferation(GO:0033688) |
0.4 | 1.4 | GO:0006939 | smooth muscle contraction(GO:0006939) |
0.4 | 0.4 | GO:2000974 | negative regulation of pro-B cell differentiation(GO:2000974) |
0.4 | 1.1 | GO:0009299 | mRNA transcription(GO:0009299) |
0.4 | 1.4 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.4 | 3.2 | GO:0071548 | response to dexamethasone(GO:0071548) |
0.4 | 2.9 | GO:0016556 | mRNA modification(GO:0016556) |
0.4 | 2.5 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
0.4 | 1.8 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
0.4 | 2.9 | GO:0098719 | sodium ion import(GO:0097369) sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
0.4 | 0.7 | GO:0045747 | positive regulation of Notch signaling pathway(GO:0045747) |
0.4 | 3.6 | GO:0006298 | mismatch repair(GO:0006298) |
0.4 | 12.5 | GO:0001824 | blastocyst development(GO:0001824) |
0.4 | 3.2 | GO:0060216 | definitive hemopoiesis(GO:0060216) |
0.4 | 2.5 | GO:0060586 | multicellular organismal iron ion homeostasis(GO:0060586) |
0.4 | 0.7 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
0.4 | 3.2 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.4 | 2.5 | GO:0010388 | cullin deneddylation(GO:0010388) |
0.4 | 0.4 | GO:0070099 | regulation of chemokine-mediated signaling pathway(GO:0070099) |
0.4 | 0.7 | GO:0071609 | chemokine (C-C motif) ligand 5 production(GO:0071609) |
0.4 | 0.4 | GO:0042668 | auditory receptor cell fate determination(GO:0042668) |
0.4 | 0.7 | GO:0002317 | plasma cell differentiation(GO:0002317) |
0.4 | 0.7 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
0.4 | 5.3 | GO:0034198 | cellular response to amino acid starvation(GO:0034198) |
0.4 | 1.4 | GO:0009109 | coenzyme catabolic process(GO:0009109) |
0.4 | 0.7 | GO:0010766 | negative regulation of sodium ion transport(GO:0010766) |
0.4 | 0.4 | GO:0007135 | meiosis II(GO:0007135) |
0.4 | 1.1 | GO:0000394 | RNA splicing, via endonucleolytic cleavage and ligation(GO:0000394) tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
0.4 | 1.4 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
0.4 | 0.4 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
0.3 | 1.4 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
0.3 | 3.5 | GO:0033235 | positive regulation of protein sumoylation(GO:0033235) |
0.3 | 1.7 | GO:0061036 | positive regulation of cartilage development(GO:0061036) |
0.3 | 12.5 | GO:0051865 | protein autoubiquitination(GO:0051865) |
0.3 | 2.8 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.3 | 2.8 | GO:0051382 | kinetochore assembly(GO:0051382) |
0.3 | 5.5 | GO:0030968 | endoplasmic reticulum unfolded protein response(GO:0030968) |
0.3 | 4.1 | GO:0006706 | steroid catabolic process(GO:0006706) |
0.3 | 1.0 | GO:0010919 | regulation of inositol phosphate biosynthetic process(GO:0010919) positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
0.3 | 0.7 | GO:0032727 | positive regulation of interferon-alpha production(GO:0032727) |
0.3 | 1.7 | GO:0001893 | maternal placenta development(GO:0001893) |
0.3 | 1.7 | GO:0071569 | protein ufmylation(GO:0071569) |
0.3 | 0.7 | GO:0001920 | negative regulation of receptor recycling(GO:0001920) |
0.3 | 0.3 | GO:0045634 | regulation of melanocyte differentiation(GO:0045634) |
0.3 | 0.7 | GO:0001757 | somite specification(GO:0001757) |
0.3 | 0.7 | GO:0051342 | regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051342) |
0.3 | 0.7 | GO:0051182 | coenzyme transport(GO:0051182) |
0.3 | 3.4 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.3 | 5.1 | GO:0000002 | mitochondrial genome maintenance(GO:0000002) |
0.3 | 0.7 | GO:0014831 | gastro-intestinal system smooth muscle contraction(GO:0014831) |
0.3 | 3.4 | GO:0061298 | retina vasculature development in camera-type eye(GO:0061298) |
0.3 | 1.7 | GO:0032460 | negative regulation of protein oligomerization(GO:0032460) |
0.3 | 0.7 | GO:0000479 | endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000479) |
0.3 | 0.3 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
0.3 | 2.3 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
0.3 | 1.3 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
0.3 | 1.0 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
0.3 | 1.0 | GO:0032506 | cytokinetic process(GO:0032506) |
0.3 | 0.3 | GO:1903441 | protein localization to ciliary membrane(GO:1903441) |
0.3 | 4.0 | GO:0045116 | protein neddylation(GO:0045116) |
0.3 | 3.9 | GO:0098868 | endochondral bone growth(GO:0003416) bone growth(GO:0098868) |
0.3 | 0.7 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
0.3 | 5.2 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
0.3 | 1.3 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.3 | 2.9 | GO:0030032 | lamellipodium assembly(GO:0030032) |
0.3 | 1.3 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
0.3 | 0.3 | GO:0009452 | 7-methylguanosine RNA capping(GO:0009452) RNA capping(GO:0036260) |
0.3 | 0.3 | GO:1903963 | arachidonic acid secretion(GO:0050482) arachidonate transport(GO:1903963) |
0.3 | 1.3 | GO:0033572 | transferrin transport(GO:0033572) |
0.3 | 1.9 | GO:0019673 | GDP-mannose metabolic process(GO:0019673) |
0.3 | 0.3 | GO:1905154 | negative regulation of membrane invagination(GO:1905154) |
0.3 | 1.0 | GO:2001199 | negative regulation of dendritic cell differentiation(GO:2001199) |
0.3 | 1.0 | GO:0031639 | plasminogen activation(GO:0031639) |
0.3 | 0.6 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
0.3 | 3.5 | GO:0060675 | ureteric bud morphogenesis(GO:0060675) |
0.3 | 13.2 | GO:0048024 | regulation of mRNA splicing, via spliceosome(GO:0048024) |
0.3 | 1.6 | GO:0072112 | renal filtration cell differentiation(GO:0061318) glomerular epithelium development(GO:0072010) glomerular visceral epithelial cell differentiation(GO:0072112) glomerular epithelial cell differentiation(GO:0072311) |
0.3 | 1.6 | GO:0071493 | cellular response to UV-B(GO:0071493) |
0.3 | 0.6 | GO:1904017 | response to Thyroglobulin triiodothyronine(GO:1904016) cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
0.3 | 1.9 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.3 | 4.1 | GO:0006144 | purine nucleobase metabolic process(GO:0006144) |
0.3 | 1.3 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.3 | 5.4 | GO:0007266 | Rho protein signal transduction(GO:0007266) |
0.3 | 0.3 | GO:1904429 | regulation of t-circle formation(GO:1904429) |
0.3 | 2.2 | GO:0002827 | positive regulation of T-helper 1 type immune response(GO:0002827) |
0.3 | 0.3 | GO:2000097 | regulation of smooth muscle cell-matrix adhesion(GO:2000097) |
0.3 | 0.3 | GO:0006041 | glucosamine metabolic process(GO:0006041) |
0.3 | 0.3 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
0.3 | 1.9 | GO:0016574 | histone ubiquitination(GO:0016574) |
0.3 | 4.7 | GO:0003009 | skeletal muscle contraction(GO:0003009) |
0.3 | 0.9 | GO:0033687 | osteoblast proliferation(GO:0033687) |
0.3 | 0.9 | GO:0060023 | soft palate development(GO:0060023) |
0.3 | 0.3 | GO:0060718 | chorionic trophoblast cell differentiation(GO:0060718) |
0.3 | 4.4 | GO:1901998 | toxin transport(GO:1901998) |
0.3 | 0.3 | GO:1902036 | regulation of hematopoietic stem cell differentiation(GO:1902036) |
0.3 | 0.9 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
0.3 | 1.3 | GO:0043297 | apical junction assembly(GO:0043297) |
0.3 | 0.9 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.3 | 0.9 | GO:0045359 | positive regulation of interferon-beta biosynthetic process(GO:0045359) |
0.3 | 0.9 | GO:0090166 | Golgi disassembly(GO:0090166) |
0.3 | 1.6 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.3 | 0.6 | GO:0030878 | thyroid gland development(GO:0030878) |
0.3 | 0.3 | GO:0035283 | central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
0.3 | 1.2 | GO:0001953 | negative regulation of cell-matrix adhesion(GO:0001953) |
0.3 | 0.6 | GO:0071839 | apoptotic process in bone marrow(GO:0071839) |
0.3 | 0.6 | GO:0060260 | regulation of transcription initiation from RNA polymerase II promoter(GO:0060260) |
0.3 | 0.9 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
0.3 | 1.2 | GO:0042953 | lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
0.3 | 0.9 | GO:0010560 | positive regulation of glycoprotein biosynthetic process(GO:0010560) |
0.3 | 0.9 | GO:2000074 | regulation of type B pancreatic cell development(GO:2000074) |
0.3 | 1.8 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
0.3 | 0.6 | GO:0007060 | male meiosis chromosome segregation(GO:0007060) |
0.3 | 0.3 | GO:0060737 | prostate gland morphogenetic growth(GO:0060737) |
0.3 | 2.4 | GO:0046548 | retinal rod cell development(GO:0046548) |
0.3 | 0.9 | GO:0000492 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
0.3 | 1.8 | GO:0032717 | negative regulation of interleukin-8 production(GO:0032717) |
0.3 | 0.3 | GO:0045064 | T-helper 2 cell differentiation(GO:0045064) |
0.3 | 0.6 | GO:2000467 | positive regulation of glycogen (starch) synthase activity(GO:2000467) |
0.3 | 5.5 | GO:0048240 | sperm capacitation(GO:0048240) |
0.3 | 0.6 | GO:1903726 | negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) negative regulation of phospholipid metabolic process(GO:1903726) |
0.3 | 4.8 | GO:0018208 | peptidyl-proline modification(GO:0018208) |
0.3 | 3.0 | GO:0070534 | protein K63-linked ubiquitination(GO:0070534) |
0.3 | 0.3 | GO:0019076 | viral release from host cell(GO:0019076) |
0.3 | 0.3 | GO:0030947 | regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030947) |
0.3 | 0.6 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
0.3 | 0.6 | GO:0034454 | microtubule anchoring at centrosome(GO:0034454) |
0.3 | 0.6 | GO:0060671 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
0.3 | 1.8 | GO:0033599 | regulation of mammary gland epithelial cell proliferation(GO:0033599) |
0.3 | 4.2 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.3 | 1.2 | GO:0018231 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
0.3 | 0.9 | GO:0016102 | retinoic acid biosynthetic process(GO:0002138) diterpenoid biosynthetic process(GO:0016102) |
0.3 | 1.8 | GO:0050684 | regulation of mRNA processing(GO:0050684) |
0.3 | 0.3 | GO:0060049 | regulation of protein glycosylation(GO:0060049) |
0.3 | 2.1 | GO:0033260 | nuclear DNA replication(GO:0033260) |
0.3 | 7.2 | GO:0045727 | positive regulation of translation(GO:0045727) |
0.3 | 0.3 | GO:2000152 | regulation of ubiquitin-specific protease activity(GO:2000152) |
0.3 | 2.1 | GO:0007080 | mitotic metaphase plate congression(GO:0007080) |
0.3 | 1.5 | GO:0046889 | positive regulation of lipid biosynthetic process(GO:0046889) |
0.3 | 0.6 | GO:0010792 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) |
0.3 | 2.9 | GO:0071398 | cellular response to fatty acid(GO:0071398) |
0.3 | 0.6 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.3 | 1.5 | GO:0071425 | hematopoietic stem cell proliferation(GO:0071425) |
0.3 | 0.6 | GO:0051974 | negative regulation of telomerase activity(GO:0051974) |
0.3 | 1.5 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
0.3 | 0.3 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
0.3 | 3.5 | GO:0031163 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.3 | 2.0 | GO:0033522 | histone H2A ubiquitination(GO:0033522) |
0.3 | 2.0 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
0.3 | 0.3 | GO:0007088 | regulation of mitotic nuclear division(GO:0007088) |
0.3 | 0.3 | GO:0006363 | termination of RNA polymerase I transcription(GO:0006363) |
0.3 | 0.6 | GO:0033622 | integrin activation(GO:0033622) |
0.3 | 0.3 | GO:0002726 | positive regulation of T cell cytokine production(GO:0002726) |
0.3 | 0.6 | GO:0006379 | mRNA cleavage(GO:0006379) |
0.3 | 1.1 | GO:0006777 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.3 | 2.0 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
0.3 | 2.5 | GO:0050869 | negative regulation of B cell activation(GO:0050869) |
0.3 | 0.6 | GO:0016080 | synaptic vesicle targeting(GO:0016080) |
0.3 | 4.0 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
0.3 | 1.7 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
0.3 | 2.2 | GO:0010863 | activation of phospholipase C activity(GO:0007202) positive regulation of phospholipase C activity(GO:0010863) |
0.3 | 1.7 | GO:0006968 | cellular defense response(GO:0006968) |
0.3 | 0.3 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
0.3 | 0.8 | GO:0060028 | convergent extension involved in axis elongation(GO:0060028) |
0.3 | 19.8 | GO:0019882 | antigen processing and presentation(GO:0019882) |
0.3 | 3.1 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.3 | 0.6 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
0.3 | 1.1 | GO:0071559 | response to transforming growth factor beta(GO:0071559) |
0.3 | 1.7 | GO:0061756 | leukocyte adhesion to vascular endothelial cell(GO:0061756) |
0.3 | 7.5 | GO:0001889 | liver development(GO:0001889) |
0.3 | 0.8 | GO:0043312 | neutrophil degranulation(GO:0043312) |
0.3 | 0.3 | GO:0072076 | nephrogenic mesenchyme development(GO:0072076) |
0.3 | 0.6 | GO:0016264 | gap junction assembly(GO:0016264) |
0.3 | 0.3 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
0.3 | 1.4 | GO:0015868 | purine ribonucleotide transport(GO:0015868) |
0.3 | 1.4 | GO:0001954 | positive regulation of cell-matrix adhesion(GO:0001954) |
0.3 | 11.2 | GO:0048705 | skeletal system morphogenesis(GO:0048705) |
0.3 | 0.5 | GO:0070141 | response to UV-A(GO:0070141) |
0.3 | 2.5 | GO:0048536 | spleen development(GO:0048536) |
0.3 | 0.3 | GO:0034035 | purine ribonucleoside bisphosphate metabolic process(GO:0034035) |
0.3 | 8.7 | GO:2001020 | regulation of response to DNA damage stimulus(GO:2001020) |
0.3 | 3.0 | GO:0050892 | intestinal absorption(GO:0050892) |
0.3 | 0.8 | GO:1900227 | positive regulation of NLRP3 inflammasome complex assembly(GO:1900227) |
0.3 | 4.9 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.3 | 0.3 | GO:0045714 | low-density lipoprotein particle receptor biosynthetic process(GO:0045713) regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045714) |
0.3 | 0.8 | GO:0042178 | xenobiotic catabolic process(GO:0042178) |
0.3 | 1.1 | GO:0046365 | monosaccharide catabolic process(GO:0046365) |
0.3 | 0.3 | GO:1903147 | negative regulation of mitophagy(GO:1903147) |
0.3 | 1.4 | GO:0032967 | positive regulation of collagen biosynthetic process(GO:0032967) |
0.3 | 0.5 | GO:1904668 | positive regulation of ubiquitin protein ligase activity(GO:1904668) |
0.3 | 2.2 | GO:0043484 | regulation of RNA splicing(GO:0043484) |
0.3 | 0.3 | GO:0030511 | positive regulation of transforming growth factor beta receptor signaling pathway(GO:0030511) positive regulation of cellular response to transforming growth factor beta stimulus(GO:1903846) |
0.3 | 4.3 | GO:0048747 | muscle fiber development(GO:0048747) |
0.3 | 6.7 | GO:0015914 | phospholipid transport(GO:0015914) |
0.3 | 1.1 | GO:0051001 | negative regulation of nitric-oxide synthase activity(GO:0051001) |
0.3 | 0.5 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
0.3 | 1.3 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.3 | 1.6 | GO:0060993 | kidney morphogenesis(GO:0060993) |
0.3 | 1.1 | GO:0019915 | lipid storage(GO:0019915) |
0.3 | 0.3 | GO:0045652 | regulation of megakaryocyte differentiation(GO:0045652) |
0.3 | 5.1 | GO:0006284 | base-excision repair(GO:0006284) |
0.3 | 0.3 | GO:0060068 | vagina development(GO:0060068) |
0.3 | 0.5 | GO:0042167 | heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
0.3 | 0.3 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
0.3 | 1.6 | GO:1902230 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902230) |
0.3 | 0.3 | GO:1901420 | negative regulation of response to alcohol(GO:1901420) |
0.3 | 0.3 | GO:1902683 | regulation of receptor localization to synapse(GO:1902683) |
0.3 | 0.8 | GO:0034508 | centromere complex assembly(GO:0034508) |
0.3 | 0.3 | GO:0033861 | negative regulation of NAD(P)H oxidase activity(GO:0033861) |
0.3 | 0.3 | GO:0009445 | putrescine metabolic process(GO:0009445) |
0.3 | 0.8 | GO:0060340 | positive regulation of type I interferon-mediated signaling pathway(GO:0060340) |
0.3 | 0.5 | GO:0033762 | response to glucagon(GO:0033762) |
0.3 | 1.1 | GO:0021684 | cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
0.3 | 3.4 | GO:0000079 | regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0000079) |
0.3 | 0.3 | GO:0009838 | abscission(GO:0009838) |
0.3 | 0.3 | GO:0036506 | maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
0.3 | 0.3 | GO:2000370 | positive regulation of clathrin-mediated endocytosis(GO:2000370) |
0.3 | 0.3 | GO:0001510 | RNA methylation(GO:0001510) |
0.3 | 0.5 | GO:1901984 | negative regulation of protein acetylation(GO:1901984) |
0.3 | 0.3 | GO:0090467 | L-arginine import(GO:0043091) arginine import(GO:0090467) L-arginine transport(GO:1902023) |
0.3 | 0.3 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
0.3 | 0.8 | GO:0010759 | positive regulation of macrophage chemotaxis(GO:0010759) |
0.3 | 2.9 | GO:0016578 | histone deubiquitination(GO:0016578) |
0.3 | 6.8 | GO:0010508 | positive regulation of autophagy(GO:0010508) |
0.3 | 0.3 | GO:0046463 | neutral lipid biosynthetic process(GO:0046460) acylglycerol biosynthetic process(GO:0046463) |
0.3 | 1.6 | GO:0061515 | myeloid cell development(GO:0061515) |
0.3 | 2.6 | GO:0042168 | heme metabolic process(GO:0042168) |
0.3 | 3.6 | GO:0043171 | peptide catabolic process(GO:0043171) |
0.3 | 12.4 | GO:0048706 | embryonic skeletal system development(GO:0048706) |
0.3 | 1.0 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
0.3 | 0.3 | GO:1903232 | melanosome assembly(GO:1903232) |
0.3 | 0.8 | GO:1901522 | positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus(GO:1901522) |
0.3 | 1.3 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.3 | 1.0 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
0.3 | 0.3 | GO:0019184 | nonribosomal peptide biosynthetic process(GO:0019184) |
0.3 | 2.8 | GO:0002347 | response to tumor cell(GO:0002347) |
0.3 | 0.5 | GO:0035095 | behavioral response to nicotine(GO:0035095) |
0.3 | 0.8 | GO:0061072 | iris morphogenesis(GO:0061072) |
0.3 | 0.3 | GO:0015809 | arginine transport(GO:0015809) lysine transport(GO:0015819) |
0.3 | 7.9 | GO:0006749 | glutathione metabolic process(GO:0006749) |
0.3 | 1.0 | GO:0021924 | cell proliferation in hindbrain(GO:0021534) cell proliferation in external granule layer(GO:0021924) cerebellar granule cell precursor proliferation(GO:0021930) |
0.3 | 1.0 | GO:0051561 | positive regulation of mitochondrial calcium ion concentration(GO:0051561) |
0.3 | 0.8 | GO:0002076 | osteoblast development(GO:0002076) |
0.3 | 0.3 | GO:0030240 | skeletal muscle thin filament assembly(GO:0030240) |
0.3 | 1.0 | GO:0071260 | cellular response to mechanical stimulus(GO:0071260) |
0.3 | 0.8 | GO:0007062 | sister chromatid cohesion(GO:0007062) |
0.3 | 0.5 | GO:0010481 | epidermal cell division(GO:0010481) regulation of epidermal cell division(GO:0010482) |
0.2 | 0.2 | GO:0070244 | negative regulation of thymocyte apoptotic process(GO:0070244) |
0.2 | 2.2 | GO:0014829 | vascular smooth muscle contraction(GO:0014829) |
0.2 | 0.2 | GO:0034067 | protein localization to Golgi apparatus(GO:0034067) |
0.2 | 2.0 | GO:0030803 | negative regulation of cyclic nucleotide biosynthetic process(GO:0030803) |
0.2 | 2.5 | GO:0006446 | regulation of translational initiation(GO:0006446) |
0.2 | 3.2 | GO:0016575 | histone deacetylation(GO:0016575) |
0.2 | 0.2 | GO:0071971 | extracellular exosome assembly(GO:0071971) |
0.2 | 0.2 | GO:0031284 | positive regulation of guanylate cyclase activity(GO:0031284) |
0.2 | 1.2 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
0.2 | 0.7 | GO:0000303 | response to superoxide(GO:0000303) |
0.2 | 0.2 | GO:0009128 | purine nucleoside monophosphate catabolic process(GO:0009128) |
0.2 | 3.2 | GO:0051225 | spindle assembly(GO:0051225) |
0.2 | 3.7 | GO:0045089 | positive regulation of innate immune response(GO:0045089) |
0.2 | 1.0 | GO:0001523 | retinoid metabolic process(GO:0001523) |
0.2 | 0.7 | GO:0000098 | sulfur amino acid catabolic process(GO:0000098) |
0.2 | 0.5 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
0.2 | 20.4 | GO:0042787 | protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0042787) |
0.2 | 0.2 | GO:0097066 | response to thyroid hormone(GO:0097066) |
0.2 | 1.2 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
0.2 | 2.7 | GO:0016925 | protein sumoylation(GO:0016925) |
0.2 | 1.0 | GO:0015012 | heparan sulfate proteoglycan biosynthetic process(GO:0015012) |
0.2 | 1.7 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
0.2 | 6.0 | GO:0003333 | amino acid transmembrane transport(GO:0003333) |
0.2 | 0.5 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
0.2 | 0.5 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.2 | 0.2 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.2 | 0.5 | GO:0032789 | saturated monocarboxylic acid metabolic process(GO:0032788) unsaturated monocarboxylic acid metabolic process(GO:0032789) |
0.2 | 0.2 | GO:0006678 | glucosylceramide metabolic process(GO:0006678) |
0.2 | 0.2 | GO:0016139 | glycoside catabolic process(GO:0016139) |
0.2 | 0.2 | GO:0055091 | phospholipid homeostasis(GO:0055091) |
0.2 | 1.6 | GO:0071480 | cellular response to gamma radiation(GO:0071480) |
0.2 | 0.9 | GO:1901387 | positive regulation of voltage-gated calcium channel activity(GO:1901387) |
0.2 | 0.2 | GO:0046470 | phosphatidylcholine metabolic process(GO:0046470) |
0.2 | 0.2 | GO:0050711 | negative regulation of interleukin-1 secretion(GO:0050711) |
0.2 | 1.2 | GO:0032922 | circadian regulation of gene expression(GO:0032922) |
0.2 | 0.5 | GO:1901796 | regulation of signal transduction by p53 class mediator(GO:1901796) |
0.2 | 0.7 | GO:1900016 | negative regulation of cytokine production involved in inflammatory response(GO:1900016) |
0.2 | 1.6 | GO:1902750 | negative regulation of cell cycle G2/M phase transition(GO:1902750) |
0.2 | 1.6 | GO:0043982 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
0.2 | 0.5 | GO:1903862 | positive regulation of oxidative phosphorylation(GO:1903862) |
0.2 | 0.2 | GO:0050968 | detection of chemical stimulus involved in sensory perception of pain(GO:0050968) |
0.2 | 0.9 | GO:1903672 | positive regulation of sprouting angiogenesis(GO:1903672) |
0.2 | 0.7 | GO:1905038 | regulation of sphingolipid biosynthetic process(GO:0090153) regulation of membrane lipid metabolic process(GO:1905038) |
0.2 | 0.5 | GO:0050832 | defense response to fungus(GO:0050832) |
0.2 | 0.7 | GO:0030210 | heparin metabolic process(GO:0030202) heparin biosynthetic process(GO:0030210) |
0.2 | 1.4 | GO:0008299 | isoprenoid biosynthetic process(GO:0008299) |
0.2 | 0.2 | GO:1990001 | inhibition of cysteine-type endopeptidase activity(GO:0097340) zymogen inhibition(GO:0097341) inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
0.2 | 0.5 | GO:0030885 | regulation of myeloid dendritic cell activation(GO:0030885) |
0.2 | 1.2 | GO:0006561 | proline biosynthetic process(GO:0006561) |
0.2 | 4.4 | GO:0002763 | positive regulation of myeloid leukocyte differentiation(GO:0002763) |
0.2 | 0.5 | GO:1901096 | regulation of autophagosome maturation(GO:1901096) |
0.2 | 4.4 | GO:0009062 | fatty acid catabolic process(GO:0009062) |
0.2 | 1.1 | GO:0051293 | establishment of spindle localization(GO:0051293) |
0.2 | 1.8 | GO:0002115 | store-operated calcium entry(GO:0002115) |
0.2 | 1.6 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
0.2 | 1.1 | GO:0000731 | DNA synthesis involved in DNA repair(GO:0000731) |
0.2 | 0.2 | GO:0090114 | COPII-coated vesicle budding(GO:0090114) |
0.2 | 0.2 | GO:1903546 | protein localization to photoreceptor outer segment(GO:1903546) |
0.2 | 1.1 | GO:0071392 | cellular response to estradiol stimulus(GO:0071392) |
0.2 | 4.1 | GO:0009813 | flavonoid biosynthetic process(GO:0009813) flavonoid glucuronidation(GO:0052696) |
0.2 | 18.2 | GO:0016042 | lipid catabolic process(GO:0016042) |
0.2 | 1.1 | GO:0090382 | phagosome maturation(GO:0090382) |
0.2 | 0.5 | GO:0051984 | positive regulation of chromosome segregation(GO:0051984) |
0.2 | 0.5 | GO:0048148 | behavioral response to cocaine(GO:0048148) |
0.2 | 0.2 | GO:0090503 | RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
0.2 | 0.7 | GO:1904294 | positive regulation of ERAD pathway(GO:1904294) |
0.2 | 0.5 | GO:0070842 | aggresome assembly(GO:0070842) |
0.2 | 5.4 | GO:0007566 | embryo implantation(GO:0007566) |
0.2 | 0.7 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
0.2 | 2.0 | GO:0045669 | positive regulation of osteoblast differentiation(GO:0045669) |
0.2 | 0.4 | GO:0009404 | toxin metabolic process(GO:0009404) |
0.2 | 13.5 | GO:0007519 | skeletal muscle tissue development(GO:0007519) |
0.2 | 2.2 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
0.2 | 0.4 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
0.2 | 1.5 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
0.2 | 1.5 | GO:0060674 | placenta blood vessel development(GO:0060674) |
0.2 | 0.2 | GO:0001957 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.2 | 0.2 | GO:0010452 | histone H3-K36 methylation(GO:0010452) |
0.2 | 3.1 | GO:0016180 | snRNA processing(GO:0016180) |
0.2 | 0.7 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.2 | 0.7 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.2 | 0.2 | GO:0071481 | cellular response to X-ray(GO:0071481) |
0.2 | 0.7 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
0.2 | 0.2 | GO:0071168 | protein localization to chromatin(GO:0071168) |
0.2 | 0.2 | GO:0030035 | microspike assembly(GO:0030035) |
0.2 | 0.2 | GO:0097499 | protein localization to nonmotile primary cilium(GO:0097499) |
0.2 | 0.4 | GO:0072402 | response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) response to intra-S DNA damage checkpoint signaling(GO:0072429) |
0.2 | 0.2 | GO:0052040 | modulation of programmed cell death in other organism(GO:0044531) modulation of apoptotic process in other organism(GO:0044532) modulation by symbiont of host programmed cell death(GO:0052040) modulation by symbiont of host apoptotic process(GO:0052150) modulation of programmed cell death in other organism involved in symbiotic interaction(GO:0052248) modulation by organism of apoptotic process in other organism involved in symbiotic interaction(GO:0052433) |
0.2 | 0.2 | GO:0048243 | regulation of norepinephrine secretion(GO:0014061) norepinephrine secretion(GO:0048243) |
0.2 | 5.1 | GO:0043409 | negative regulation of MAPK cascade(GO:0043409) |
0.2 | 0.2 | GO:0003071 | renal system process involved in regulation of systemic arterial blood pressure(GO:0003071) |
0.2 | 0.4 | GO:0019348 | dolichol metabolic process(GO:0019348) |
0.2 | 0.6 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
0.2 | 0.8 | GO:0070307 | lens fiber cell development(GO:0070307) |
0.2 | 1.9 | GO:0030835 | negative regulation of actin filament depolymerization(GO:0030835) |
0.2 | 1.5 | GO:0033561 | regulation of water loss via skin(GO:0033561) |
0.2 | 1.2 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
0.2 | 1.0 | GO:0035329 | hippo signaling(GO:0035329) |
0.2 | 0.2 | GO:0000291 | nuclear-transcribed mRNA catabolic process, exonucleolytic(GO:0000291) |
0.2 | 0.4 | GO:0045602 | negative regulation of endothelial cell differentiation(GO:0045602) |
0.2 | 0.2 | GO:0039534 | negative regulation of MDA-5 signaling pathway(GO:0039534) |
0.2 | 0.4 | GO:2000279 | negative regulation of DNA biosynthetic process(GO:2000279) |
0.2 | 1.0 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
0.2 | 0.4 | GO:0008211 | glucocorticoid metabolic process(GO:0008211) |
0.2 | 0.6 | GO:0006528 | asparagine metabolic process(GO:0006528) |
0.2 | 0.8 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
0.2 | 1.2 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.2 | 0.6 | GO:0030223 | neutrophil differentiation(GO:0030223) |
0.2 | 0.4 | GO:0071440 | regulation of histone H3-K14 acetylation(GO:0071440) |
0.2 | 1.6 | GO:0051205 | protein insertion into membrane(GO:0051205) |
0.2 | 1.0 | GO:0071479 | cellular response to ionizing radiation(GO:0071479) |
0.2 | 2.8 | GO:0061001 | regulation of dendritic spine morphogenesis(GO:0061001) |
0.2 | 0.8 | GO:0030913 | paranodal junction assembly(GO:0030913) |
0.2 | 0.6 | GO:1900037 | regulation of cellular response to hypoxia(GO:1900037) |
0.2 | 0.6 | GO:0010025 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
0.2 | 0.4 | GO:0051464 | positive regulation of cortisol secretion(GO:0051464) |
0.2 | 0.2 | GO:0070102 | interleukin-6-mediated signaling pathway(GO:0070102) |
0.2 | 0.4 | GO:0072012 | glomerulus vasculature development(GO:0072012) |
0.2 | 1.4 | GO:0010634 | positive regulation of epithelial cell migration(GO:0010634) |
0.2 | 1.4 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.2 | 0.8 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
0.2 | 0.6 | GO:0002934 | desmosome organization(GO:0002934) |
0.2 | 0.4 | GO:0051496 | positive regulation of stress fiber assembly(GO:0051496) |
0.2 | 3.6 | GO:0006406 | mRNA export from nucleus(GO:0006406) mRNA-containing ribonucleoprotein complex export from nucleus(GO:0071427) |
0.2 | 1.4 | GO:0071466 | cellular response to xenobiotic stimulus(GO:0071466) |
0.2 | 2.8 | GO:0030488 | tRNA methylation(GO:0030488) |
0.2 | 0.6 | GO:0048368 | lateral mesoderm development(GO:0048368) |
0.2 | 35.6 | GO:0006397 | mRNA processing(GO:0006397) |
0.2 | 0.2 | GO:0015911 | plasma membrane long-chain fatty acid transport(GO:0015911) fatty acid transmembrane transport(GO:1902001) |
0.2 | 0.4 | GO:0010889 | regulation of sequestering of triglyceride(GO:0010889) |
0.2 | 0.2 | GO:0060312 | regulation of blood vessel remodeling(GO:0060312) |
0.2 | 0.8 | GO:0050710 | negative regulation of cytokine secretion(GO:0050710) |
0.2 | 0.2 | GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
0.2 | 0.8 | GO:0007051 | spindle organization(GO:0007051) |
0.2 | 1.8 | GO:0043248 | proteasome assembly(GO:0043248) |
0.2 | 0.2 | GO:0043320 | natural killer cell degranulation(GO:0043320) |
0.2 | 0.4 | GO:0090026 | positive regulation of monocyte chemotaxis(GO:0090026) |
0.2 | 1.7 | GO:0009143 | nucleoside triphosphate catabolic process(GO:0009143) |
0.2 | 0.2 | GO:0000729 | DNA double-strand break processing(GO:0000729) |
0.2 | 1.9 | GO:0099517 | anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
0.2 | 0.4 | GO:0030042 | actin filament depolymerization(GO:0030042) |
0.2 | 0.8 | GO:0007020 | microtubule nucleation(GO:0007020) |
0.2 | 0.8 | GO:0046325 | negative regulation of glucose import(GO:0046325) |
0.2 | 0.2 | GO:0042256 | mature ribosome assembly(GO:0042256) |
0.2 | 0.4 | GO:0061157 | mRNA destabilization(GO:0061157) |
0.2 | 0.2 | GO:0034204 | lipid translocation(GO:0034204) |
0.2 | 0.2 | GO:0009650 | UV protection(GO:0009650) |
0.2 | 0.2 | GO:0048296 | isotype switching to IgA isotypes(GO:0048290) regulation of isotype switching to IgA isotypes(GO:0048296) |
0.2 | 0.2 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
0.2 | 2.0 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.2 | 0.2 | GO:0061043 | regulation of vascular wound healing(GO:0061043) |
0.2 | 0.7 | GO:1901032 | negative regulation of response to reactive oxygen species(GO:1901032) |
0.2 | 0.4 | GO:2000359 | regulation of binding of sperm to zona pellucida(GO:2000359) |
0.2 | 0.4 | GO:0007398 | ectoderm development(GO:0007398) |
0.2 | 0.2 | GO:0010718 | positive regulation of epithelial to mesenchymal transition(GO:0010718) |
0.2 | 0.6 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.2 | 0.9 | GO:0044088 | regulation of vacuole organization(GO:0044088) |
0.2 | 0.6 | GO:1904659 | glucose transmembrane transport(GO:1904659) |
0.2 | 0.9 | GO:0009249 | protein lipoylation(GO:0009249) |
0.2 | 0.7 | GO:0007263 | nitric oxide mediated signal transduction(GO:0007263) |
0.2 | 1.6 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
0.2 | 2.6 | GO:0010862 | positive regulation of pathway-restricted SMAD protein phosphorylation(GO:0010862) |
0.2 | 0.2 | GO:0002820 | negative regulation of adaptive immune response(GO:0002820) |
0.2 | 0.2 | GO:1901873 | regulation of post-translational protein modification(GO:1901873) negative regulation of post-translational protein modification(GO:1901874) |
0.2 | 8.5 | GO:0008033 | tRNA processing(GO:0008033) |
0.2 | 0.7 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.2 | 0.2 | GO:0042699 | follicle-stimulating hormone signaling pathway(GO:0042699) |
0.2 | 0.5 | GO:2000036 | regulation of stem cell population maintenance(GO:2000036) |
0.2 | 0.2 | GO:0072053 | renal inner medulla development(GO:0072053) |
0.2 | 0.5 | GO:0006244 | pyrimidine nucleotide catabolic process(GO:0006244) |
0.2 | 3.0 | GO:0030433 | ER-associated ubiquitin-dependent protein catabolic process(GO:0030433) |
0.2 | 0.5 | GO:0010884 | positive regulation of lipid storage(GO:0010884) |
0.2 | 0.2 | GO:0050881 | multicellular organismal movement(GO:0050879) musculoskeletal movement(GO:0050881) |
0.2 | 2.1 | GO:0006308 | DNA catabolic process(GO:0006308) |
0.2 | 3.4 | GO:0030218 | erythrocyte differentiation(GO:0030218) |
0.2 | 0.5 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
0.2 | 7.1 | GO:0000209 | protein polyubiquitination(GO:0000209) |
0.2 | 0.9 | GO:0050951 | sensory perception of temperature stimulus(GO:0050951) |
0.2 | 2.5 | GO:0072332 | intrinsic apoptotic signaling pathway by p53 class mediator(GO:0072332) |
0.2 | 0.2 | GO:0051025 | negative regulation of immunoglobulin secretion(GO:0051025) |
0.2 | 0.4 | GO:0006702 | androgen biosynthetic process(GO:0006702) |
0.2 | 1.2 | GO:0070584 | mitochondrion morphogenesis(GO:0070584) |
0.2 | 0.7 | GO:0034551 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
0.2 | 0.2 | GO:0032466 | negative regulation of cytokinesis(GO:0032466) |
0.2 | 1.4 | GO:0001675 | acrosome assembly(GO:0001675) |
0.2 | 0.2 | GO:0048875 | chemical homeostasis within a tissue(GO:0048875) |
0.2 | 1.2 | GO:0048286 | lung alveolus development(GO:0048286) |
0.2 | 0.3 | GO:0014055 | acetylcholine secretion, neurotransmission(GO:0014055) regulation of acetylcholine secretion, neurotransmission(GO:0014056) |
0.2 | 0.5 | GO:0006851 | mitochondrial calcium ion transport(GO:0006851) |
0.2 | 0.2 | GO:0070305 | response to cGMP(GO:0070305) |
0.2 | 1.0 | GO:0007093 | mitotic cell cycle checkpoint(GO:0007093) |
0.2 | 2.0 | GO:1903076 | regulation of protein localization to plasma membrane(GO:1903076) regulation of protein localization to cell periphery(GO:1904375) |
0.2 | 0.5 | GO:0042640 | anagen(GO:0042640) |
0.2 | 0.8 | GO:0009896 | positive regulation of catabolic process(GO:0009896) |
0.2 | 0.3 | GO:0007000 | nucleolus organization(GO:0007000) |
0.2 | 0.3 | GO:0002886 | regulation of myeloid leukocyte mediated immunity(GO:0002886) regulation of mast cell activation involved in immune response(GO:0033006) regulation of mast cell degranulation(GO:0043304) |
0.2 | 0.2 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
0.2 | 0.5 | GO:0060048 | cardiac muscle contraction(GO:0060048) |
0.2 | 0.5 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
0.2 | 2.3 | GO:1900046 | regulation of blood coagulation(GO:0030193) regulation of hemostasis(GO:1900046) |
0.2 | 0.2 | GO:0001865 | NK T cell differentiation(GO:0001865) |
0.2 | 0.3 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
0.2 | 0.5 | GO:0070234 | positive regulation of T cell apoptotic process(GO:0070234) |
0.2 | 0.5 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
0.2 | 0.5 | GO:0009642 | response to light intensity(GO:0009642) |
0.2 | 0.5 | GO:0030242 | pexophagy(GO:0030242) |
0.2 | 0.3 | GO:1902307 | positive regulation of sodium ion transmembrane transport(GO:1902307) |
0.2 | 0.2 | GO:0021681 | cerebellar granular layer development(GO:0021681) |
0.2 | 4.6 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.2 | 0.3 | GO:0015889 | cobalamin transport(GO:0015889) |
0.2 | 0.6 | GO:0036303 | lymphangiogenesis(GO:0001946) lymph vessel morphogenesis(GO:0036303) |
0.2 | 0.2 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
0.2 | 0.5 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.2 | 0.2 | GO:0072678 | T cell migration(GO:0072678) |
0.2 | 0.3 | GO:0042138 | meiotic DNA double-strand break formation(GO:0042138) |
0.2 | 2.4 | GO:0007602 | phototransduction(GO:0007602) |
0.2 | 0.2 | GO:0045601 | regulation of endothelial cell differentiation(GO:0045601) |
0.2 | 0.3 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
0.2 | 0.6 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
0.2 | 0.9 | GO:0042407 | cristae formation(GO:0042407) |
0.2 | 0.6 | GO:0002176 | male germ cell proliferation(GO:0002176) germ cell proliferation(GO:0036093) |
0.2 | 0.2 | GO:1902237 | positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902237) |
0.2 | 0.3 | GO:0045639 | positive regulation of myeloid cell differentiation(GO:0045639) |
0.2 | 0.2 | GO:0097531 | mast cell migration(GO:0097531) |
0.2 | 0.3 | GO:0060487 | lung epithelial cell differentiation(GO:0060487) |
0.2 | 0.2 | GO:0018904 | ether metabolic process(GO:0018904) |
0.2 | 0.3 | GO:0046629 | gamma-delta T cell differentiation(GO:0042492) gamma-delta T cell activation(GO:0046629) |
0.2 | 0.5 | GO:2000310 | regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
0.2 | 0.5 | GO:0002082 | regulation of oxidative phosphorylation(GO:0002082) |
0.2 | 0.2 | GO:1903795 | regulation of inorganic anion transmembrane transport(GO:1903795) |
0.2 | 0.2 | GO:0002248 | connective tissue replacement involved in inflammatory response wound healing(GO:0002248) connective tissue replacement(GO:0097709) |
0.2 | 0.3 | GO:0045063 | T-helper 1 cell differentiation(GO:0045063) |
0.2 | 0.2 | GO:0035989 | tendon development(GO:0035989) |
0.2 | 0.2 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
0.2 | 0.2 | GO:0014022 | neural plate elongation(GO:0014022) convergent extension involved in neural plate elongation(GO:0022007) |
0.2 | 0.2 | GO:0031282 | regulation of guanylate cyclase activity(GO:0031282) |
0.2 | 0.3 | GO:0035809 | regulation of urine volume(GO:0035809) |
0.2 | 0.2 | GO:0035747 | natural killer cell chemotaxis(GO:0035747) regulation of natural killer cell chemotaxis(GO:2000501) |
0.2 | 0.2 | GO:0006109 | regulation of carbohydrate metabolic process(GO:0006109) |
0.2 | 0.3 | GO:0048009 | insulin-like growth factor receptor signaling pathway(GO:0048009) |
0.2 | 0.2 | GO:0010804 | negative regulation of tumor necrosis factor-mediated signaling pathway(GO:0010804) |
0.2 | 0.5 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
0.2 | 0.3 | GO:0060632 | regulation of microtubule-based movement(GO:0060632) |
0.2 | 0.2 | GO:0001779 | natural killer cell differentiation(GO:0001779) |
0.1 | 1.3 | GO:0034315 | regulation of Arp2/3 complex-mediated actin nucleation(GO:0034315) |
0.1 | 0.3 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
0.1 | 0.3 | GO:0070253 | somatostatin secretion(GO:0070253) |
0.1 | 0.3 | GO:0061462 | protein localization to lysosome(GO:0061462) |
0.1 | 0.3 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
0.1 | 2.7 | GO:0043433 | negative regulation of sequence-specific DNA binding transcription factor activity(GO:0043433) |
0.1 | 0.1 | GO:0050872 | white fat cell differentiation(GO:0050872) |
0.1 | 0.6 | GO:0046173 | polyol biosynthetic process(GO:0046173) |
0.1 | 0.1 | GO:0014049 | positive regulation of glutamate secretion(GO:0014049) |
0.1 | 0.1 | GO:0060754 | positive regulation of mast cell chemotaxis(GO:0060754) |
0.1 | 0.1 | GO:0046929 | negative regulation of neurotransmitter secretion(GO:0046929) |
0.1 | 0.1 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.1 | 4.1 | GO:0007179 | transforming growth factor beta receptor signaling pathway(GO:0007179) |
0.1 | 0.3 | GO:0018216 | peptidyl-arginine methylation(GO:0018216) peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) peptidyl-arginine N-methylation(GO:0035246) peptidyl-arginine omega-N-methylation(GO:0035247) |
0.1 | 0.1 | GO:0044849 | estrous cycle(GO:0044849) |
0.1 | 0.1 | GO:0070198 | protein localization to chromosome, telomeric region(GO:0070198) |
0.1 | 0.3 | GO:0010760 | negative regulation of macrophage chemotaxis(GO:0010760) |
0.1 | 0.3 | GO:0042226 | interleukin-6 biosynthetic process(GO:0042226) |
0.1 | 0.3 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.1 | 0.1 | GO:0050746 | regulation of lipoprotein metabolic process(GO:0050746) |
0.1 | 0.3 | GO:0050651 | dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
0.1 | 3.2 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
0.1 | 1.3 | GO:0048266 | behavioral response to pain(GO:0048266) |
0.1 | 0.3 | GO:2000425 | regulation of apoptotic cell clearance(GO:2000425) positive regulation of apoptotic cell clearance(GO:2000427) |
0.1 | 1.2 | GO:0090200 | positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
0.1 | 0.7 | GO:0022617 | extracellular matrix disassembly(GO:0022617) |
0.1 | 0.7 | GO:0072595 | maintenance of protein localization in organelle(GO:0072595) |
0.1 | 0.4 | GO:0001570 | vasculogenesis(GO:0001570) |
0.1 | 0.1 | GO:0042977 | activation of JAK2 kinase activity(GO:0042977) |
0.1 | 0.1 | GO:0007098 | centrosome cycle(GO:0007098) |
0.1 | 0.7 | GO:0061337 | cardiac conduction(GO:0061337) |
0.1 | 3.7 | GO:0050821 | protein stabilization(GO:0050821) |
0.1 | 0.9 | GO:0006907 | pinocytosis(GO:0006907) |
0.1 | 11.2 | GO:0006396 | RNA processing(GO:0006396) |
0.1 | 0.1 | GO:0071711 | basement membrane organization(GO:0071711) |
0.1 | 0.7 | GO:0050860 | negative regulation of T cell receptor signaling pathway(GO:0050860) |
0.1 | 0.3 | GO:0030948 | negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
0.1 | 0.8 | GO:0042795 | snRNA transcription from RNA polymerase II promoter(GO:0042795) |
0.1 | 0.4 | GO:0032331 | negative regulation of chondrocyte differentiation(GO:0032331) |
0.1 | 1.8 | GO:0009166 | nucleotide catabolic process(GO:0009166) |
0.1 | 2.1 | GO:0007340 | acrosome reaction(GO:0007340) |
0.1 | 0.4 | GO:0071173 | mitotic spindle assembly checkpoint(GO:0007094) spindle assembly checkpoint(GO:0071173) |
0.1 | 0.4 | GO:0045581 | negative regulation of T cell differentiation(GO:0045581) |
0.1 | 0.6 | GO:0023058 | adaptation of signaling pathway(GO:0023058) |
0.1 | 1.1 | GO:0005978 | glycogen biosynthetic process(GO:0005978) glucan biosynthetic process(GO:0009250) |
0.1 | 0.1 | GO:0042940 | D-amino acid transport(GO:0042940) |
0.1 | 0.1 | GO:0043923 | positive regulation by host of viral transcription(GO:0043923) |
0.1 | 3.2 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
0.1 | 2.5 | GO:0043966 | histone H3 acetylation(GO:0043966) |
0.1 | 0.4 | GO:0051781 | positive regulation of cell division(GO:0051781) |
0.1 | 0.3 | GO:0051444 | negative regulation of ligase activity(GO:0051352) negative regulation of ubiquitin-protein transferase activity(GO:0051444) |
0.1 | 0.4 | GO:2000738 | positive regulation of stem cell differentiation(GO:2000738) |
0.1 | 0.4 | GO:0032897 | negative regulation of viral transcription(GO:0032897) |
0.1 | 0.1 | GO:0042790 | transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:0042790) |
0.1 | 0.1 | GO:0044860 | protein localization to plasma membrane raft(GO:0044860) |
0.1 | 7.1 | GO:0006457 | protein folding(GO:0006457) |
0.1 | 0.1 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.1 | 2.3 | GO:0072583 | clathrin-mediated endocytosis(GO:0072583) |
0.1 | 0.5 | GO:0042273 | ribosomal large subunit biogenesis(GO:0042273) |
0.1 | 0.4 | GO:0042635 | positive regulation of hair cycle(GO:0042635) |
0.1 | 0.7 | GO:1903556 | negative regulation of tumor necrosis factor production(GO:0032720) negative regulation of tumor necrosis factor superfamily cytokine production(GO:1903556) |
0.1 | 0.9 | GO:0000723 | telomere maintenance(GO:0000723) telomere organization(GO:0032200) |
0.1 | 1.5 | GO:0014823 | response to activity(GO:0014823) |
0.1 | 5.5 | GO:0009566 | fertilization(GO:0009566) |
0.1 | 0.3 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
0.1 | 0.1 | GO:0019359 | nicotinamide nucleotide biosynthetic process(GO:0019359) |
0.1 | 1.9 | GO:0045638 | negative regulation of myeloid cell differentiation(GO:0045638) |
0.1 | 0.4 | GO:2000045 | regulation of G1/S transition of mitotic cell cycle(GO:2000045) |
0.1 | 0.3 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
0.1 | 8.7 | GO:0051321 | meiotic cell cycle(GO:0051321) |
0.1 | 2.3 | GO:0045069 | regulation of viral genome replication(GO:0045069) |
0.1 | 0.3 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.1 | 1.1 | GO:0006182 | cGMP biosynthetic process(GO:0006182) |
0.1 | 0.1 | GO:0000722 | telomere maintenance via recombination(GO:0000722) |
0.1 | 0.3 | GO:0051181 | cofactor transport(GO:0051181) |
0.1 | 0.1 | GO:0001781 | neutrophil apoptotic process(GO:0001781) |
0.1 | 0.3 | GO:0051014 | actin filament severing(GO:0051014) |
0.1 | 0.4 | GO:0010955 | negative regulation of protein processing(GO:0010955) negative regulation of protein maturation(GO:1903318) |
0.1 | 0.5 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
0.1 | 0.1 | GO:0051875 | pigment granule localization(GO:0051875) |
0.1 | 0.3 | GO:0048008 | platelet-derived growth factor receptor signaling pathway(GO:0048008) |
0.1 | 0.1 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
0.1 | 0.3 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
0.1 | 0.5 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
0.1 | 0.1 | GO:0032099 | negative regulation of appetite(GO:0032099) |
0.1 | 0.1 | GO:1901069 | guanosine-containing compound catabolic process(GO:1901069) |
0.1 | 0.1 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.1 | 1.8 | GO:0035458 | cellular response to interferon-beta(GO:0035458) |
0.1 | 0.4 | GO:0032482 | Rab protein signal transduction(GO:0032482) |
0.1 | 2.3 | GO:1902652 | cholesterol metabolic process(GO:0008203) secondary alcohol metabolic process(GO:1902652) |
0.1 | 1.8 | GO:0016126 | sterol biosynthetic process(GO:0016126) |
0.1 | 0.3 | GO:0051904 | pigment granule transport(GO:0051904) |
0.1 | 0.3 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
0.1 | 1.5 | GO:0045807 | positive regulation of endocytosis(GO:0045807) |
0.1 | 0.1 | GO:0051560 | mitochondrial calcium ion homeostasis(GO:0051560) |
0.1 | 0.9 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
0.1 | 0.4 | GO:0043278 | response to isoquinoline alkaloid(GO:0014072) response to morphine(GO:0043278) |
0.1 | 0.3 | GO:0009437 | carnitine metabolic process(GO:0009437) |
0.1 | 0.1 | GO:0006779 | porphyrin-containing compound biosynthetic process(GO:0006779) tetrapyrrole biosynthetic process(GO:0033014) |
0.1 | 0.3 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.1 | 0.3 | GO:0032642 | regulation of chemokine production(GO:0032642) |
0.1 | 0.1 | GO:0050755 | chemokine metabolic process(GO:0050755) |
0.1 | 1.4 | GO:0030104 | water homeostasis(GO:0030104) |
0.1 | 0.2 | GO:0051220 | cytoplasmic sequestering of protein(GO:0051220) |
0.1 | 0.1 | GO:0071462 | cellular response to water stimulus(GO:0071462) |
0.1 | 0.1 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
0.1 | 0.1 | GO:0042439 | ethanolamine-containing compound metabolic process(GO:0042439) |
0.1 | 0.2 | GO:0035493 | SNARE complex assembly(GO:0035493) |
0.1 | 0.6 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.1 | 0.1 | GO:1904037 | positive regulation of epithelial cell apoptotic process(GO:1904037) |
0.1 | 0.2 | GO:0002337 | B-1 B cell differentiation(GO:0001923) B-1a B cell differentiation(GO:0002337) |
0.1 | 1.0 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.1 | 1.0 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
0.1 | 0.1 | GO:0090027 | negative regulation of monocyte chemotaxis(GO:0090027) |
0.1 | 0.9 | GO:2000134 | negative regulation of G1/S transition of mitotic cell cycle(GO:2000134) |
0.1 | 0.1 | GO:0035562 | negative regulation of chromatin binding(GO:0035562) |
0.1 | 0.1 | GO:0071895 | odontoblast differentiation(GO:0071895) |
0.1 | 0.5 | GO:0009186 | deoxyribonucleoside diphosphate metabolic process(GO:0009186) |
0.1 | 0.2 | GO:1904251 | regulation of bile acid metabolic process(GO:1904251) |
0.1 | 1.0 | GO:0001990 | regulation of systemic arterial blood pressure by hormone(GO:0001990) |
0.1 | 0.6 | GO:0030225 | macrophage differentiation(GO:0030225) |
0.1 | 0.2 | GO:0048754 | branching morphogenesis of an epithelial tube(GO:0048754) |
0.1 | 0.4 | GO:0097120 | receptor localization to synapse(GO:0097120) |
0.1 | 0.1 | GO:0034145 | positive regulation of toll-like receptor 4 signaling pathway(GO:0034145) |
0.1 | 1.4 | GO:0046854 | phosphatidylinositol phosphorylation(GO:0046854) |
0.1 | 0.2 | GO:0007379 | segment specification(GO:0007379) |
0.1 | 0.6 | GO:0006071 | glycerol metabolic process(GO:0006071) |
0.1 | 0.5 | GO:0042983 | amyloid precursor protein biosynthetic process(GO:0042983) regulation of amyloid precursor protein biosynthetic process(GO:0042984) |
0.1 | 0.1 | GO:0015846 | polyamine transport(GO:0015846) |
0.1 | 0.4 | GO:0006346 | methylation-dependent chromatin silencing(GO:0006346) |
0.1 | 0.1 | GO:0006415 | translational termination(GO:0006415) |
0.1 | 0.1 | GO:0042359 | vitamin D metabolic process(GO:0042359) |
0.1 | 0.2 | GO:0046498 | S-adenosylhomocysteine metabolic process(GO:0046498) |
0.1 | 0.1 | GO:0035457 | cellular response to interferon-alpha(GO:0035457) |
0.1 | 0.2 | GO:0002070 | epithelial cell maturation(GO:0002070) |
0.1 | 8.8 | GO:0016567 | protein ubiquitination(GO:0016567) |
0.1 | 0.2 | GO:0010165 | response to X-ray(GO:0010165) |
0.1 | 0.1 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
0.1 | 0.3 | GO:0043206 | extracellular fibril organization(GO:0043206) |
0.1 | 10.9 | GO:0010466 | negative regulation of peptidase activity(GO:0010466) |
0.1 | 0.1 | GO:0072526 | pyridine-containing compound catabolic process(GO:0072526) |
0.1 | 1.5 | GO:0060976 | coronary vasculature development(GO:0060976) |
0.1 | 0.2 | GO:0060693 | regulation of branching involved in salivary gland morphogenesis(GO:0060693) |
0.1 | 0.2 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.1 | 0.1 | GO:1902742 | apoptotic process involved in development(GO:1902742) |
0.1 | 0.6 | GO:0070873 | regulation of glycogen metabolic process(GO:0070873) |
0.1 | 0.1 | GO:0070257 | positive regulation of mucus secretion(GO:0070257) |
0.1 | 0.2 | GO:0031577 | spindle checkpoint(GO:0031577) |
0.1 | 1.2 | GO:0014910 | regulation of smooth muscle cell migration(GO:0014910) |
0.1 | 0.1 | GO:0052055 | modulation by symbiont of host molecular function(GO:0052055) modulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052203) modulation by host of symbiont catalytic activity(GO:0052422) |
0.1 | 0.1 | GO:0010944 | negative regulation of transcription by competitive promoter binding(GO:0010944) |
0.1 | 0.1 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
0.1 | 0.3 | GO:0006265 | DNA topological change(GO:0006265) |
0.1 | 0.2 | GO:0019363 | pyridine nucleotide biosynthetic process(GO:0019363) |
0.1 | 0.2 | GO:0050764 | regulation of phagocytosis(GO:0050764) |
0.1 | 0.1 | GO:1900377 | negative regulation of melanin biosynthetic process(GO:0048022) negative regulation of secondary metabolite biosynthetic process(GO:1900377) |
0.1 | 2.6 | GO:0051168 | nuclear export(GO:0051168) |
0.1 | 0.8 | GO:0043467 | regulation of generation of precursor metabolites and energy(GO:0043467) |
0.1 | 0.1 | GO:1990791 | dorsal root ganglion development(GO:1990791) |
0.1 | 0.3 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.1 | 0.2 | GO:0008582 | regulation of synaptic growth at neuromuscular junction(GO:0008582) |
0.1 | 0.8 | GO:0016926 | protein desumoylation(GO:0016926) |
0.1 | 0.3 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.1 | 0.5 | GO:0051180 | vitamin transport(GO:0051180) |
0.1 | 2.1 | GO:0007059 | chromosome segregation(GO:0007059) |
0.1 | 1.1 | GO:0007229 | integrin-mediated signaling pathway(GO:0007229) |
0.1 | 0.3 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.1 | 2.3 | GO:1902105 | regulation of leukocyte differentiation(GO:1902105) |
0.1 | 0.5 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
0.1 | 1.5 | GO:0006101 | citrate metabolic process(GO:0006101) |
0.1 | 1.3 | GO:0010921 | regulation of phosphatase activity(GO:0010921) |
0.1 | 0.2 | GO:0046909 | intermembrane transport(GO:0046909) |
0.1 | 0.2 | GO:0032808 | lacrimal gland development(GO:0032808) |
0.1 | 0.2 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
0.1 | 3.2 | GO:0007067 | mitotic nuclear division(GO:0007067) |
0.1 | 0.1 | GO:1900424 | regulation of defense response to bacterium(GO:1900424) |
0.1 | 0.1 | GO:0060988 | lipid tube assembly(GO:0060988) |
0.1 | 2.2 | GO:0000910 | cytokinesis(GO:0000910) |
0.1 | 0.2 | GO:0006098 | pentose-phosphate shunt(GO:0006098) |
0.1 | 0.2 | GO:0002884 | regulation of type IV hypersensitivity(GO:0001807) negative regulation of hypersensitivity(GO:0002884) |
0.1 | 0.3 | GO:1903429 | regulation of cell maturation(GO:1903429) |
0.1 | 0.1 | GO:0042522 | regulation of tyrosine phosphorylation of Stat5 protein(GO:0042522) |
0.1 | 0.5 | GO:0009225 | nucleotide-sugar metabolic process(GO:0009225) |
0.1 | 0.2 | GO:0008340 | determination of adult lifespan(GO:0008340) |
0.1 | 1.3 | GO:0048659 | smooth muscle cell proliferation(GO:0048659) |
0.1 | 0.3 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
0.1 | 0.1 | GO:0043587 | tongue morphogenesis(GO:0043587) |
0.1 | 0.5 | GO:0052646 | alditol phosphate metabolic process(GO:0052646) |
0.1 | 2.4 | GO:0043627 | response to estrogen(GO:0043627) |
0.1 | 0.1 | GO:0010832 | negative regulation of myotube differentiation(GO:0010832) |
0.1 | 0.2 | GO:0002438 | acute inflammatory response to antigenic stimulus(GO:0002438) |
0.1 | 0.6 | GO:0019441 | tryptophan catabolic process(GO:0006569) tryptophan catabolic process to kynurenine(GO:0019441) indole-containing compound catabolic process(GO:0042436) indolalkylamine catabolic process(GO:0046218) |
0.1 | 1.4 | GO:0001649 | osteoblast differentiation(GO:0001649) |
0.1 | 0.1 | GO:1905097 | regulation of guanyl-nucleotide exchange factor activity(GO:1905097) |
0.1 | 0.3 | GO:0009303 | rRNA transcription(GO:0009303) |
0.1 | 0.9 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
0.1 | 0.7 | GO:0045637 | regulation of myeloid cell differentiation(GO:0045637) |
0.1 | 5.6 | GO:0008654 | phospholipid biosynthetic process(GO:0008654) |
0.1 | 0.1 | GO:2000664 | interleukin-5 secretion(GO:0072603) interleukin-13 secretion(GO:0072611) regulation of interleukin-5 secretion(GO:2000662) positive regulation of interleukin-5 secretion(GO:2000664) regulation of interleukin-13 secretion(GO:2000665) positive regulation of interleukin-13 secretion(GO:2000667) |
0.1 | 0.2 | GO:0035928 | rRNA import into mitochondrion(GO:0035928) |
0.1 | 0.3 | GO:0030857 | negative regulation of epithelial cell differentiation(GO:0030857) |
0.1 | 0.1 | GO:0006734 | NADH metabolic process(GO:0006734) |
0.1 | 0.5 | GO:0006828 | manganese ion transport(GO:0006828) |
0.1 | 0.3 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
0.1 | 0.1 | GO:0045907 | positive regulation of vasoconstriction(GO:0045907) |
0.1 | 2.2 | GO:0010811 | positive regulation of cell-substrate adhesion(GO:0010811) |
0.1 | 1.1 | GO:0015991 | energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) ATP hydrolysis coupled proton transport(GO:0015991) ATP hydrolysis coupled transmembrane transport(GO:0090662) |
0.1 | 0.3 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.1 | 1.0 | GO:0043550 | regulation of lipid kinase activity(GO:0043550) |
0.1 | 0.1 | GO:0050849 | negative regulation of calcium-mediated signaling(GO:0050849) |
0.1 | 0.2 | GO:0009624 | response to nematode(GO:0009624) |
0.1 | 0.2 | GO:0019068 | virion assembly(GO:0019068) |
0.1 | 0.5 | GO:0046827 | positive regulation of protein export from nucleus(GO:0046827) |
0.1 | 0.9 | GO:0006414 | translational elongation(GO:0006414) |
0.1 | 0.1 | GO:0033280 | response to vitamin D(GO:0033280) |
0.1 | 0.2 | GO:0006623 | protein targeting to vacuole(GO:0006623) |
0.1 | 0.1 | GO:0033194 | response to hydroperoxide(GO:0033194) |
0.1 | 3.8 | GO:0070646 | protein modification by small protein removal(GO:0070646) |
0.1 | 0.1 | GO:1902309 | negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
0.1 | 0.1 | GO:0008228 | opsonization(GO:0008228) |
0.1 | 0.1 | GO:0070782 | phosphatidylserine exposure on apoptotic cell surface(GO:0070782) |
0.1 | 0.6 | GO:0036065 | fucosylation(GO:0036065) |
0.1 | 0.1 | GO:1901142 | insulin metabolic process(GO:1901142) |
0.1 | 0.6 | GO:0006221 | pyrimidine nucleotide biosynthetic process(GO:0006221) |
0.1 | 0.1 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.1 | 1.1 | GO:0050853 | B cell receptor signaling pathway(GO:0050853) |
0.1 | 0.1 | GO:0043455 | regulation of secondary metabolic process(GO:0043455) |
0.1 | 0.1 | GO:0008594 | photoreceptor cell morphogenesis(GO:0008594) |
0.1 | 0.2 | GO:0010544 | negative regulation of platelet activation(GO:0010544) |
0.1 | 1.6 | GO:0048477 | oogenesis(GO:0048477) |
0.1 | 0.9 | GO:0042254 | ribosome biogenesis(GO:0042254) |
0.1 | 0.1 | GO:0006900 | membrane budding(GO:0006900) |
0.1 | 2.0 | GO:0031424 | keratinization(GO:0031424) |
0.1 | 0.1 | GO:0030825 | positive regulation of cGMP metabolic process(GO:0030825) |
0.1 | 0.1 | GO:0042088 | T-helper 1 type immune response(GO:0042088) |
0.1 | 0.1 | GO:0009972 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
0.1 | 0.7 | GO:0043149 | contractile actin filament bundle assembly(GO:0030038) stress fiber assembly(GO:0043149) |
0.1 | 0.3 | GO:0032785 | negative regulation of DNA-templated transcription, elongation(GO:0032785) negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
0.1 | 0.7 | GO:0007588 | excretion(GO:0007588) |
0.1 | 1.1 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
0.1 | 0.1 | GO:0007468 | regulation of rhodopsin gene expression(GO:0007468) |
0.1 | 0.2 | GO:0016137 | glycoside metabolic process(GO:0016137) |
0.1 | 0.1 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
0.1 | 0.3 | GO:0034063 | stress granule assembly(GO:0034063) |
0.1 | 0.5 | GO:1990403 | embryonic brain development(GO:1990403) |
0.1 | 0.1 | GO:0051450 | myoblast proliferation(GO:0051450) |
0.1 | 0.1 | GO:0035864 | response to potassium ion(GO:0035864) cellular response to potassium ion(GO:0035865) |
0.1 | 0.1 | GO:0032494 | response to peptidoglycan(GO:0032494) |
0.1 | 0.2 | GO:0046621 | negative regulation of organ growth(GO:0046621) |
0.1 | 0.1 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.1 | 0.5 | GO:0045742 | positive regulation of epidermal growth factor receptor signaling pathway(GO:0045742) |
0.1 | 0.3 | GO:0043001 | Golgi to plasma membrane protein transport(GO:0043001) |
0.1 | 0.4 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) |
0.1 | 0.6 | GO:0006490 | oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
0.1 | 0.4 | GO:0001947 | heart looping(GO:0001947) |
0.1 | 0.2 | GO:0045838 | positive regulation of membrane potential(GO:0045838) |
0.1 | 0.7 | GO:0044843 | cell cycle G1/S phase transition(GO:0044843) |
0.1 | 0.1 | GO:0000305 | response to oxygen radical(GO:0000305) |
0.1 | 0.3 | GO:0070233 | negative regulation of T cell apoptotic process(GO:0070233) |
0.1 | 0.2 | GO:0006739 | NADP metabolic process(GO:0006739) |
0.1 | 0.1 | GO:0014904 | myotube cell development(GO:0014904) |
0.1 | 0.6 | GO:2001239 | regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001239) |
0.1 | 1.2 | GO:0007041 | lysosomal transport(GO:0007041) |
0.1 | 2.7 | GO:0050912 | detection of chemical stimulus involved in sensory perception of taste(GO:0050912) |
0.1 | 0.1 | GO:0045088 | regulation of innate immune response(GO:0045088) |
0.1 | 0.1 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
0.1 | 0.4 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
0.1 | 0.1 | GO:0006289 | nucleotide-excision repair(GO:0006289) |
0.1 | 0.7 | GO:0030261 | chromosome condensation(GO:0030261) |
0.1 | 0.1 | GO:0051106 | regulation of DNA ligation(GO:0051105) positive regulation of DNA ligation(GO:0051106) |
0.1 | 0.2 | GO:0008616 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.1 | 0.1 | GO:0090270 | fibroblast growth factor production(GO:0090269) regulation of fibroblast growth factor production(GO:0090270) |
0.1 | 1.0 | GO:0019835 | cytolysis(GO:0019835) |
0.1 | 0.5 | GO:0007565 | female pregnancy(GO:0007565) |
0.1 | 0.3 | GO:0055088 | lipid homeostasis(GO:0055088) |
0.1 | 0.2 | GO:0070723 | response to cholesterol(GO:0070723) |
0.1 | 0.6 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
0.1 | 0.1 | GO:0010948 | negative regulation of cell cycle process(GO:0010948) |
0.1 | 0.7 | GO:0035304 | regulation of protein dephosphorylation(GO:0035304) |
0.1 | 0.2 | GO:0006999 | nuclear pore organization(GO:0006999) |
0.1 | 0.3 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.1 | 0.5 | GO:0007520 | myoblast fusion(GO:0007520) |
0.1 | 0.2 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.1 | 0.1 | GO:0010666 | positive regulation of striated muscle cell apoptotic process(GO:0010663) positive regulation of cardiac muscle cell apoptotic process(GO:0010666) |
0.1 | 0.3 | GO:0042711 | maternal behavior(GO:0042711) |
0.1 | 0.2 | GO:0051973 | positive regulation of telomerase activity(GO:0051973) |
0.1 | 0.1 | GO:0070232 | regulation of T cell apoptotic process(GO:0070232) |
0.1 | 0.1 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
0.1 | 0.1 | GO:0010259 | multicellular organism aging(GO:0010259) |
0.1 | 0.4 | GO:0015858 | nucleoside transport(GO:0015858) |
0.1 | 0.1 | GO:0034143 | regulation of toll-like receptor 4 signaling pathway(GO:0034143) |
0.1 | 0.1 | GO:2000401 | regulation of lymphocyte migration(GO:2000401) |
0.1 | 0.1 | GO:0006824 | cobalt ion transport(GO:0006824) |
0.1 | 0.4 | GO:0050798 | activated T cell proliferation(GO:0050798) |
0.1 | 0.1 | GO:0042474 | middle ear morphogenesis(GO:0042474) |
0.1 | 0.5 | GO:1902017 | regulation of cilium assembly(GO:1902017) |
0.1 | 0.1 | GO:0000012 | single strand break repair(GO:0000012) |
0.1 | 0.1 | GO:0019530 | taurine metabolic process(GO:0019530) |
0.1 | 0.4 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.1 | 0.1 | GO:0046208 | spermine catabolic process(GO:0046208) |
0.1 | 0.6 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
0.1 | 2.7 | GO:0043086 | negative regulation of catalytic activity(GO:0043086) |
0.1 | 0.1 | GO:0071221 | response to bacterial lipoprotein(GO:0032493) response to bacterial lipopeptide(GO:0070339) cellular response to bacterial lipoprotein(GO:0071220) cellular response to bacterial lipopeptide(GO:0071221) response to diacyl bacterial lipopeptide(GO:0071724) response to triacyl bacterial lipopeptide(GO:0071725) cellular response to diacyl bacterial lipopeptide(GO:0071726) cellular response to triacyl bacterial lipopeptide(GO:0071727) |
0.1 | 0.3 | GO:0000070 | mitotic sister chromatid segregation(GO:0000070) |
0.1 | 0.1 | GO:0046164 | alcohol catabolic process(GO:0046164) |
0.1 | 0.3 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) |
0.1 | 0.1 | GO:0035902 | response to immobilization stress(GO:0035902) |
0.1 | 0.1 | GO:0002931 | response to ischemia(GO:0002931) |
0.1 | 0.1 | GO:0050765 | negative regulation of phagocytosis(GO:0050765) |
0.1 | 0.5 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.1 | 2.2 | GO:0008643 | carbohydrate transport(GO:0008643) |
0.1 | 0.1 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
0.1 | 0.3 | GO:0010831 | positive regulation of myotube differentiation(GO:0010831) |
0.1 | 0.1 | GO:0002525 | acute inflammatory response to non-antigenic stimulus(GO:0002525) |
0.1 | 0.1 | GO:0051583 | dopamine uptake involved in synaptic transmission(GO:0051583) catecholamine uptake involved in synaptic transmission(GO:0051934) |
0.1 | 0.1 | GO:0070972 | protein localization to endoplasmic reticulum(GO:0070972) |
0.1 | 0.2 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.1 | 0.1 | GO:0032814 | regulation of natural killer cell activation(GO:0032814) |
0.1 | 0.8 | GO:0042035 | regulation of cytokine biosynthetic process(GO:0042035) |
0.1 | 0.1 | GO:0001573 | ganglioside metabolic process(GO:0001573) |
0.1 | 0.5 | GO:0002437 | inflammatory response to antigenic stimulus(GO:0002437) |
0.1 | 0.1 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
0.1 | 0.1 | GO:0014856 | skeletal muscle satellite cell proliferation(GO:0014841) skeletal muscle cell proliferation(GO:0014856) |
0.1 | 3.7 | GO:0070482 | response to oxygen levels(GO:0070482) |
0.1 | 0.1 | GO:0010596 | negative regulation of endothelial cell migration(GO:0010596) |
0.1 | 0.7 | GO:0030239 | myofibril assembly(GO:0030239) |
0.1 | 0.1 | GO:0034115 | negative regulation of heterotypic cell-cell adhesion(GO:0034115) regulation of cell-cell adhesion involved in gastrulation(GO:0070587) |
0.1 | 0.1 | GO:0042373 | vitamin K metabolic process(GO:0042373) |
0.1 | 2.9 | GO:0006260 | DNA replication(GO:0006260) |
0.1 | 0.1 | GO:0021670 | lateral ventricle development(GO:0021670) |
0.1 | 0.2 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.1 | 2.1 | GO:0002286 | T cell activation involved in immune response(GO:0002286) |
0.1 | 0.2 | GO:0007207 | adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
0.1 | 0.3 | GO:0072663 | protein targeting to peroxisome(GO:0006625) peroxisomal transport(GO:0043574) protein localization to peroxisome(GO:0072662) establishment of protein localization to peroxisome(GO:0072663) |
0.1 | 0.6 | GO:0010257 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.1 | 3.8 | GO:0006631 | fatty acid metabolic process(GO:0006631) |
0.1 | 0.1 | GO:0097011 | cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) response to granulocyte macrophage colony-stimulating factor(GO:0097012) |
0.1 | 0.1 | GO:0070586 | cell-cell adhesion involved in gastrulation(GO:0070586) |
0.1 | 0.1 | GO:0032703 | negative regulation of interleukin-2 production(GO:0032703) |
0.1 | 0.1 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
0.1 | 0.1 | GO:0000076 | DNA replication checkpoint(GO:0000076) |
0.1 | 0.2 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
0.1 | 0.3 | GO:0030033 | microvillus assembly(GO:0030033) |
0.1 | 0.1 | GO:0032329 | L-serine transport(GO:0015825) serine transport(GO:0032329) |
0.1 | 0.2 | GO:1902993 | positive regulation of beta-amyloid formation(GO:1902004) positive regulation of amyloid precursor protein catabolic process(GO:1902993) |
0.1 | 0.4 | GO:0006081 | cellular aldehyde metabolic process(GO:0006081) |
0.1 | 0.9 | GO:0090002 | establishment of protein localization to plasma membrane(GO:0090002) |
0.1 | 0.1 | GO:1901538 | DNA methylation involved in embryo development(GO:0043045) changes to DNA methylation involved in embryo development(GO:1901538) |
0.1 | 0.1 | GO:0044406 | adhesion of symbiont to host(GO:0044406) |
0.1 | 0.3 | GO:0007274 | neuromuscular synaptic transmission(GO:0007274) |
0.1 | 0.1 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) |
0.1 | 0.1 | GO:0031642 | negative regulation of myelination(GO:0031642) |
0.1 | 0.1 | GO:0046033 | AMP metabolic process(GO:0046033) |
0.1 | 6.2 | GO:0019236 | response to pheromone(GO:0019236) |
0.1 | 0.1 | GO:0009649 | entrainment of circadian clock(GO:0009649) |
0.1 | 4.9 | GO:0006897 | endocytosis(GO:0006897) |
0.1 | 0.1 | GO:0031572 | G2 DNA damage checkpoint(GO:0031572) |
0.1 | 0.1 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.1 | 0.1 | GO:0043030 | regulation of macrophage activation(GO:0043030) |
0.1 | 0.1 | GO:0035751 | regulation of lysosomal lumen pH(GO:0035751) |
0.1 | 0.2 | GO:1902042 | negative regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902042) |
0.1 | 0.1 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
0.1 | 0.6 | GO:0006413 | translational initiation(GO:0006413) |
0.1 | 0.1 | GO:0051385 | response to mineralocorticoid(GO:0051385) |
0.1 | 0.1 | GO:0044257 | cellular protein catabolic process(GO:0044257) |
0.1 | 0.1 | GO:0045019 | negative regulation of nitric oxide biosynthetic process(GO:0045019) negative regulation of nitric oxide metabolic process(GO:1904406) |
0.1 | 0.3 | GO:0002687 | positive regulation of leukocyte migration(GO:0002687) |
0.1 | 0.1 | GO:0090527 | actin filament reorganization(GO:0090527) |
0.1 | 0.7 | GO:0006040 | amino sugar metabolic process(GO:0006040) |
0.1 | 0.1 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
0.1 | 0.2 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
0.1 | 0.1 | GO:0070206 | protein trimerization(GO:0070206) |
0.1 | 0.2 | GO:0006638 | neutral lipid metabolic process(GO:0006638) |
0.1 | 0.1 | GO:0002710 | negative regulation of T cell mediated immunity(GO:0002710) |
0.1 | 0.1 | GO:0035898 | parathyroid hormone secretion(GO:0035898) |
0.1 | 0.2 | GO:0018211 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.1 | 0.1 | GO:0021557 | oculomotor nerve development(GO:0021557) |
0.1 | 0.1 | GO:0042424 | catechol-containing compound catabolic process(GO:0019614) catecholamine catabolic process(GO:0042424) |
0.1 | 0.2 | GO:2000573 | positive regulation of DNA biosynthetic process(GO:2000573) |
0.1 | 0.1 | GO:0003170 | heart valve development(GO:0003170) |
0.1 | 0.6 | GO:0035725 | sodium ion transmembrane transport(GO:0035725) |
0.1 | 0.1 | GO:0016072 | rRNA metabolic process(GO:0016072) |
0.1 | 0.1 | GO:0016540 | protein autoprocessing(GO:0016540) |
0.1 | 0.2 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
0.1 | 0.9 | GO:0000045 | autophagosome assembly(GO:0000045) |
0.1 | 0.1 | GO:0060033 | anatomical structure regression(GO:0060033) |
0.1 | 0.2 | GO:0016486 | peptide hormone processing(GO:0016486) |
0.1 | 0.1 | GO:2000325 | regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
0.1 | 0.1 | GO:0042851 | L-alanine metabolic process(GO:0042851) |
0.0 | 3.2 | GO:0051603 | proteolysis involved in cellular protein catabolic process(GO:0051603) |
0.0 | 0.1 | GO:0044380 | protein localization to cytoskeleton(GO:0044380) |
0.0 | 0.0 | GO:1901620 | regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901620) |
0.0 | 0.1 | GO:0002063 | chondrocyte development(GO:0002063) |
0.0 | 0.1 | GO:0010225 | response to UV-C(GO:0010225) |
0.0 | 0.1 | GO:0003014 | renal system process(GO:0003014) |
0.0 | 0.0 | GO:1903706 | regulation of hemopoiesis(GO:1903706) |
0.0 | 0.1 | GO:0010172 | embryonic body morphogenesis(GO:0010172) |
0.0 | 0.1 | GO:0007320 | insemination(GO:0007320) |
0.0 | 0.1 | GO:0032328 | alanine transport(GO:0032328) |
0.0 | 0.1 | GO:0032418 | lysosome localization(GO:0032418) |
0.0 | 0.0 | GO:0006368 | transcription elongation from RNA polymerase II promoter(GO:0006368) |
0.0 | 0.1 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.0 | 0.1 | GO:0036344 | platelet formation(GO:0030220) platelet morphogenesis(GO:0036344) |
0.0 | 0.2 | GO:0042246 | tissue regeneration(GO:0042246) |
0.0 | 0.0 | GO:0034162 | toll-like receptor 9 signaling pathway(GO:0034162) |
0.0 | 0.1 | GO:0006884 | cell volume homeostasis(GO:0006884) |
0.0 | 0.1 | GO:0034453 | microtubule anchoring(GO:0034453) |
0.0 | 0.0 | GO:0032768 | regulation of monooxygenase activity(GO:0032768) |
0.0 | 0.0 | GO:0045839 | negative regulation of mitotic nuclear division(GO:0045839) |
0.0 | 0.1 | GO:0050909 | sensory perception of taste(GO:0050909) |
0.0 | 0.5 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.0 | 0.1 | GO:0043029 | T cell homeostasis(GO:0043029) |
0.0 | 0.0 | GO:0001553 | luteinization(GO:0001553) |
0.0 | 0.0 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) |
0.0 | 0.0 | GO:0090214 | spongiotrophoblast layer developmental growth(GO:0090214) |
0.0 | 0.1 | GO:0033003 | regulation of mast cell activation(GO:0033003) |
0.0 | 0.0 | GO:0002036 | regulation of L-glutamate transport(GO:0002036) |
0.0 | 6.3 | GO:0006518 | peptide metabolic process(GO:0006518) |
0.0 | 0.0 | GO:0015791 | polyol transport(GO:0015791) |
0.0 | 0.0 | GO:0060856 | establishment of blood-brain barrier(GO:0060856) |
0.0 | 0.0 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
0.0 | 0.0 | GO:0097501 | stress response to metal ion(GO:0097501) |
0.0 | 0.0 | GO:1903901 | negative regulation of viral life cycle(GO:1903901) |
0.0 | 0.1 | GO:0010719 | negative regulation of epithelial to mesenchymal transition(GO:0010719) |
0.0 | 0.0 | GO:0072523 | purine-containing compound catabolic process(GO:0072523) |
0.0 | 0.1 | GO:0000288 | nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:0000288) |
0.0 | 0.0 | GO:0060442 | branching involved in prostate gland morphogenesis(GO:0060442) |
0.0 | 0.1 | GO:0042756 | drinking behavior(GO:0042756) |
0.0 | 0.0 | GO:0070417 | cellular response to cold(GO:0070417) |
0.0 | 0.0 | GO:0010840 | regulation of circadian sleep/wake cycle, wakefulness(GO:0010840) positive regulation of circadian sleep/wake cycle, wakefulness(GO:0010841) circadian sleep/wake cycle, wakefulness(GO:0042746) |
0.0 | 0.2 | GO:0032098 | regulation of appetite(GO:0032098) |
0.0 | 0.2 | GO:0001937 | negative regulation of endothelial cell proliferation(GO:0001937) |
0.0 | 0.0 | GO:0046122 | dGTP metabolic process(GO:0046070) purine deoxyribonucleoside metabolic process(GO:0046122) |
0.0 | 0.0 | GO:0071354 | cellular response to interleukin-6(GO:0071354) |
0.0 | 0.0 | GO:0008216 | spermidine metabolic process(GO:0008216) |
0.0 | 0.1 | GO:0031648 | protein destabilization(GO:0031648) |
0.0 | 0.1 | GO:0006360 | transcription from RNA polymerase I promoter(GO:0006360) |
0.0 | 0.1 | GO:0043392 | negative regulation of DNA binding(GO:0043392) |
0.0 | 0.2 | GO:0009060 | aerobic respiration(GO:0009060) |
0.0 | 0.0 | GO:0001787 | natural killer cell proliferation(GO:0001787) |
0.0 | 2.6 | GO:0042742 | defense response to bacterium(GO:0042742) |
0.0 | 0.0 | GO:0051602 | response to electrical stimulus(GO:0051602) |
0.0 | 0.0 | GO:0042939 | glutathione transport(GO:0034635) tripeptide transport(GO:0042939) |
0.0 | 0.1 | GO:0071806 | intracellular protein transmembrane transport(GO:0065002) protein transmembrane transport(GO:0071806) |
0.0 | 0.0 | GO:0019042 | viral latency(GO:0019042) |
0.0 | 0.1 | GO:0014002 | astrocyte development(GO:0014002) |
0.0 | 0.0 | GO:0036297 | interstrand cross-link repair(GO:0036297) |
0.0 | 0.0 | GO:0048557 | embryonic digestive tract morphogenesis(GO:0048557) |
0.0 | 0.0 | GO:0032800 | receptor biosynthetic process(GO:0032800) |
0.0 | 0.2 | GO:0071880 | adenylate cyclase-activating adrenergic receptor signaling pathway(GO:0071880) |
0.0 | 0.1 | GO:0098876 | vesicle-mediated transport to the plasma membrane(GO:0098876) |
0.0 | 0.0 | GO:0050703 | interleukin-1 alpha secretion(GO:0050703) |
0.0 | 0.1 | GO:0001906 | cell killing(GO:0001906) |
0.0 | 0.0 | GO:0060022 | hard palate development(GO:0060022) |
0.0 | 0.0 | GO:0032693 | negative regulation of interleukin-10 production(GO:0032693) |
0.0 | 0.0 | GO:0009247 | glycolipid biosynthetic process(GO:0009247) |
0.0 | 32.2 | GO:0007608 | sensory perception of smell(GO:0007608) |
0.0 | 0.0 | GO:0007386 | compartment pattern specification(GO:0007386) |
0.0 | 0.0 | GO:0001836 | release of cytochrome c from mitochondria(GO:0001836) |
0.0 | 0.0 | GO:0070664 | negative regulation of leukocyte proliferation(GO:0070664) |
0.0 | 0.1 | GO:0034446 | substrate adhesion-dependent cell spreading(GO:0034446) |
0.0 | 0.0 | GO:1902175 | regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902175) |
0.0 | 0.0 | GO:0021548 | pons development(GO:0021548) |
0.0 | 0.0 | GO:0002446 | neutrophil mediated immunity(GO:0002446) |
0.0 | 0.0 | GO:0006705 | mineralocorticoid biosynthetic process(GO:0006705) |
0.0 | 0.1 | GO:0007528 | neuromuscular junction development(GO:0007528) |
0.0 | 0.0 | GO:0006353 | DNA-templated transcription, termination(GO:0006353) |
0.0 | 0.1 | GO:0042481 | regulation of odontogenesis(GO:0042481) |
0.0 | 0.0 | GO:0050854 | regulation of antigen receptor-mediated signaling pathway(GO:0050854) |
0.0 | 0.1 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
0.0 | 0.0 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
0.0 | 0.0 | GO:0046500 | S-adenosylmethionine metabolic process(GO:0046500) |
0.0 | 0.0 | GO:0050779 | RNA destabilization(GO:0050779) |
0.0 | 1.4 | GO:0009617 | response to bacterium(GO:0009617) |
0.0 | 0.0 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
0.0 | 0.0 | GO:0048313 | Golgi inheritance(GO:0048313) |
0.0 | 0.0 | GO:0003084 | positive regulation of systemic arterial blood pressure(GO:0003084) |
0.0 | 0.3 | GO:0002902 | regulation of B cell apoptotic process(GO:0002902) |
0.0 | 0.0 | GO:0033628 | regulation of cell adhesion mediated by integrin(GO:0033628) |
0.0 | 0.0 | GO:0002507 | tolerance induction(GO:0002507) |
0.0 | 0.0 | GO:0006826 | iron ion transport(GO:0006826) |
0.0 | 0.0 | GO:0030656 | regulation of vitamin metabolic process(GO:0030656) |
0.0 | 0.0 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.0 | 0.0 | GO:0045616 | regulation of keratinocyte differentiation(GO:0045616) |
0.0 | 0.1 | GO:0000725 | double-strand break repair via homologous recombination(GO:0000724) recombinational repair(GO:0000725) |
0.0 | 0.0 | GO:0097211 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
0.0 | 1.0 | GO:0006869 | lipid transport(GO:0006869) |
0.0 | 0.1 | GO:0008631 | intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0008631) |
0.0 | 0.0 | GO:0045759 | negative regulation of action potential(GO:0045759) |
0.0 | 0.0 | GO:0006949 | syncytium formation(GO:0006949) |
0.0 | 0.0 | GO:0006577 | amino-acid betaine metabolic process(GO:0006577) |
0.0 | 0.0 | GO:0031000 | response to caffeine(GO:0031000) |
0.0 | 0.4 | GO:0019318 | hexose metabolic process(GO:0019318) |
0.0 | 0.0 | GO:0002313 | mature B cell differentiation involved in immune response(GO:0002313) |
0.0 | 0.1 | GO:0051923 | sulfation(GO:0051923) |
0.0 | 0.1 | GO:0007289 | spermatid nucleus differentiation(GO:0007289) |
0.0 | 0.0 | GO:0070228 | regulation of lymphocyte apoptotic process(GO:0070228) |
0.0 | 0.1 | GO:0050884 | neuromuscular process controlling posture(GO:0050884) |
0.0 | 0.1 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.0 | 0.0 | GO:0048102 | autophagic cell death(GO:0048102) |
0.0 | 0.0 | GO:0033685 | negative regulation of luteinizing hormone secretion(GO:0033685) |
0.0 | 0.0 | GO:0016322 | neuron remodeling(GO:0016322) |
0.0 | 0.0 | GO:0008078 | mesodermal cell migration(GO:0008078) |
0.0 | 0.0 | GO:0043535 | regulation of blood vessel endothelial cell migration(GO:0043535) |
0.0 | 0.0 | GO:0070986 | left/right axis specification(GO:0070986) |
0.0 | 0.0 | GO:0045059 | positive thymic T cell selection(GO:0045059) |
0.0 | 0.0 | GO:2000253 | positive regulation of feeding behavior(GO:2000253) |
0.0 | 0.0 | GO:0097284 | hepatocyte apoptotic process(GO:0097284) |
0.0 | 0.1 | GO:2001243 | negative regulation of intrinsic apoptotic signaling pathway(GO:2001243) |
0.0 | 0.2 | GO:0007606 | sensory perception of chemical stimulus(GO:0007606) |
0.0 | 0.0 | GO:0060648 | mammary gland bud morphogenesis(GO:0060648) |
0.0 | 0.0 | GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
0.0 | 0.0 | GO:0048318 | axial mesoderm development(GO:0048318) |
0.0 | 0.0 | GO:0071577 | zinc II ion transmembrane transport(GO:0071577) |
0.0 | 0.0 | GO:0006624 | vacuolar protein processing(GO:0006624) |
0.0 | 0.0 | GO:0009597 | detection of virus(GO:0009597) |
0.0 | 0.0 | GO:0051482 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway(GO:0051482) |
0.0 | 0.0 | GO:0046040 | IMP metabolic process(GO:0046040) |
0.0 | 0.0 | GO:1900078 | positive regulation of cellular response to insulin stimulus(GO:1900078) |
0.0 | 0.0 | GO:0018377 | protein myristoylation(GO:0018377) |
0.0 | 0.0 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.0 | 0.1 | GO:0006493 | protein O-linked glycosylation(GO:0006493) |
0.0 | 0.0 | GO:0008355 | olfactory learning(GO:0008355) |
0.0 | 0.0 | GO:2000479 | regulation of cAMP-dependent protein kinase activity(GO:2000479) |
0.0 | 0.0 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
0.0 | 0.1 | GO:0014020 | primary neural tube formation(GO:0014020) |
0.0 | 0.0 | GO:0051835 | positive regulation of synapse structural plasticity(GO:0051835) |
0.0 | 0.0 | GO:0072643 | interferon-gamma secretion(GO:0072643) |
0.0 | 0.0 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
7.6 | 22.9 | GO:0097413 | Lewy body(GO:0097413) |
6.6 | 99.0 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
4.9 | 34.5 | GO:0090543 | Flemming body(GO:0090543) |
4.0 | 11.9 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
3.5 | 3.5 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
3.3 | 9.9 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
3.2 | 12.7 | GO:0097452 | GAIT complex(GO:0097452) |
3.0 | 8.9 | GO:0097443 | sorting endosome(GO:0097443) |
2.9 | 8.7 | GO:0043259 | laminin-10 complex(GO:0043259) |
2.7 | 8.0 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
2.5 | 2.5 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
2.4 | 28.7 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
2.2 | 33.6 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
2.1 | 39.4 | GO:1902562 | NuA4 histone acetyltransferase complex(GO:0035267) H4/H2A histone acetyltransferase complex(GO:0043189) H4 histone acetyltransferase complex(GO:1902562) |
2.0 | 6.0 | GO:0034679 | integrin alpha9-beta1 complex(GO:0034679) |
2.0 | 19.8 | GO:0031010 | ISWI-type complex(GO:0031010) |
1.9 | 25.3 | GO:0031528 | microvillus membrane(GO:0031528) |
1.9 | 9.7 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
1.9 | 5.8 | GO:0036488 | CHOP-C/EBP complex(GO:0036488) |
1.9 | 7.7 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
1.9 | 9.6 | GO:0000275 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
1.8 | 7.4 | GO:0032437 | cuticular plate(GO:0032437) |
1.6 | 12.5 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
1.5 | 10.8 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
1.5 | 12.1 | GO:0032591 | dendritic spine membrane(GO:0032591) |
1.5 | 4.5 | GO:0097451 | glial limiting end-foot(GO:0097451) |
1.5 | 10.5 | GO:0005833 | hemoglobin complex(GO:0005833) |
1.5 | 4.4 | GO:0017133 | mitochondrial electron transfer flavoprotein complex(GO:0017133) electron transfer flavoprotein complex(GO:0045251) |
1.4 | 4.3 | GO:0097513 | myosin II filament(GO:0097513) |
1.4 | 4.2 | GO:0070552 | BRISC complex(GO:0070552) |
1.4 | 4.2 | GO:0005955 | calcineurin complex(GO:0005955) |
1.4 | 11.0 | GO:0005861 | troponin complex(GO:0005861) |
1.4 | 12.3 | GO:0030426 | growth cone(GO:0030426) |
1.3 | 4.0 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
1.3 | 7.6 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
1.3 | 5.0 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
1.2 | 7.1 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
1.2 | 5.8 | GO:0016461 | unconventional myosin complex(GO:0016461) |
1.2 | 67.4 | GO:0000118 | histone deacetylase complex(GO:0000118) |
1.2 | 10.4 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
1.1 | 9.1 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
1.1 | 4.5 | GO:0000942 | condensed nuclear chromosome outer kinetochore(GO:0000942) |
1.1 | 10.1 | GO:0071439 | clathrin complex(GO:0071439) |
1.1 | 21.2 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
1.1 | 25.6 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
1.1 | 3.3 | GO:0034457 | Mpp10 complex(GO:0034457) |
1.1 | 8.9 | GO:0005753 | mitochondrial proton-transporting ATP synthase complex(GO:0005753) |
1.1 | 1.1 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
1.1 | 4.4 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
1.1 | 12.0 | GO:0032797 | SMN complex(GO:0032797) |
1.1 | 4.3 | GO:0000178 | exosome (RNase complex)(GO:0000178) |
1.1 | 5.4 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
1.1 | 14.0 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
1.1 | 8.5 | GO:0045179 | apical cortex(GO:0045179) |
1.0 | 7.2 | GO:0071014 | post-mRNA release spliceosomal complex(GO:0071014) |
1.0 | 4.0 | GO:0031988 | membrane-bounded vesicle(GO:0031988) |
1.0 | 3.0 | GO:0035189 | Rb-E2F complex(GO:0035189) |
1.0 | 9.7 | GO:0031143 | pseudopodium(GO:0031143) |
0.9 | 9.4 | GO:0002102 | podosome(GO:0002102) |
0.9 | 2.8 | GO:0031417 | NatC complex(GO:0031417) |
0.9 | 3.7 | GO:0005726 | perichromatin fibrils(GO:0005726) |
0.9 | 6.5 | GO:0005688 | U6 snRNP(GO:0005688) |
0.9 | 8.3 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.9 | 2.7 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.9 | 2.7 | GO:0097512 | cardiac myofibril(GO:0097512) |
0.9 | 0.9 | GO:0097454 | Schwann cell microvillus(GO:0097454) |
0.9 | 10.5 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.9 | 2.6 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
0.9 | 63.4 | GO:0030863 | cortical cytoskeleton(GO:0030863) |
0.9 | 2.6 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
0.9 | 4.3 | GO:0072559 | NLRP3 inflammasome complex(GO:0072559) |
0.8 | 9.2 | GO:0031430 | M band(GO:0031430) |
0.8 | 11.7 | GO:0005640 | nuclear outer membrane(GO:0005640) |
0.8 | 4.2 | GO:0005827 | polar microtubule(GO:0005827) |
0.8 | 15.7 | GO:0045120 | pronucleus(GO:0045120) |
0.8 | 5.7 | GO:1990204 | oxidoreductase complex(GO:1990204) |
0.8 | 1.6 | GO:0071141 | SMAD protein complex(GO:0071141) |
0.8 | 12.7 | GO:0043034 | costamere(GO:0043034) |
0.8 | 7.9 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
0.8 | 3.2 | GO:0000974 | Prp19 complex(GO:0000974) |
0.8 | 3.1 | GO:0033269 | internode region of axon(GO:0033269) |
0.8 | 6.2 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
0.8 | 3.8 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.8 | 3.8 | GO:0033093 | Weibel-Palade body(GO:0033093) |
0.8 | 11.5 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.8 | 2.3 | GO:0070110 | ciliary neurotrophic factor receptor complex(GO:0070110) |
0.8 | 3.0 | GO:0071953 | elastic fiber(GO:0071953) |
0.8 | 21.9 | GO:0015030 | Cajal body(GO:0015030) |
0.7 | 0.7 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
0.7 | 5.1 | GO:0097431 | mitotic spindle pole(GO:0097431) |
0.7 | 2.2 | GO:0070938 | contractile ring(GO:0070938) |
0.7 | 2.2 | GO:0032444 | activin responsive factor complex(GO:0032444) |
0.7 | 2.2 | GO:0005915 | zonula adherens(GO:0005915) |
0.7 | 2.1 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
0.7 | 3.5 | GO:0005638 | lamin filament(GO:0005638) |
0.7 | 2.1 | GO:0044327 | dendritic spine head(GO:0044327) |
0.7 | 1.4 | GO:0036449 | microtubule minus-end(GO:0036449) |
0.7 | 13.0 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.7 | 4.7 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
0.7 | 1.4 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
0.7 | 0.7 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.7 | 13.3 | GO:0031941 | filamentous actin(GO:0031941) |
0.7 | 10.0 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.7 | 7.3 | GO:0035102 | PRC1 complex(GO:0035102) |
0.7 | 2.0 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.7 | 6.5 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
0.7 | 2.6 | GO:0005818 | aster(GO:0005818) |
0.6 | 1.3 | GO:0032133 | chromosome passenger complex(GO:0032133) |
0.6 | 1.9 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
0.6 | 6.4 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.6 | 2.6 | GO:0099738 | cell cortex region(GO:0099738) |
0.6 | 1.9 | GO:0033063 | Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
0.6 | 1.3 | GO:0071203 | WASH complex(GO:0071203) |
0.6 | 1.9 | GO:0005745 | m-AAA complex(GO:0005745) |
0.6 | 1.9 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
0.6 | 2.5 | GO:0001651 | dense fibrillar component(GO:0001651) |
0.6 | 3.1 | GO:0071437 | invadopodium(GO:0071437) |
0.6 | 4.9 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.6 | 3.6 | GO:0030119 | AP-type membrane coat adaptor complex(GO:0030119) |
0.6 | 1.2 | GO:1990635 | proximal dendrite(GO:1990635) |
0.6 | 13.9 | GO:0031519 | PcG protein complex(GO:0031519) |
0.6 | 1.2 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
0.6 | 6.0 | GO:0005844 | polysome(GO:0005844) |
0.6 | 4.8 | GO:0070578 | RISC-loading complex(GO:0070578) |
0.6 | 13.1 | GO:0000791 | euchromatin(GO:0000791) |
0.6 | 1.2 | GO:0032010 | phagolysosome(GO:0032010) |
0.6 | 7.1 | GO:0032994 | protein-lipid complex(GO:0032994) |
0.6 | 24.8 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.6 | 7.1 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.6 | 10.5 | GO:0031985 | Golgi cisterna(GO:0031985) |
0.6 | 1.8 | GO:0044354 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.6 | 2.9 | GO:0005579 | membrane attack complex(GO:0005579) |
0.6 | 7.6 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
0.6 | 5.8 | GO:0033270 | paranode region of axon(GO:0033270) |
0.6 | 2.3 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.6 | 1.7 | GO:0097149 | centralspindlin complex(GO:0097149) |
0.6 | 3.4 | GO:0005796 | Golgi lumen(GO:0005796) |
0.6 | 1.7 | GO:0034464 | BBSome(GO:0034464) |
0.6 | 5.1 | GO:0030673 | axolemma(GO:0030673) |
0.6 | 24.2 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.6 | 1.1 | GO:0005682 | U5 snRNP(GO:0005682) |
0.6 | 1.7 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
0.6 | 5.0 | GO:0051233 | spindle midzone(GO:0051233) |
0.6 | 2.2 | GO:0042629 | mast cell granule(GO:0042629) |
0.6 | 23.2 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.5 | 3.8 | GO:0042382 | paraspeckles(GO:0042382) |
0.5 | 2.2 | GO:0031298 | replication fork protection complex(GO:0031298) |
0.5 | 1.6 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.5 | 10.9 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.5 | 3.8 | GO:0044666 | MLL3/4 complex(GO:0044666) |
0.5 | 1.6 | GO:0016342 | catenin complex(GO:0016342) |
0.5 | 2.2 | GO:0008622 | epsilon DNA polymerase complex(GO:0008622) |
0.5 | 28.1 | GO:0005811 | lipid particle(GO:0005811) |
0.5 | 15.7 | GO:0072686 | mitotic spindle(GO:0072686) |
0.5 | 1.6 | GO:0097255 | R2TP complex(GO:0097255) |
0.5 | 11.3 | GO:0001725 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
0.5 | 2.1 | GO:0070776 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.5 | 0.5 | GO:0032279 | asymmetric synapse(GO:0032279) |
0.5 | 5.3 | GO:0046540 | U4/U6 x U5 tri-snRNP complex(GO:0046540) |
0.5 | 83.5 | GO:0016604 | nuclear body(GO:0016604) |
0.5 | 6.8 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.5 | 1.6 | GO:0044194 | cytolytic granule(GO:0044194) |
0.5 | 2.1 | GO:0043025 | neuronal cell body(GO:0043025) |
0.5 | 11.8 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.5 | 14.8 | GO:0043231 | intracellular membrane-bounded organelle(GO:0043231) |
0.5 | 19.4 | GO:0016363 | nuclear matrix(GO:0016363) |
0.5 | 0.5 | GO:0042575 | DNA polymerase complex(GO:0042575) |
0.5 | 3.0 | GO:0031209 | SCAR complex(GO:0031209) |
0.5 | 6.6 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.5 | 3.0 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.5 | 5.5 | GO:0032039 | integrator complex(GO:0032039) |
0.5 | 2.5 | GO:0070820 | tertiary granule(GO:0070820) |
0.5 | 3.0 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) |
0.5 | 4.9 | GO:0001527 | microfibril(GO:0001527) |
0.5 | 2.0 | GO:0034993 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.5 | 1.5 | GO:0000805 | X chromosome(GO:0000805) |
0.5 | 1.5 | GO:0005712 | chiasma(GO:0005712) |
0.5 | 4.4 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
0.5 | 10.7 | GO:0008305 | integrin complex(GO:0008305) |
0.5 | 1.9 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.5 | 1.9 | GO:0031502 | dolichyl-phosphate-mannose-protein mannosyltransferase complex(GO:0031502) |
0.5 | 9.5 | GO:0000792 | heterochromatin(GO:0000792) |
0.5 | 8.5 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
0.5 | 4.2 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.5 | 4.7 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.5 | 0.5 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
0.5 | 1.8 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.5 | 11.5 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
0.5 | 2.7 | GO:0035371 | microtubule plus-end(GO:0035371) |
0.4 | 0.9 | GO:0009279 | cell outer membrane(GO:0009279) cell envelope(GO:0030313) external encapsulating structure part(GO:0044462) |
0.4 | 3.1 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.4 | 2.6 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.4 | 108.9 | GO:0005925 | focal adhesion(GO:0005925) |
0.4 | 2.2 | GO:0042641 | actomyosin(GO:0042641) |
0.4 | 2.2 | GO:0032991 | macromolecular complex(GO:0032991) |
0.4 | 0.4 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
0.4 | 3.0 | GO:0036038 | MKS complex(GO:0036038) |
0.4 | 0.8 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
0.4 | 8.8 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.4 | 3.8 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
0.4 | 0.4 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.4 | 2.1 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.4 | 2.0 | GO:0000788 | nuclear nucleosome(GO:0000788) |
0.4 | 2.4 | GO:0035869 | ciliary transition zone(GO:0035869) |
0.4 | 0.8 | GO:0032300 | mismatch repair complex(GO:0032300) |
0.4 | 2.4 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.4 | 16.7 | GO:0031228 | intrinsic component of Golgi membrane(GO:0031228) |
0.4 | 2.4 | GO:0097539 | ciliary transition fiber(GO:0097539) |
0.4 | 6.9 | GO:0090544 | BAF-type complex(GO:0090544) |
0.4 | 14.5 | GO:0045171 | intercellular bridge(GO:0045171) |
0.4 | 16.1 | GO:0009295 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
0.4 | 17.2 | GO:0000794 | condensed nuclear chromosome(GO:0000794) |
0.4 | 0.8 | GO:0005914 | spot adherens junction(GO:0005914) |
0.4 | 1.6 | GO:0005774 | vacuolar membrane(GO:0005774) |
0.4 | 1.6 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
0.4 | 1.6 | GO:0031983 | vesicle lumen(GO:0031983) |
0.4 | 0.8 | GO:0031262 | Ndc80 complex(GO:0031262) |
0.4 | 0.4 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
0.4 | 2.3 | GO:0097208 | alveolar lamellar body(GO:0097208) |
0.4 | 0.8 | GO:0016528 | sarcoplasm(GO:0016528) |
0.4 | 1.9 | GO:0061617 | MICOS complex(GO:0061617) |
0.4 | 5.4 | GO:0000779 | condensed chromosome, centromeric region(GO:0000779) |
0.4 | 5.8 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.4 | 5.0 | GO:0031672 | A band(GO:0031672) |
0.4 | 0.8 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.4 | 1.1 | GO:1990423 | RZZ complex(GO:1990423) |
0.4 | 3.8 | GO:0035861 | site of double-strand break(GO:0035861) |
0.4 | 0.8 | GO:0070531 | BRCA1-A complex(GO:0070531) |
0.4 | 1.5 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
0.4 | 0.8 | GO:0033647 | host intracellular organelle(GO:0033647) host intracellular membrane-bounded organelle(GO:0033648) |
0.4 | 1.5 | GO:0031313 | extrinsic component of vacuolar membrane(GO:0000306) extrinsic component of endosome membrane(GO:0031313) |
0.4 | 5.3 | GO:0030904 | retromer complex(GO:0030904) |
0.4 | 1.9 | GO:1904115 | axon cytoplasm(GO:1904115) |
0.4 | 132.2 | GO:0005813 | centrosome(GO:0005813) |
0.4 | 4.1 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
0.4 | 1.5 | GO:0015629 | actin cytoskeleton(GO:0015629) |
0.4 | 0.7 | GO:0042583 | chromaffin granule(GO:0042583) |
0.4 | 6.7 | GO:0000152 | nuclear ubiquitin ligase complex(GO:0000152) |
0.4 | 9.2 | GO:0016459 | myosin complex(GO:0016459) |
0.4 | 0.7 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.4 | 1.8 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.4 | 3.3 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.4 | 0.7 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.4 | 0.7 | GO:0030312 | external encapsulating structure(GO:0030312) |
0.4 | 0.7 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
0.4 | 5.0 | GO:0032838 | cell projection cytoplasm(GO:0032838) |
0.4 | 23.6 | GO:0090575 | RNA polymerase II transcription factor complex(GO:0090575) |
0.4 | 7.1 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.4 | 5.0 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.4 | 0.7 | GO:0045259 | proton-transporting ATP synthase complex(GO:0045259) |
0.4 | 2.5 | GO:0031932 | TORC2 complex(GO:0031932) |
0.4 | 0.4 | GO:0000812 | Swr1 complex(GO:0000812) |
0.4 | 0.4 | GO:0031527 | filopodium membrane(GO:0031527) |
0.3 | 60.6 | GO:0005667 | transcription factor complex(GO:0005667) |
0.3 | 4.2 | GO:0031231 | intrinsic component of peroxisomal membrane(GO:0031231) |
0.3 | 165.4 | GO:0005730 | nucleolus(GO:0005730) |
0.3 | 0.7 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.3 | 5.8 | GO:0030286 | dynein complex(GO:0030286) |
0.3 | 0.7 | GO:0070939 | Dsl1p complex(GO:0070939) |
0.3 | 0.3 | GO:0097450 | astrocyte end-foot(GO:0097450) |
0.3 | 0.3 | GO:0030056 | hemidesmosome(GO:0030056) |
0.3 | 17.6 | GO:0005901 | caveola(GO:0005901) |
0.3 | 1.3 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
0.3 | 43.7 | GO:0005759 | mitochondrial matrix(GO:0005759) |
0.3 | 3.0 | GO:0071004 | U2-type prespliceosome(GO:0071004) |
0.3 | 0.7 | GO:0033061 | DNA recombinase mediator complex(GO:0033061) |
0.3 | 1.7 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.3 | 10.5 | GO:1903293 | protein serine/threonine phosphatase complex(GO:0008287) phosphatase complex(GO:1903293) |
0.3 | 1.0 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.3 | 1.6 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.3 | 25.6 | GO:0005581 | collagen trimer(GO:0005581) |
0.3 | 9.0 | GO:0005921 | gap junction(GO:0005921) |
0.3 | 3.5 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.3 | 356.2 | GO:0005783 | endoplasmic reticulum(GO:0005783) |
0.3 | 1.3 | GO:0070187 | telosome(GO:0070187) |
0.3 | 1.3 | GO:1990130 | Iml1 complex(GO:1990130) |
0.3 | 0.9 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.3 | 1.5 | GO:0005902 | microvillus(GO:0005902) |
0.3 | 0.9 | GO:0000782 | telomere cap complex(GO:0000782) nuclear telomere cap complex(GO:0000783) |
0.3 | 3.4 | GO:0031304 | intrinsic component of mitochondrial inner membrane(GO:0031304) |
0.3 | 0.3 | GO:0019815 | B cell receptor complex(GO:0019815) |
0.3 | 0.3 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.3 | 278.0 | GO:0005654 | nucleoplasm(GO:0005654) |
0.3 | 0.9 | GO:0001891 | phagocytic cup(GO:0001891) |
0.3 | 2.3 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.3 | 7.6 | GO:0010008 | endosome membrane(GO:0010008) |
0.3 | 268.7 | GO:0005739 | mitochondrion(GO:0005739) |
0.3 | 7.6 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.3 | 0.8 | GO:0044309 | neuron spine(GO:0044309) |
0.3 | 2.8 | GO:0005614 | interstitial matrix(GO:0005614) |
0.3 | 1.1 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
0.3 | 1.1 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.3 | 1.1 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
0.3 | 5.4 | GO:0012505 | endomembrane system(GO:0012505) |
0.3 | 2.1 | GO:0000502 | proteasome complex(GO:0000502) |
0.3 | 0.5 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
0.3 | 1.6 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.3 | 0.5 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
0.3 | 2.6 | GO:0005694 | chromosome(GO:0005694) |
0.3 | 0.3 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.3 | 0.3 | GO:0045177 | apical part of cell(GO:0045177) |
0.3 | 0.5 | GO:0097470 | ribbon synapse(GO:0097470) |
0.3 | 0.3 | GO:0005683 | U7 snRNP(GO:0005683) |
0.3 | 7.6 | GO:0042995 | cell projection(GO:0042995) |
0.3 | 5.6 | GO:0071013 | catalytic step 2 spliceosome(GO:0071013) |
0.3 | 7.6 | GO:0055037 | recycling endosome(GO:0055037) |
0.3 | 0.3 | GO:0097458 | neuron part(GO:0097458) |
0.2 | 1.0 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.2 | 3.7 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.2 | 0.7 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.2 | 2.7 | GO:0005903 | brush border(GO:0005903) |
0.2 | 1.0 | GO:0031512 | motile primary cilium(GO:0031512) |
0.2 | 575.8 | GO:0005634 | nucleus(GO:0005634) |
0.2 | 0.2 | GO:0090533 | cation-transporting ATPase complex(GO:0090533) |
0.2 | 0.9 | GO:0005874 | microtubule(GO:0005874) |
0.2 | 0.9 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
0.2 | 1.6 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.2 | 1.6 | GO:0043196 | varicosity(GO:0043196) |
0.2 | 0.5 | GO:0005871 | kinesin complex(GO:0005871) |
0.2 | 0.4 | GO:0097440 | apical dendrite(GO:0097440) |
0.2 | 1.1 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.2 | 4.6 | GO:0030139 | endocytic vesicle(GO:0030139) |
0.2 | 7.5 | GO:0000139 | Golgi membrane(GO:0000139) |
0.2 | 7.0 | GO:0005770 | late endosome(GO:0005770) |
0.2 | 0.9 | GO:0030057 | desmosome(GO:0030057) |
0.2 | 1.3 | GO:0035770 | ribonucleoprotein granule(GO:0035770) cytoplasmic ribonucleoprotein granule(GO:0036464) |
0.2 | 0.4 | GO:0030118 | clathrin coat(GO:0030118) |
0.2 | 0.6 | GO:0031091 | platelet alpha granule(GO:0031091) |
0.2 | 0.6 | GO:0000322 | storage vacuole(GO:0000322) |
0.2 | 1.0 | GO:0031907 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.2 | 1.0 | GO:0031514 | motile cilium(GO:0031514) |
0.2 | 1.0 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.2 | 1.6 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.2 | 3.6 | GO:0045211 | postsynaptic membrane(GO:0045211) |
0.2 | 0.8 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.2 | 0.4 | GO:0001520 | outer dense fiber(GO:0001520) |
0.2 | 197.9 | GO:0070062 | extracellular exosome(GO:0070062) |
0.2 | 0.2 | GO:0097546 | ciliary base(GO:0097546) |
0.2 | 3.6 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.2 | 1.7 | GO:0009898 | cytoplasmic side of plasma membrane(GO:0009898) |
0.2 | 0.9 | GO:0042383 | sarcolemma(GO:0042383) |
0.2 | 0.9 | GO:0097225 | sperm midpiece(GO:0097225) |
0.2 | 1.3 | GO:0036128 | CatSper complex(GO:0036128) |
0.2 | 0.2 | GO:0000938 | GARP complex(GO:0000938) |
0.2 | 0.3 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.2 | 10.6 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.2 | 1.0 | GO:1903561 | extracellular vesicle(GO:1903561) |
0.2 | 5.6 | GO:0043296 | apical junction complex(GO:0043296) |
0.2 | 4.9 | GO:0030016 | myofibril(GO:0030016) |
0.2 | 0.8 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.2 | 0.3 | GO:1990923 | PET complex(GO:1990923) |
0.2 | 0.3 | GO:0045178 | basal part of cell(GO:0045178) |
0.2 | 3.3 | GO:0016324 | apical plasma membrane(GO:0016324) |
0.2 | 0.2 | GO:0032587 | ruffle membrane(GO:0032587) |
0.1 | 0.1 | GO:0033162 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.1 | 0.7 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.1 | 0.1 | GO:0046691 | intracellular canaliculus(GO:0046691) |
0.1 | 0.1 | GO:0005840 | ribosome(GO:0005840) |
0.1 | 0.7 | GO:0016234 | inclusion body(GO:0016234) |
0.1 | 3.5 | GO:0072372 | primary cilium(GO:0072372) |
0.1 | 0.1 | GO:0031248 | protein acetyltransferase complex(GO:0031248) acetyltransferase complex(GO:1902493) |
0.1 | 12.1 | GO:0000323 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.1 | 0.3 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.1 | 2.0 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.1 | 2.0 | GO:0036064 | ciliary basal body(GO:0036064) |
0.1 | 0.5 | GO:0030054 | cell junction(GO:0030054) |
0.1 | 0.1 | GO:0032426 | stereocilium tip(GO:0032426) |
0.1 | 0.5 | GO:0005815 | microtubule organizing center(GO:0005815) |
0.1 | 0.2 | GO:0005795 | Golgi stack(GO:0005795) |
0.1 | 31.4 | GO:0005829 | cytosol(GO:0005829) |
0.1 | 0.8 | GO:0030496 | midbody(GO:0030496) |
0.1 | 0.1 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.1 | 0.1 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
0.1 | 0.3 | GO:0042587 | glycogen granule(GO:0042587) |
0.1 | 0.7 | GO:0019897 | extrinsic component of plasma membrane(GO:0019897) |
0.1 | 0.3 | GO:0020005 | symbiont-containing vacuole membrane(GO:0020005) |
0.1 | 163.0 | GO:0005737 | cytoplasm(GO:0005737) |
0.1 | 0.3 | GO:0031982 | vesicle(GO:0031982) |
0.1 | 21.3 | GO:0009986 | cell surface(GO:0009986) |
0.1 | 2.9 | GO:0043235 | receptor complex(GO:0043235) |
0.1 | 0.5 | GO:0005732 | small nucleolar ribonucleoprotein complex(GO:0005732) |
0.1 | 0.3 | GO:0031253 | cell projection membrane(GO:0031253) |
0.1 | 0.1 | GO:0044316 | cone cell pedicle(GO:0044316) |
0.1 | 0.3 | GO:0030027 | lamellipodium(GO:0030027) |
0.1 | 0.1 | GO:0071797 | LUBAC complex(GO:0071797) |
0.1 | 0.1 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.1 | 0.2 | GO:0072562 | blood microparticle(GO:0072562) |
0.1 | 0.2 | GO:0035859 | Seh1-associated complex(GO:0035859) |
0.1 | 37.5 | GO:0005887 | integral component of plasma membrane(GO:0005887) |
0.1 | 0.1 | GO:0000922 | spindle pole(GO:0000922) |
0.1 | 0.7 | GO:0005604 | basement membrane(GO:0005604) |
0.1 | 139.8 | GO:0016021 | integral component of membrane(GO:0016021) |
0.1 | 41.1 | GO:0005576 | extracellular region(GO:0005576) |
0.1 | 0.1 | GO:0043209 | myelin sheath(GO:0043209) |
0.1 | 14.3 | GO:0016020 | membrane(GO:0016020) |
0.1 | 0.2 | GO:0005911 | cell-cell junction(GO:0005911) |
0.0 | 0.0 | GO:0005819 | spindle(GO:0005819) |
0.0 | 10.5 | GO:0005623 | cell(GO:0005623) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
7.2 | 21.6 | GO:0019770 | IgG receptor activity(GO:0019770) |
7.0 | 21.1 | GO:0035515 | oxidative RNA demethylase activity(GO:0035515) |
6.8 | 20.3 | GO:0048030 | disaccharide binding(GO:0048030) |
6.6 | 125.5 | GO:0003746 | translation elongation factor activity(GO:0003746) |
5.4 | 21.5 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
5.2 | 5.2 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
4.6 | 18.2 | GO:0031852 | mu-type opioid receptor binding(GO:0031852) |
4.2 | 12.6 | GO:0015143 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
3.5 | 10.4 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
3.3 | 26.2 | GO:0008430 | selenium binding(GO:0008430) |
3.1 | 9.4 | GO:0005350 | purine nucleobase transmembrane transporter activity(GO:0005345) pyrimidine nucleobase transmembrane transporter activity(GO:0005350) nucleobase transmembrane transporter activity(GO:0015205) |
3.1 | 12.3 | GO:0008865 | fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
3.0 | 14.9 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
2.9 | 14.4 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
2.9 | 8.6 | GO:0030172 | troponin C binding(GO:0030172) |
2.8 | 16.7 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
2.7 | 8.1 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
2.6 | 31.5 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
2.6 | 7.7 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) |
2.4 | 9.7 | GO:0016401 | palmitoyl-CoA oxidase activity(GO:0016401) |
2.4 | 9.6 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
2.4 | 7.1 | GO:0070698 | type I activin receptor binding(GO:0070698) |
2.3 | 11.6 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
2.3 | 11.4 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
2.2 | 6.7 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) DNA (cytosine-5-)-methyltransferase activity, acting on CpG substrates(GO:0051718) |
2.2 | 13.0 | GO:0030274 | LIM domain binding(GO:0030274) |
2.0 | 8.2 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
2.0 | 8.2 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
2.0 | 30.5 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
2.0 | 2.0 | GO:0004698 | calcium-dependent protein kinase C activity(GO:0004698) |
2.0 | 6.1 | GO:0030350 | iron-responsive element binding(GO:0030350) |
2.0 | 10.1 | GO:0004945 | angiotensin type II receptor activity(GO:0004945) |
2.0 | 11.7 | GO:0035312 | 5'-3' exodeoxyribonuclease activity(GO:0035312) |
1.9 | 9.6 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
1.9 | 5.7 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
1.9 | 5.7 | GO:0004793 | threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
1.9 | 7.5 | GO:0043515 | kinetochore binding(GO:0043515) |
1.9 | 7.5 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
1.8 | 14.8 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
1.8 | 11.0 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
1.8 | 7.2 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
1.7 | 7.0 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
1.7 | 8.7 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
1.7 | 6.9 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
1.7 | 8.4 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
1.7 | 46.7 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
1.7 | 51.5 | GO:0008536 | Ran GTPase binding(GO:0008536) |
1.7 | 13.3 | GO:0016832 | aldehyde-lyase activity(GO:0016832) |
1.7 | 5.0 | GO:0098748 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
1.6 | 4.9 | GO:0050252 | retinol O-fatty-acyltransferase activity(GO:0050252) |
1.6 | 3.2 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
1.6 | 4.8 | GO:0015087 | cobalt ion transmembrane transporter activity(GO:0015087) |
1.6 | 1.6 | GO:1990715 | mRNA CDS binding(GO:1990715) |
1.5 | 6.2 | GO:0031720 | haptoglobin binding(GO:0031720) |
1.5 | 10.8 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
1.5 | 41.0 | GO:0001103 | RNA polymerase II repressing transcription factor binding(GO:0001103) |
1.5 | 23.9 | GO:0019825 | oxygen binding(GO:0019825) |
1.5 | 10.4 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
1.5 | 4.4 | GO:0102007 | lactonohydrolase activity(GO:0046573) acyl-L-homoserine-lactone lactonohydrolase activity(GO:0102007) |
1.5 | 2.9 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
1.4 | 4.3 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
1.4 | 11.3 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
1.4 | 5.6 | GO:0015057 | thrombin receptor activity(GO:0015057) |
1.4 | 4.2 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
1.4 | 4.1 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) |
1.4 | 8.2 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
1.3 | 3.9 | GO:1990188 | euchromatin binding(GO:1990188) |
1.3 | 1.3 | GO:0070061 | fructose binding(GO:0070061) |
1.3 | 11.6 | GO:0070410 | co-SMAD binding(GO:0070410) |
1.3 | 3.8 | GO:1990460 | leptin receptor binding(GO:1990460) |
1.3 | 8.9 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
1.3 | 6.4 | GO:0038085 | vascular endothelial growth factor binding(GO:0038085) |
1.3 | 2.5 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
1.3 | 1.3 | GO:0051723 | protein methylesterase activity(GO:0051723) |
1.3 | 5.1 | GO:0031781 | melanocortin receptor binding(GO:0031779) type 3 melanocortin receptor binding(GO:0031781) type 4 melanocortin receptor binding(GO:0031782) |
1.3 | 5.1 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
1.3 | 5.0 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
1.2 | 4.9 | GO:0015038 | glutathione disulfide oxidoreductase activity(GO:0015038) |
1.2 | 3.7 | GO:0016743 | carboxyl- or carbamoyltransferase activity(GO:0016743) |
1.2 | 20.7 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
1.2 | 18.2 | GO:0030275 | LRR domain binding(GO:0030275) |
1.2 | 2.4 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
1.2 | 3.6 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
1.2 | 11.9 | GO:0050308 | sugar-phosphatase activity(GO:0050308) |
1.2 | 47.5 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
1.2 | 3.5 | GO:0050692 | DBD domain binding(GO:0050692) |
1.2 | 4.7 | GO:0086007 | voltage-gated calcium channel activity involved in cardiac muscle cell action potential(GO:0086007) |
1.2 | 5.9 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
1.2 | 3.5 | GO:0015154 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
1.2 | 5.8 | GO:0004075 | biotin carboxylase activity(GO:0004075) |
1.2 | 26.5 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
1.1 | 4.6 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
1.1 | 36.6 | GO:0070330 | aromatase activity(GO:0070330) |
1.1 | 5.7 | GO:0016841 | ammonia-lyase activity(GO:0016841) |
1.1 | 3.4 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
1.1 | 3.4 | GO:0015440 | peptide-transporting ATPase activity(GO:0015440) |
1.1 | 8.9 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
1.1 | 2.2 | GO:0016840 | carbon-nitrogen lyase activity(GO:0016840) amidine-lyase activity(GO:0016842) |
1.1 | 4.3 | GO:0070883 | pre-miRNA binding(GO:0070883) |
1.1 | 2.1 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
1.1 | 1.1 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
1.1 | 5.3 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
1.0 | 16.7 | GO:0008143 | poly(A) binding(GO:0008143) |
1.0 | 2.1 | GO:0042609 | CD4 receptor binding(GO:0042609) |
1.0 | 1.0 | GO:0001013 | RNA polymerase I regulatory region DNA binding(GO:0001013) |
1.0 | 4.1 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) |
1.0 | 1.0 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
1.0 | 18.4 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
1.0 | 4.0 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
1.0 | 4.0 | GO:0015199 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
1.0 | 4.0 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
1.0 | 3.0 | GO:0005024 | transforming growth factor beta-activated receptor activity(GO:0005024) |
1.0 | 3.0 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
1.0 | 3.9 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
1.0 | 1.9 | GO:0051870 | methotrexate binding(GO:0051870) |
1.0 | 2.9 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
1.0 | 1.9 | GO:0019789 | SUMO transferase activity(GO:0019789) |
1.0 | 2.9 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
1.0 | 8.6 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
1.0 | 4.8 | GO:0004111 | creatine kinase activity(GO:0004111) |
1.0 | 8.6 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
1.0 | 5.7 | GO:0043910 | CTP:2,3-di-O-geranylgeranyl-sn-glycero-1-phosphate cytidyltransferase activity(GO:0043338) phospholactate guanylyltransferase activity(GO:0043814) ATP:coenzyme F420 adenylyltransferase activity(GO:0043910) UDP-N-acetylgalactosamine diphosphorylase activity(GO:0052630) |
0.9 | 1.9 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
0.9 | 5.6 | GO:0061505 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.9 | 2.8 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.9 | 5.6 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
0.9 | 3.7 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
0.9 | 4.6 | GO:0050649 | testosterone 6-beta-hydroxylase activity(GO:0050649) |
0.9 | 13.5 | GO:0008308 | voltage-gated anion channel activity(GO:0008308) |
0.9 | 2.7 | GO:0003696 | satellite DNA binding(GO:0003696) |
0.9 | 3.5 | GO:0004849 | uridine kinase activity(GO:0004849) |
0.9 | 3.5 | GO:0019237 | centromeric DNA binding(GO:0019237) |
0.9 | 9.7 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
0.9 | 3.5 | GO:0052717 | N-cyclopropylmelamine deaminase activity(GO:0034547) N-cyclopropylammeline deaminase activity(GO:0034548) N-cyclopropylammelide alkylamino hydrolase activity(GO:0034549) 2,5-diamino-6-ribitylamino-4(3H)-pyrimidinone 5'-phosphate deaminase activity(GO:0043723) tRNA-specific adenosine-37 deaminase activity(GO:0043829) archaeal-specific GTP cyclohydrolase activity(GO:0044682) tRNA-specific adenosine-34 deaminase activity(GO:0052717) |
0.9 | 8.8 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.9 | 5.3 | GO:0018741 | alkyl sulfatase activity(GO:0018741) endosulfan hemisulfate sulfatase activity(GO:0034889) endosulfan sulfate hydrolase activity(GO:0034902) |
0.9 | 7.0 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.9 | 5.2 | GO:0030983 | mismatched DNA binding(GO:0030983) |
0.9 | 2.6 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
0.9 | 1.7 | GO:0004096 | catalase activity(GO:0004096) |
0.9 | 0.9 | GO:0070644 | vitamin D response element binding(GO:0070644) |
0.8 | 1.7 | GO:0034040 | lipid-transporting ATPase activity(GO:0034040) |
0.8 | 14.3 | GO:0019200 | carbohydrate kinase activity(GO:0019200) |
0.8 | 1.7 | GO:0005072 | transforming growth factor beta receptor, cytoplasmic mediator activity(GO:0005072) |
0.8 | 4.2 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.8 | 1.7 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
0.8 | 8.4 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.8 | 2.5 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) |
0.8 | 13.4 | GO:0016646 | oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor(GO:0016646) |
0.8 | 2.5 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.8 | 4.2 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.8 | 1.7 | GO:0034594 | phosphatidylinositol trisphosphate phosphatase activity(GO:0034594) |
0.8 | 4.2 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.8 | 11.5 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.8 | 2.4 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.8 | 3.3 | GO:0015562 | efflux transmembrane transporter activity(GO:0015562) |
0.8 | 4.9 | GO:0032041 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) |
0.8 | 1.6 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.8 | 0.8 | GO:0018423 | protein C-terminal leucine carboxyl O-methyltransferase activity(GO:0018423) |
0.8 | 4.8 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.8 | 1.6 | GO:0031711 | bradykinin receptor binding(GO:0031711) |
0.8 | 3.2 | GO:0042731 | PH domain binding(GO:0042731) |
0.8 | 2.4 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.8 | 8.8 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.8 | 2.4 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
0.8 | 3.2 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.8 | 9.4 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.8 | 2.3 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.8 | 1.6 | GO:0008494 | translation activator activity(GO:0008494) |
0.8 | 7.0 | GO:0016653 | oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor(GO:0016653) |
0.8 | 2.3 | GO:0031013 | troponin I binding(GO:0031013) |
0.8 | 8.4 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
0.8 | 2.3 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.8 | 6.1 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.8 | 17.6 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
0.8 | 5.3 | GO:0019966 | interleukin-1 binding(GO:0019966) |
0.8 | 80.0 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
0.7 | 5.2 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.7 | 18.4 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.7 | 9.5 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.7 | 0.7 | GO:0005119 | smoothened binding(GO:0005119) hedgehog family protein binding(GO:0097108) |
0.7 | 2.2 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.7 | 0.7 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
0.7 | 1.4 | GO:1904288 | BAT3 complex binding(GO:1904288) |
0.7 | 2.9 | GO:0061665 | SUMO ligase activity(GO:0061665) |
0.7 | 2.1 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
0.7 | 2.9 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.7 | 5.0 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.7 | 8.5 | GO:0035173 | histone kinase activity(GO:0035173) |
0.7 | 4.9 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
0.7 | 0.7 | GO:0031418 | L-ascorbic acid binding(GO:0031418) |
0.7 | 10.5 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.7 | 3.5 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
0.7 | 15.3 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.7 | 9.0 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
0.7 | 5.5 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.7 | 18.0 | GO:0017069 | snRNA binding(GO:0017069) |
0.7 | 0.7 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
0.7 | 4.1 | GO:0002054 | nucleobase binding(GO:0002054) |
0.7 | 2.0 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.7 | 28.8 | GO:0001227 | transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001227) |
0.7 | 2.7 | GO:0010858 | calcium-dependent protein kinase regulator activity(GO:0010858) |
0.7 | 1.3 | GO:0034618 | arginine binding(GO:0034618) |
0.7 | 7.3 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.7 | 2.0 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
0.7 | 1.3 | GO:0004771 | sterol esterase activity(GO:0004771) |
0.7 | 5.3 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
0.7 | 2.7 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.7 | 6.6 | GO:0048038 | quinone binding(GO:0048038) |
0.7 | 1.3 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.7 | 2.0 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
0.7 | 3.9 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.7 | 4.6 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
0.7 | 13.1 | GO:0030515 | snoRNA binding(GO:0030515) |
0.7 | 3.3 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
0.6 | 1.9 | GO:0008107 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.6 | 27.8 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
0.6 | 9.0 | GO:0043274 | phospholipase binding(GO:0043274) |
0.6 | 7.7 | GO:0052890 | oxidoreductase activity, acting on the CH-CH group of donors, with a flavin as acceptor(GO:0052890) |
0.6 | 1.9 | GO:0004104 | cholinesterase activity(GO:0004104) |
0.6 | 10.9 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
0.6 | 15.4 | GO:0051990 | (R)-2-hydroxyglutarate dehydrogenase activity(GO:0051990) |
0.6 | 1.9 | GO:0004064 | arylesterase activity(GO:0004064) |
0.6 | 3.8 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
0.6 | 1.3 | GO:0000702 | oxidized base lesion DNA N-glycosylase activity(GO:0000702) |
0.6 | 0.6 | GO:0052743 | inositol tetrakisphosphate phosphatase activity(GO:0052743) |
0.6 | 4.4 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.6 | 0.6 | GO:0004303 | estradiol 17-beta-dehydrogenase activity(GO:0004303) |
0.6 | 2.5 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
0.6 | 31.6 | GO:0001046 | core promoter sequence-specific DNA binding(GO:0001046) |
0.6 | 7.4 | GO:0019841 | retinol binding(GO:0019841) |
0.6 | 5.6 | GO:0005542 | folic acid binding(GO:0005542) |
0.6 | 2.5 | GO:0008559 | xenobiotic-transporting ATPase activity(GO:0008559) |
0.6 | 6.1 | GO:0004622 | lysophospholipase activity(GO:0004622) |
0.6 | 2.5 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.6 | 0.6 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
0.6 | 1.8 | GO:0080130 | L-phenylalanine:2-oxoglutarate aminotransferase activity(GO:0080130) |
0.6 | 2.4 | GO:0071253 | connexin binding(GO:0071253) |
0.6 | 1.8 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.6 | 1.8 | GO:0015265 | urea channel activity(GO:0015265) |
0.6 | 16.4 | GO:0070063 | RNA polymerase binding(GO:0070063) |
0.6 | 6.6 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) |
0.6 | 6.5 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.6 | 1.2 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
0.6 | 5.9 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.6 | 7.6 | GO:0004467 | long-chain fatty acid-CoA ligase activity(GO:0004467) |
0.6 | 1.8 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
0.6 | 2.3 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
0.6 | 1.7 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.6 | 5.2 | GO:0008235 | metalloexopeptidase activity(GO:0008235) |
0.6 | 1.7 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.6 | 4.6 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.6 | 2.9 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
0.6 | 2.3 | GO:1990239 | steroid hormone binding(GO:1990239) |
0.6 | 9.2 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.6 | 0.6 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
0.6 | 23.2 | GO:0002161 | aminoacyl-tRNA editing activity(GO:0002161) |
0.6 | 6.2 | GO:0015643 | toxic substance binding(GO:0015643) |
0.6 | 1.7 | GO:0000171 | ribonuclease MRP activity(GO:0000171) |
0.6 | 5.0 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.6 | 1.7 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
0.6 | 16.1 | GO:0033613 | activating transcription factor binding(GO:0033613) |
0.6 | 1.1 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
0.5 | 14.8 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.5 | 0.5 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
0.5 | 1.6 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
0.5 | 3.8 | GO:0070513 | death domain binding(GO:0070513) |
0.5 | 0.5 | GO:0016595 | glutamate binding(GO:0016595) |
0.5 | 15.1 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.5 | 1.1 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
0.5 | 1.6 | GO:0008142 | oxysterol binding(GO:0008142) |
0.5 | 0.5 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.5 | 2.1 | GO:0016918 | retinal binding(GO:0016918) |
0.5 | 1.6 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.5 | 1.1 | GO:0015563 | uptake transmembrane transporter activity(GO:0015563) |
0.5 | 6.9 | GO:0000907 | sulfonate dioxygenase activity(GO:0000907) 2,4-dichlorophenoxyacetate alpha-ketoglutarate dioxygenase activity(GO:0018602) hypophosphite dioxygenase activity(GO:0034792) gibberellin 2-beta-dioxygenase activity(GO:0045543) C-19 gibberellin 2-beta-dioxygenase activity(GO:0052634) C-20 gibberellin 2-beta-dioxygenase activity(GO:0052635) |
0.5 | 1.6 | GO:0031994 | insulin-like growth factor I binding(GO:0031994) |
0.5 | 4.2 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
0.5 | 1.6 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
0.5 | 2.6 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.5 | 9.4 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.5 | 2.1 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
0.5 | 2.0 | GO:0048531 | beta-1,3-galactosyltransferase activity(GO:0048531) |
0.5 | 2.0 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.5 | 25.0 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.5 | 9.1 | GO:0031369 | translation initiation factor binding(GO:0031369) |
0.5 | 0.5 | GO:0008193 | tRNA guanylyltransferase activity(GO:0008193) |
0.5 | 1.5 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
0.5 | 3.5 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.5 | 2.0 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.5 | 4.5 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
0.5 | 19.1 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
0.5 | 1.0 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
0.5 | 3.5 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
0.5 | 4.0 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
0.5 | 26.4 | GO:0001158 | enhancer sequence-specific DNA binding(GO:0001158) |
0.5 | 15.9 | GO:0032934 | sterol binding(GO:0032934) |
0.5 | 1.5 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
0.5 | 3.0 | GO:0005436 | sodium:phosphate symporter activity(GO:0005436) sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
0.5 | 3.9 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.5 | 4.9 | GO:0030291 | protein serine/threonine kinase inhibitor activity(GO:0030291) |
0.5 | 0.5 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.5 | 2.0 | GO:0030984 | kininogen binding(GO:0030984) |
0.5 | 2.0 | GO:0008381 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.5 | 1.0 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.5 | 1.5 | GO:0051022 | Rho GDP-dissociation inhibitor binding(GO:0051022) |
0.5 | 10.7 | GO:0042805 | actinin binding(GO:0042805) |
0.5 | 1.9 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.5 | 5.3 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.5 | 2.4 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.5 | 1.9 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.5 | 1.0 | GO:0019213 | deacetylase activity(GO:0019213) |
0.5 | 11.0 | GO:0032947 | protein complex scaffold(GO:0032947) |
0.5 | 0.9 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.5 | 10.4 | GO:0001047 | core promoter binding(GO:0001047) |
0.5 | 1.4 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
0.5 | 0.9 | GO:0005168 | neurotrophin TRKA receptor binding(GO:0005168) |
0.5 | 1.4 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.5 | 3.7 | GO:0001221 | transcription cofactor binding(GO:0001221) |
0.5 | 3.7 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) |
0.5 | 4.2 | GO:0070182 | DNA polymerase binding(GO:0070182) |
0.5 | 1.9 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.5 | 4.7 | GO:0036002 | pre-mRNA binding(GO:0036002) |
0.5 | 5.6 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.5 | 1.4 | GO:0015093 | ferrous iron transmembrane transporter activity(GO:0015093) |
0.5 | 10.6 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.5 | 4.6 | GO:0001618 | virus receptor activity(GO:0001618) |
0.5 | 6.9 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.5 | 0.5 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
0.5 | 1.4 | GO:0005499 | vitamin D binding(GO:0005499) |
0.5 | 2.3 | GO:0008199 | ferric iron binding(GO:0008199) |
0.5 | 5.0 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.5 | 0.5 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
0.4 | 3.1 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.4 | 5.4 | GO:0043295 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
0.4 | 1.3 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.4 | 5.8 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.4 | 6.7 | GO:0005527 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.4 | 12.0 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.4 | 24.4 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.4 | 1.3 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.4 | 1.8 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.4 | 4.8 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.4 | 37.8 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.4 | 3.9 | GO:0018024 | histone-lysine N-methyltransferase activity(GO:0018024) |
0.4 | 3.9 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
0.4 | 11.3 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.4 | 4.7 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.4 | 2.1 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
0.4 | 0.4 | GO:0032052 | bile acid binding(GO:0032052) |
0.4 | 1.3 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.4 | 0.9 | GO:0031893 | vasopressin receptor binding(GO:0031893) |
0.4 | 0.4 | GO:0008425 | C-methyltransferase activity(GO:0008169) 2-polyprenyl-6-methoxy-1,4-benzoquinone methyltransferase activity(GO:0008425) quinone cofactor methyltransferase activity(GO:0030580) |
0.4 | 1.7 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.4 | 1.7 | GO:0052833 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
0.4 | 4.2 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
0.4 | 325.9 | GO:0008270 | zinc ion binding(GO:0008270) |
0.4 | 1.7 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.4 | 12.9 | GO:0042826 | histone deacetylase binding(GO:0042826) |
0.4 | 4.5 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
0.4 | 10.6 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) cyclin-dependent protein kinase activity(GO:0097472) |
0.4 | 3.3 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
0.4 | 2.0 | GO:0042979 | ornithine decarboxylase regulator activity(GO:0042979) |
0.4 | 1.2 | GO:0035198 | miRNA binding(GO:0035198) |
0.4 | 46.0 | GO:0019902 | phosphatase binding(GO:0019902) |
0.4 | 2.4 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.4 | 0.4 | GO:0032557 | pyrimidine ribonucleotide binding(GO:0032557) |
0.4 | 18.0 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.4 | 1.2 | GO:0001595 | angiotensin receptor activity(GO:0001595) |
0.4 | 1.2 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
0.4 | 1.2 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.4 | 3.2 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.4 | 2.0 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.4 | 1.2 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.4 | 2.4 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
0.4 | 0.4 | GO:0015927 | trehalase activity(GO:0015927) |
0.4 | 0.4 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.4 | 2.3 | GO:0001968 | fibronectin binding(GO:0001968) |
0.4 | 0.4 | GO:0004520 | endodeoxyribonuclease activity(GO:0004520) |
0.4 | 0.8 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.4 | 21.6 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.4 | 1.5 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.4 | 0.4 | GO:0004069 | L-aspartate:2-oxoglutarate aminotransferase activity(GO:0004069) |
0.4 | 1.9 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.4 | 0.4 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
0.4 | 19.6 | GO:0038024 | cargo receptor activity(GO:0038024) |
0.4 | 4.5 | GO:0005112 | Notch binding(GO:0005112) |
0.4 | 3.0 | GO:0016668 | oxidoreductase activity, acting on a sulfur group of donors, NAD(P) as acceptor(GO:0016668) |
0.4 | 3.3 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.4 | 1.1 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.4 | 1.1 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.4 | 0.4 | GO:2001069 | glycogen binding(GO:2001069) |
0.4 | 0.7 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.4 | 0.7 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.4 | 12.0 | GO:0044824 | integrase activity(GO:0008907) T/G mismatch-specific endonuclease activity(GO:0043765) retroviral integrase activity(GO:0044823) retroviral 3' processing activity(GO:0044824) |
0.4 | 0.7 | GO:0019107 | myristoyltransferase activity(GO:0019107) |
0.4 | 3.3 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
0.4 | 2.2 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.4 | 1.1 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.4 | 0.7 | GO:0051373 | FATZ binding(GO:0051373) |
0.4 | 1.4 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
0.4 | 1.8 | GO:0070990 | snRNP binding(GO:0070990) U1 snRNP binding(GO:1990446) |
0.4 | 0.7 | GO:0034979 | NAD-dependent protein deacetylase activity(GO:0034979) |
0.4 | 0.4 | GO:0016418 | S-acetyltransferase activity(GO:0016418) |
0.4 | 3.2 | GO:0022821 | potassium ion antiporter activity(GO:0022821) |
0.4 | 1.4 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.4 | 3.2 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.4 | 0.7 | GO:0050543 | icosatetraenoic acid binding(GO:0050543) |
0.3 | 1.0 | GO:0031490 | chromatin DNA binding(GO:0031490) |
0.3 | 2.1 | GO:0004032 | alditol:NADP+ 1-oxidoreductase activity(GO:0004032) |
0.3 | 0.7 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
0.3 | 1.7 | GO:0050733 | RS domain binding(GO:0050733) |
0.3 | 1.0 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.3 | 1.4 | GO:0047238 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) |
0.3 | 5.8 | GO:0022829 | wide pore channel activity(GO:0022829) |
0.3 | 1.0 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.3 | 4.4 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.3 | 10.2 | GO:0005507 | copper ion binding(GO:0005507) |
0.3 | 1.7 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.3 | 2.7 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.3 | 14.3 | GO:0005518 | collagen binding(GO:0005518) |
0.3 | 1.7 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.3 | 0.3 | GO:0035651 | AP-3 adaptor complex binding(GO:0035651) |
0.3 | 1.7 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
0.3 | 10.0 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
0.3 | 0.3 | GO:0042171 | lysophosphatidic acid acyltransferase activity(GO:0042171) |
0.3 | 1.7 | GO:0004768 | stearoyl-CoA 9-desaturase activity(GO:0004768) |
0.3 | 2.3 | GO:0016723 | oxidoreductase activity, oxidizing metal ions, NAD or NADP as acceptor(GO:0016723) |
0.3 | 5.9 | GO:0030552 | cAMP binding(GO:0030552) |
0.3 | 2.3 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.3 | 1.0 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
0.3 | 25.4 | GO:0061659 | ubiquitin protein ligase activity(GO:0061630) ubiquitin-like protein ligase activity(GO:0061659) |
0.3 | 2.6 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.3 | 1.9 | GO:0032183 | SUMO binding(GO:0032183) |
0.3 | 0.3 | GO:0000339 | RNA cap binding(GO:0000339) |
0.3 | 0.3 | GO:0016886 | ligase activity, forming phosphoric ester bonds(GO:0016886) |
0.3 | 0.3 | GO:0008905 | mannose-phosphate guanylyltransferase activity(GO:0008905) |
0.3 | 1.0 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
0.3 | 2.2 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.3 | 18.6 | GO:0003713 | transcription coactivator activity(GO:0003713) |
0.3 | 11.0 | GO:0030276 | clathrin binding(GO:0030276) |
0.3 | 7.9 | GO:0003684 | damaged DNA binding(GO:0003684) |
0.3 | 4.1 | GO:0022841 | leak channel activity(GO:0022840) potassium ion leak channel activity(GO:0022841) narrow pore channel activity(GO:0022842) |
0.3 | 1.3 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
0.3 | 0.9 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
0.3 | 0.6 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
0.3 | 2.5 | GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen(GO:0016709) |
0.3 | 0.9 | GO:0016880 | acid-ammonia (or amide) ligase activity(GO:0016880) |
0.3 | 0.9 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.3 | 1.5 | GO:0015114 | phosphate ion transmembrane transporter activity(GO:0015114) |
0.3 | 1.2 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
0.3 | 0.6 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
0.3 | 1.5 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.3 | 1.2 | GO:0031419 | cobalamin binding(GO:0031419) |
0.3 | 3.9 | GO:0046961 | proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
0.3 | 0.3 | GO:0016015 | morphogen activity(GO:0016015) |
0.3 | 21.6 | GO:0005506 | iron ion binding(GO:0005506) |
0.3 | 11.4 | GO:0015078 | hydrogen ion transmembrane transporter activity(GO:0015078) |
0.3 | 0.9 | GO:0016661 | oxidoreductase activity, acting on other nitrogenous compounds as donors(GO:0016661) |
0.3 | 13.1 | GO:0000988 | transcription factor activity, protein binding(GO:0000988) |
0.3 | 19.4 | GO:0004809 | tRNA (guanine-N2-)-methyltransferase activity(GO:0004809) |
0.3 | 0.3 | GO:0036435 | K48-linked polyubiquitin binding(GO:0036435) |
0.3 | 2.1 | GO:0034891 | pinocarveol dehydrogenase activity(GO:0018446) chloral hydrate dehydrogenase activity(GO:0018447) hydroxymethylmethylsilanediol oxidase activity(GO:0018448) 1-phenylethanol dehydrogenase activity(GO:0018449) myrtenol dehydrogenase activity(GO:0018450) cis-1,2-dihydroxy-1,2-dihydro-8-carboxynaphthalene dehydrogenase activity(GO:0034522) 3-hydroxy-4-methyloctanoyl-CoA dehydrogenase activity(GO:0034582) 2-hydroxy-4-isopropenylcyclohexane-1-carboxyl-CoA dehydrogenase activity(GO:0034778) cis-9,10-dihydroanthracene-9,10-diol dehydrogenase activity(GO:0034817) citronellol dehydrogenase activity(GO:0034821) naphthyl-2-hydroxymethyl-succinyl-CoA dehydrogenase activity(GO:0034847) 2,4,4-trimethyl-1-pentanol dehydrogenase activity(GO:0034863) 2,4,4-trimethyl-3-hydroxypentanoyl-CoA dehydrogenase activity(GO:0034868) 1-hydroxy-4,4-dimethylpentan-3-one dehydrogenase activity(GO:0034871) endosulfan diol dehydrogenase activity(GO:0034891) endosulfan hydroxyether dehydrogenase activity(GO:0034901) 3-hydroxy-2-methylhexanoyl-CoA dehydrogenase activity(GO:0034918) 3-hydroxy-2,6-dimethyl-5-methylene-heptanoyl-CoA dehydrogenase activity(GO:0034944) versicolorin reductase activity(GO:0042469) ketoreductase activity(GO:0045703) |
0.3 | 2.9 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
0.3 | 0.3 | GO:0019957 | C-C chemokine binding(GO:0019957) |
0.3 | 0.3 | GO:0005057 | receptor signaling protein activity(GO:0005057) |
0.3 | 11.7 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.3 | 0.9 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
0.3 | 0.3 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.3 | 3.2 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.3 | 4.1 | GO:0015149 | hexose transmembrane transporter activity(GO:0015149) |
0.3 | 1.5 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.3 | 1.7 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.3 | 0.3 | GO:0034452 | dynactin binding(GO:0034452) |
0.3 | 3.8 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.3 | 1.1 | GO:0016936 | galactoside binding(GO:0016936) |
0.3 | 1.1 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
0.3 | 6.9 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.3 | 0.9 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.3 | 0.3 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
0.3 | 2.0 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.3 | 0.3 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
0.3 | 15.0 | GO:0008168 | methyltransferase activity(GO:0008168) |
0.3 | 1.1 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
0.3 | 7.3 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
0.3 | 2.8 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.3 | 2.5 | GO:0005521 | lamin binding(GO:0005521) |
0.3 | 0.6 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
0.3 | 1.7 | GO:0030955 | potassium ion binding(GO:0030955) |
0.3 | 2.5 | GO:0061650 | ubiquitin-like protein conjugating enzyme activity(GO:0061650) |
0.3 | 0.3 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.3 | 0.6 | GO:0000217 | DNA secondary structure binding(GO:0000217) |
0.3 | 0.5 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.3 | 1.1 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.3 | 16.5 | GO:0042393 | histone binding(GO:0042393) |
0.3 | 0.5 | GO:0033592 | RNA strand annealing activity(GO:0033592) |
0.3 | 0.3 | GO:0070840 | dynein complex binding(GO:0070840) |
0.3 | 0.8 | GO:0051032 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.3 | 2.1 | GO:0043022 | ribosome binding(GO:0043022) |
0.3 | 1.6 | GO:0008097 | 5S rRNA binding(GO:0008097) |
0.3 | 1.1 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
0.3 | 9.9 | GO:0017048 | Rho GTPase binding(GO:0017048) |
0.3 | 5.9 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.3 | 0.3 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.3 | 0.8 | GO:0000309 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.3 | 3.4 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.3 | 8.1 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.3 | 0.5 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.3 | 36.3 | GO:0008134 | transcription factor binding(GO:0008134) |
0.3 | 0.3 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.3 | 1.0 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
0.3 | 0.8 | GO:0035381 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.3 | 9.3 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.3 | 4.1 | GO:0008483 | transaminase activity(GO:0008483) |
0.3 | 4.7 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.3 | 2.3 | GO:0019209 | kinase activator activity(GO:0019209) |
0.3 | 1.3 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.3 | 9.2 | GO:0004860 | protein kinase inhibitor activity(GO:0004860) |
0.3 | 1.0 | GO:0031705 | bombesin receptor binding(GO:0031705) |
0.3 | 8.2 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.3 | 4.1 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.3 | 0.8 | GO:0004866 | endopeptidase inhibitor activity(GO:0004866) |
0.3 | 54.0 | GO:0000981 | RNA polymerase II transcription factor activity, sequence-specific DNA binding(GO:0000981) |
0.3 | 1.0 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
0.2 | 1.7 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.2 | 2.0 | GO:0061733 | peptide-lysine-N-acetyltransferase activity(GO:0061733) |
0.2 | 1.0 | GO:0003884 | D-amino-acid oxidase activity(GO:0003884) |
0.2 | 2.7 | GO:0016701 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen(GO:0016701) |
0.2 | 0.7 | GO:0008422 | beta-glucosidase activity(GO:0008422) |
0.2 | 0.2 | GO:0016649 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
0.2 | 0.7 | GO:1990405 | protein antigen binding(GO:1990405) |
0.2 | 3.4 | GO:0003924 | GTPase activity(GO:0003924) |
0.2 | 1.5 | GO:0019887 | protein kinase regulator activity(GO:0019887) |
0.2 | 11.2 | GO:0008186 | ATP-dependent RNA helicase activity(GO:0004004) RNA-dependent ATPase activity(GO:0008186) |
0.2 | 11.8 | GO:0005178 | integrin binding(GO:0005178) |
0.2 | 0.7 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
0.2 | 2.9 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.2 | 4.3 | GO:0046914 | transition metal ion binding(GO:0046914) |
0.2 | 0.2 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.2 | 1.0 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
0.2 | 0.7 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.2 | 0.5 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.2 | 1.9 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
0.2 | 2.9 | GO:0001614 | purinergic nucleotide receptor activity(GO:0001614) nucleotide receptor activity(GO:0016502) |
0.2 | 1.2 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.2 | 1.7 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.2 | 3.6 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
0.2 | 0.7 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
0.2 | 0.5 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
0.2 | 0.7 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.2 | 2.4 | GO:0045502 | dynein binding(GO:0045502) |
0.2 | 0.9 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
0.2 | 0.9 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
0.2 | 1.6 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.2 | 3.3 | GO:0001948 | glycoprotein binding(GO:0001948) |
0.2 | 1.2 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.2 | 2.3 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.2 | 0.5 | GO:0016889 | endodeoxyribonuclease activity, producing 3'-phosphomonoesters(GO:0016889) |
0.2 | 1.2 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
0.2 | 0.5 | GO:0031432 | titin binding(GO:0031432) |
0.2 | 1.6 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
0.2 | 2.5 | GO:0004312 | fatty acid synthase activity(GO:0004312) |
0.2 | 2.2 | GO:0008187 | poly-pyrimidine tract binding(GO:0008187) |
0.2 | 0.4 | GO:0042165 | neurotransmitter binding(GO:0042165) |
0.2 | 1.1 | GO:0016443 | bidentate ribonuclease III activity(GO:0016443) |
0.2 | 1.1 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.2 | 0.2 | GO:0042301 | phosphate ion binding(GO:0042301) |
0.2 | 0.9 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.2 | 0.2 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.2 | 0.7 | GO:0019767 | IgE receptor activity(GO:0019767) |
0.2 | 1.5 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.2 | 0.4 | GO:0050780 | dopamine receptor binding(GO:0050780) |
0.2 | 0.7 | GO:0017022 | myosin binding(GO:0017022) |
0.2 | 2.4 | GO:0015929 | hexosaminidase activity(GO:0015929) |
0.2 | 0.7 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.2 | 2.8 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.2 | 6.5 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.2 | 1.7 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
0.2 | 4.3 | GO:0015020 | glucuronosyltransferase activity(GO:0015020) |
0.2 | 0.6 | GO:0055102 | lipase inhibitor activity(GO:0055102) |
0.2 | 0.2 | GO:0019961 | interferon binding(GO:0019961) |
0.2 | 0.6 | GO:0051731 | polynucleotide 5'-hydroxyl-kinase activity(GO:0051731) ATP-dependent polynucleotide kinase activity(GO:0051734) |
0.2 | 3.0 | GO:0000978 | RNA polymerase II core promoter proximal region sequence-specific DNA binding(GO:0000978) |
0.2 | 0.2 | GO:0032405 | MutLalpha complex binding(GO:0032405) |
0.2 | 0.8 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
0.2 | 0.6 | GO:0016717 | acyl-CoA desaturase activity(GO:0016215) oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water(GO:0016717) |
0.2 | 0.2 | GO:0032404 | mismatch repair complex binding(GO:0032404) MutSalpha complex binding(GO:0032407) |
0.2 | 1.1 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
0.2 | 0.4 | GO:0047105 | aminobutyraldehyde dehydrogenase activity(GO:0019145) 4-trimethylammoniobutyraldehyde dehydrogenase activity(GO:0047105) |
0.2 | 0.4 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
0.2 | 2.1 | GO:0004177 | aminopeptidase activity(GO:0004177) |
0.2 | 4.8 | GO:0003682 | chromatin binding(GO:0003682) |
0.2 | 0.8 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
0.2 | 2.9 | GO:0070566 | adenylyltransferase activity(GO:0070566) |
0.2 | 0.2 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
0.2 | 5.8 | GO:0016830 | carbon-carbon lyase activity(GO:0016830) |
0.2 | 28.5 | GO:0016818 | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides(GO:0016818) |
0.2 | 0.6 | GO:0042834 | peptidoglycan binding(GO:0042834) |
0.2 | 0.2 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
0.2 | 0.4 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
0.2 | 0.6 | GO:0001848 | complement binding(GO:0001848) |
0.2 | 12.3 | GO:0101005 | thiol-dependent ubiquitinyl hydrolase activity(GO:0036459) ubiquitinyl hydrolase activity(GO:0101005) |
0.2 | 20.7 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.2 | 48.4 | GO:0005525 | GTP binding(GO:0005525) |
0.2 | 1.2 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
0.2 | 3.4 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.2 | 1.0 | GO:0002094 | polyprenyltransferase activity(GO:0002094) |
0.2 | 1.4 | GO:0015266 | protein channel activity(GO:0015266) |
0.2 | 5.9 | GO:0016881 | acid-amino acid ligase activity(GO:0016881) |
0.2 | 2.2 | GO:0050661 | NADP binding(GO:0050661) |
0.2 | 2.2 | GO:0045296 | cadherin binding(GO:0045296) |
0.2 | 0.2 | GO:0043141 | ATP-dependent 5'-3' DNA helicase activity(GO:0043141) |
0.2 | 19.8 | GO:0001071 | nucleic acid binding transcription factor activity(GO:0001071) transcription factor activity, sequence-specific DNA binding(GO:0003700) |
0.2 | 0.6 | GO:0043566 | structure-specific DNA binding(GO:0043566) |
0.2 | 1.0 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.2 | 0.6 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.2 | 0.6 | GO:0008417 | fucosyltransferase activity(GO:0008417) |
0.2 | 0.2 | GO:0008310 | single-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008310) |
0.2 | 0.6 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
0.2 | 0.2 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
0.2 | 3.2 | GO:0015928 | fucosidase activity(GO:0015928) |
0.2 | 1.1 | GO:0097153 | cysteine-type endopeptidase activity involved in apoptotic process(GO:0097153) |
0.2 | 2.7 | GO:0031072 | heat shock protein binding(GO:0031072) |
0.2 | 0.6 | GO:0034185 | apolipoprotein binding(GO:0034185) |
0.2 | 0.4 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
0.2 | 2.4 | GO:0008047 | enzyme activator activity(GO:0008047) |
0.2 | 96.1 | GO:0044822 | poly(A) RNA binding(GO:0044822) |
0.2 | 4.7 | GO:0052770 | coenzyme F390-A hydrolase activity(GO:0052770) coenzyme F390-G hydrolase activity(GO:0052771) |
0.2 | 14.8 | GO:0003774 | motor activity(GO:0003774) |
0.2 | 0.4 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) |
0.2 | 0.6 | GO:0008408 | 3'-5' exonuclease activity(GO:0008408) |
0.2 | 0.4 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.2 | 4.0 | GO:0046906 | heme binding(GO:0020037) tetrapyrrole binding(GO:0046906) |
0.2 | 0.4 | GO:0043842 | Kdo transferase activity(GO:0043842) |
0.2 | 0.4 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.2 | 5.8 | GO:0016790 | thiolester hydrolase activity(GO:0016790) |
0.2 | 1.8 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.2 | 29.2 | GO:0019901 | protein kinase binding(GO:0019901) |
0.2 | 0.7 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.2 | 6.5 | GO:0004540 | ribonuclease activity(GO:0004540) |
0.2 | 0.7 | GO:0003840 | gamma-glutamyltransferase activity(GO:0003840) glutathione hydrolase activity(GO:0036374) |
0.2 | 1.2 | GO:0003796 | lysozyme activity(GO:0003796) |
0.2 | 0.7 | GO:0015278 | calcium-release channel activity(GO:0015278) ligand-gated calcium channel activity(GO:0099604) |
0.2 | 0.7 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
0.2 | 0.5 | GO:0004033 | aldo-keto reductase (NADP) activity(GO:0004033) |
0.2 | 0.2 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.2 | 0.5 | GO:0061731 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.2 | 0.7 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.2 | 0.2 | GO:0019862 | IgA binding(GO:0019862) |
0.2 | 1.0 | GO:0035257 | nuclear hormone receptor binding(GO:0035257) |
0.2 | 0.7 | GO:0042015 | interleukin-20 binding(GO:0042015) |
0.2 | 0.7 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.2 | 96.0 | GO:0003677 | DNA binding(GO:0003677) |
0.2 | 0.2 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.2 | 0.2 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
0.2 | 0.3 | GO:0097027 | ubiquitin-protein transferase activator activity(GO:0097027) |
0.2 | 0.2 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
0.2 | 0.8 | GO:0008200 | ion channel inhibitor activity(GO:0008200) |
0.2 | 0.2 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
0.2 | 2.1 | GO:0043914 | NADPH:sulfur oxidoreductase activity(GO:0043914) |
0.2 | 2.1 | GO:0043130 | ubiquitin binding(GO:0043130) |
0.2 | 0.2 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.2 | 0.2 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
0.2 | 0.3 | GO:0004977 | melanocortin receptor activity(GO:0004977) |
0.2 | 3.3 | GO:0016748 | succinyltransferase activity(GO:0016748) |
0.2 | 0.5 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.2 | 0.6 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.2 | 1.5 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.2 | 0.3 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.2 | 0.6 | GO:0043121 | neurotrophin binding(GO:0043121) nerve growth factor binding(GO:0048406) |
0.2 | 0.6 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.2 | 0.9 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.2 | 3.0 | GO:0030165 | PDZ domain binding(GO:0030165) |
0.2 | 0.5 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.2 | 0.5 | GO:0008260 | 3-oxoacid CoA-transferase activity(GO:0008260) |
0.2 | 0.2 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.2 | 8.3 | GO:0004896 | cytokine receptor activity(GO:0004896) |
0.2 | 1.2 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.2 | 0.5 | GO:0004942 | anaphylatoxin receptor activity(GO:0004942) |
0.2 | 0.2 | GO:0038181 | bile acid receptor activity(GO:0038181) |
0.1 | 0.4 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
0.1 | 0.4 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
0.1 | 0.3 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.1 | 1.2 | GO:0004029 | aldehyde dehydrogenase (NAD) activity(GO:0004029) |
0.1 | 3.1 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.1 | 0.7 | GO:0043021 | ribonucleoprotein complex binding(GO:0043021) |
0.1 | 0.4 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
0.1 | 1.0 | GO:0005372 | water transmembrane transporter activity(GO:0005372) |
0.1 | 0.1 | GO:0015232 | heme transporter activity(GO:0015232) |
0.1 | 1.3 | GO:0004568 | chitinase activity(GO:0004568) |
0.1 | 0.7 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.1 | 1.5 | GO:0019900 | kinase binding(GO:0019900) |
0.1 | 20.8 | GO:0003779 | actin binding(GO:0003779) |
0.1 | 7.3 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
0.1 | 0.3 | GO:0033691 | sialic acid binding(GO:0033691) |
0.1 | 0.4 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.1 | 14.3 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.1 | 0.3 | GO:0044548 | S100 protein binding(GO:0044548) |
0.1 | 1.4 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.1 | 0.7 | GO:0010853 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
0.1 | 3.4 | GO:0008009 | chemokine activity(GO:0008009) |
0.1 | 0.1 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.1 | 1.0 | GO:0050660 | flavin adenine dinucleotide binding(GO:0050660) |
0.1 | 0.5 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
0.1 | 0.1 | GO:0032182 | ubiquitin-like protein binding(GO:0032182) |
0.1 | 1.5 | GO:0016811 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides(GO:0016811) |
0.1 | 0.1 | GO:0016859 | cis-trans isomerase activity(GO:0016859) |
0.1 | 0.4 | GO:0070139 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
0.1 | 0.1 | GO:0003964 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
0.1 | 1.3 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.1 | 0.3 | GO:0005347 | ATP transmembrane transporter activity(GO:0005347) |
0.1 | 1.1 | GO:0016620 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor(GO:0016620) |
0.1 | 0.4 | GO:0035251 | UDP-glucosyltransferase activity(GO:0035251) |
0.1 | 0.3 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.1 | 3.2 | GO:0016651 | oxidoreductase activity, acting on NAD(P)H(GO:0016651) |
0.1 | 0.2 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) norepinephrine binding(GO:0051380) |
0.1 | 0.7 | GO:0008144 | drug binding(GO:0008144) |
0.1 | 0.1 | GO:0035473 | lipase binding(GO:0035473) |
0.1 | 0.2 | GO:0016803 | ether hydrolase activity(GO:0016803) |
0.1 | 0.4 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
0.1 | 4.6 | GO:0008527 | taste receptor activity(GO:0008527) |
0.1 | 0.5 | GO:0015651 | quaternary ammonium group transmembrane transporter activity(GO:0015651) |
0.1 | 0.7 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.1 | 0.6 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
0.1 | 0.4 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.1 | 18.3 | GO:0004674 | protein serine/threonine kinase activity(GO:0004674) |
0.1 | 0.8 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.1 | 0.1 | GO:0097506 | uracil DNA N-glycosylase activity(GO:0004844) deaminated base DNA N-glycosylase activity(GO:0097506) |
0.1 | 0.1 | GO:0004583 | dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity(GO:0004583) |
0.1 | 0.1 | GO:0015145 | monosaccharide transmembrane transporter activity(GO:0015145) |
0.1 | 0.2 | GO:0016801 | adenosylhomocysteinase activity(GO:0004013) hydrolase activity, acting on ether bonds(GO:0016801) trialkylsulfonium hydrolase activity(GO:0016802) |
0.1 | 0.7 | GO:0097110 | scaffold protein binding(GO:0097110) |
0.1 | 2.1 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.1 | 0.2 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.1 | 0.2 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.1 | 0.1 | GO:0004518 | nuclease activity(GO:0004518) |
0.1 | 0.4 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.1 | 0.2 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
0.1 | 1.0 | GO:0008376 | acetylgalactosaminyltransferase activity(GO:0008376) |
0.1 | 0.4 | GO:0032813 | tumor necrosis factor receptor superfamily binding(GO:0032813) |
0.1 | 4.4 | GO:0046983 | protein dimerization activity(GO:0046983) |
0.1 | 0.6 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.1 | 0.2 | GO:0048019 | receptor antagonist activity(GO:0048019) |
0.1 | 0.2 | GO:0070034 | telomerase RNA binding(GO:0070034) |
0.1 | 2.8 | GO:0008083 | growth factor activity(GO:0008083) |
0.1 | 0.3 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.1 | 0.3 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
0.1 | 16.1 | GO:0017171 | serine hydrolase activity(GO:0017171) |
0.1 | 1.4 | GO:0051117 | ATPase binding(GO:0051117) |
0.1 | 0.4 | GO:0031210 | phosphatidylcholine binding(GO:0031210) |
0.1 | 0.5 | GO:0017040 | ceramidase activity(GO:0017040) |
0.1 | 0.2 | GO:0005113 | patched binding(GO:0005113) |
0.1 | 0.5 | GO:0042300 | pivalyl-CoA mutase activity(GO:0034784) o-hydroxylaminobenzoate mutase activity(GO:0034951) lupeol synthase activity(GO:0042299) beta-amyrin synthase activity(GO:0042300) baruol synthase activity(GO:0080011) |
0.1 | 0.5 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.1 | 0.3 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.1 | 0.3 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.1 | 1.6 | GO:0008028 | monocarboxylic acid transmembrane transporter activity(GO:0008028) |
0.1 | 0.1 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.1 | 4.6 | GO:0008528 | G-protein coupled peptide receptor activity(GO:0008528) |
0.1 | 0.5 | GO:0019843 | rRNA binding(GO:0019843) |
0.1 | 0.1 | GO:0097016 | L27 domain binding(GO:0097016) |
0.1 | 5.1 | GO:0031625 | ubiquitin protein ligase binding(GO:0031625) |
0.1 | 0.2 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.1 | 0.2 | GO:0043199 | sulfate binding(GO:0043199) |
0.1 | 0.1 | GO:0019842 | vitamin binding(GO:0019842) |
0.1 | 0.4 | GO:0051400 | BH domain binding(GO:0051400) |
0.1 | 0.3 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.1 | 0.5 | GO:0005338 | nucleotide-sugar transmembrane transporter activity(GO:0005338) |
0.1 | 20.0 | GO:0005198 | structural molecule activity(GO:0005198) |
0.1 | 0.1 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
0.1 | 0.8 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
0.1 | 0.3 | GO:0015026 | coreceptor activity(GO:0015026) |
0.1 | 0.3 | GO:0004439 | phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity(GO:0004439) |
0.1 | 0.3 | GO:0070628 | proteasome binding(GO:0070628) |
0.1 | 0.4 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.1 | 0.2 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
0.1 | 0.6 | GO:0004812 | aminoacyl-tRNA ligase activity(GO:0004812) |
0.1 | 1.9 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
0.1 | 0.1 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.1 | 10.0 | GO:0003676 | nucleic acid binding(GO:0003676) |
0.1 | 0.5 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.1 | 0.3 | GO:0004536 | deoxyribonuclease activity(GO:0004536) |
0.1 | 6.8 | GO:0030246 | carbohydrate binding(GO:0030246) |
0.1 | 0.3 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.1 | 0.1 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.1 | 2.1 | GO:0016616 | oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor(GO:0016616) |
0.1 | 0.1 | GO:0008320 | protein transmembrane transporter activity(GO:0008320) |
0.1 | 0.1 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.1 | 3.6 | GO:0008146 | sulfotransferase activity(GO:0008146) |
0.1 | 0.4 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.1 | 2.6 | GO:0008201 | heparin binding(GO:0008201) |
0.1 | 0.1 | GO:1902282 | voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1902282) |
0.1 | 1.2 | GO:0004889 | acetylcholine-activated cation-selective channel activity(GO:0004889) |
0.1 | 0.1 | GO:0031690 | adrenergic receptor binding(GO:0031690) |
0.1 | 0.1 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
0.1 | 0.2 | GO:0016641 | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor(GO:0016641) |
0.1 | 0.1 | GO:0019187 | beta-1,4-mannosyltransferase activity(GO:0019187) |
0.1 | 0.9 | GO:0047485 | protein N-terminus binding(GO:0047485) |
0.1 | 1.3 | GO:0008392 | arachidonic acid epoxygenase activity(GO:0008392) |
0.1 | 0.3 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
0.1 | 0.1 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.1 | 0.4 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
0.1 | 0.4 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.1 | 0.7 | GO:0008013 | beta-catenin binding(GO:0008013) |
0.1 | 0.1 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.1 | 0.1 | GO:0046848 | hydroxyapatite binding(GO:0046848) |
0.1 | 0.3 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.1 | 0.1 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.1 | 0.3 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.1 | 0.4 | GO:0016879 | ligase activity, forming carbon-nitrogen bonds(GO:0016879) |
0.1 | 1.0 | GO:0052689 | carboxylic ester hydrolase activity(GO:0052689) |
0.1 | 6.3 | GO:0016503 | pheromone receptor activity(GO:0016503) |
0.1 | 1.0 | GO:0051087 | chaperone binding(GO:0051087) |
0.1 | 0.1 | GO:0047751 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) cholestenone 5-alpha-reductase activity(GO:0047751) |
0.1 | 0.1 | GO:0016823 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
0.1 | 11.6 | GO:0005509 | calcium ion binding(GO:0005509) |
0.1 | 0.1 | GO:0038100 | nodal binding(GO:0038100) |
0.1 | 0.3 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.1 | 3.0 | GO:0015171 | amino acid transmembrane transporter activity(GO:0015171) |
0.1 | 0.2 | GO:0010181 | FMN binding(GO:0010181) |
0.1 | 0.6 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.1 | 0.1 | GO:0035325 | Toll-like receptor binding(GO:0035325) |
0.1 | 0.3 | GO:0015926 | glucosidase activity(GO:0015926) |
0.1 | 0.2 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.1 | 0.3 | GO:0044390 | ubiquitin-like protein conjugating enzyme binding(GO:0044390) |
0.1 | 0.3 | GO:0004180 | carboxypeptidase activity(GO:0004180) |
0.1 | 0.3 | GO:0030507 | spectrin binding(GO:0030507) |
0.1 | 1.0 | GO:0005227 | calcium activated cation channel activity(GO:0005227) |
0.1 | 0.4 | GO:0017046 | peptide hormone binding(GO:0017046) |
0.1 | 0.1 | GO:0004645 | phosphorylase activity(GO:0004645) |
0.0 | 0.1 | GO:0043531 | ADP binding(GO:0043531) |
0.0 | 4.4 | GO:0005179 | hormone activity(GO:0005179) |
0.0 | 0.2 | GO:0030548 | acetylcholine receptor regulator activity(GO:0030548) neurotransmitter receptor regulator activity(GO:0099602) |
0.0 | 0.8 | GO:0016836 | hydro-lyase activity(GO:0016836) |
0.0 | 0.6 | GO:0016874 | ligase activity(GO:0016874) |
0.0 | 2.9 | GO:0005126 | cytokine receptor binding(GO:0005126) |
0.0 | 0.0 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.0 | 0.1 | GO:0015197 | peptide transporter activity(GO:0015197) |
0.0 | 0.1 | GO:0004497 | monooxygenase activity(GO:0004497) |
0.0 | 0.0 | GO:0019863 | IgE binding(GO:0019863) |
0.0 | 9.2 | GO:0042802 | identical protein binding(GO:0042802) |
0.0 | 0.9 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.0 | 0.2 | GO:0035256 | G-protein coupled glutamate receptor binding(GO:0035256) |
0.0 | 12.6 | GO:0004930 | G-protein coupled receptor activity(GO:0004930) |
0.0 | 0.3 | GO:0016929 | SUMO-specific protease activity(GO:0016929) |
0.0 | 0.0 | GO:0015665 | alcohol transmembrane transporter activity(GO:0015665) |
0.0 | 0.2 | GO:0043621 | protein self-association(GO:0043621) |
0.0 | 0.0 | GO:0044389 | ubiquitin-like protein ligase binding(GO:0044389) |
0.0 | 0.0 | GO:0046979 | TAP1 binding(GO:0046978) TAP2 binding(GO:0046979) |
0.0 | 0.1 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.0 | 0.0 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.0 | 0.0 | GO:0008061 | chitin binding(GO:0008061) |
0.0 | 0.7 | GO:0005085 | guanyl-nucleotide exchange factor activity(GO:0005085) |
0.0 | 0.6 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.0 | 0.2 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
0.0 | 0.0 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) ErbB-3 class receptor binding(GO:0043125) |
0.0 | 0.0 | GO:0032190 | acrosin binding(GO:0032190) |
0.0 | 0.1 | GO:0045309 | protein phosphorylated amino acid binding(GO:0045309) |
0.0 | 0.1 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) |
0.0 | 28.5 | GO:0004984 | olfactory receptor activity(GO:0004984) |
0.0 | 0.2 | GO:0061134 | peptidase regulator activity(GO:0061134) |
0.0 | 0.0 | GO:0016706 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors(GO:0016706) |
0.0 | 0.0 | GO:0030249 | guanylate cyclase regulator activity(GO:0030249) |
0.0 | 0.3 | GO:0005496 | steroid binding(GO:0005496) |
0.0 | 0.0 | GO:0046332 | SMAD binding(GO:0046332) |
0.0 | 0.0 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.0 | 0.0 | GO:0016413 | O-acetyltransferase activity(GO:0016413) |
0.0 | 0.0 | GO:0070405 | ammonium ion binding(GO:0070405) |
0.0 | 0.0 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.0 | 0.0 | GO:0033612 | receptor serine/threonine kinase binding(GO:0033612) |
0.0 | 0.2 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
0.0 | 0.1 | GO:0015296 | anion:cation symporter activity(GO:0015296) |
0.0 | 0.0 | GO:0005326 | neurotransmitter transporter activity(GO:0005326) |
0.0 | 0.1 | GO:0019534 | toxin transporter activity(GO:0019534) |
0.0 | 0.1 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
0.0 | 0.0 | GO:0019955 | cytokine binding(GO:0019955) |
0.0 | 0.1 | GO:1901476 | carbohydrate transmembrane transporter activity(GO:0015144) carbohydrate transporter activity(GO:1901476) |
0.0 | 0.0 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.0 | 0.0 | GO:0000026 | alpha-1,2-mannosyltransferase activity(GO:0000026) |
0.0 | 0.0 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.0 | 0.0 | GO:0039706 | co-receptor binding(GO:0039706) |
0.0 | 0.1 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.0 | 0.0 | GO:0002046 | opsin binding(GO:0002046) |
0.0 | 0.0 | GO:0046915 | transition metal ion transmembrane transporter activity(GO:0046915) |
0.0 | 1.2 | GO:0044877 | macromolecular complex binding(GO:0044877) |
0.0 | 0.0 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
0.0 | 0.0 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.0 | 0.0 | GO:0046527 | glucosyltransferase activity(GO:0046527) |
0.0 | 0.0 | GO:0015248 | sterol transporter activity(GO:0015248) |
0.0 | 0.0 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.5 | 83.8 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
1.4 | 42.7 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
1.3 | 62.8 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
1.3 | 17.5 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
1.2 | 29.0 | PID BARD1 PATHWAY | BARD1 signaling events |
1.2 | 10.7 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
1.2 | 1.2 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
1.1 | 7.7 | ST STAT3 PATHWAY | STAT3 Pathway |
1.1 | 33.0 | PID ARF6 PATHWAY | Arf6 signaling events |
1.1 | 20.4 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
1.0 | 9.4 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.9 | 8.7 | PID ALK2 PATHWAY | ALK2 signaling events |
0.9 | 11.2 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.9 | 14.5 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.8 | 9.3 | PID ALK1 PATHWAY | ALK1 signaling events |
0.8 | 45.2 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.8 | 6.7 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.8 | 11.7 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.8 | 21.7 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.8 | 18.4 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.8 | 4.8 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.8 | 11.7 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.8 | 10.9 | PID IGF1 PATHWAY | IGF1 pathway |
0.8 | 16.3 | PID RHOA PATHWAY | RhoA signaling pathway |
0.8 | 48.8 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.7 | 8.8 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.7 | 22.5 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.7 | 7.7 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.7 | 5.6 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.7 | 9.0 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.7 | 8.8 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.7 | 13.4 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.7 | 2.0 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.6 | 2.6 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.6 | 1.3 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.6 | 34.9 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.6 | 0.6 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.6 | 8.3 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.6 | 4.0 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.6 | 16.4 | PID AURORA B PATHWAY | Aurora B signaling |
0.6 | 17.6 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.5 | 6.9 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.5 | 6.2 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.5 | 5.6 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.5 | 14.7 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.5 | 10.1 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.5 | 3.0 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.5 | 10.3 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.5 | 6.2 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.5 | 6.7 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.5 | 9.0 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.5 | 37.0 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.5 | 16.0 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.5 | 13.0 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.5 | 1.8 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.4 | 4.0 | PID AURORA A PATHWAY | Aurora A signaling |
0.4 | 7.1 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.4 | 8.9 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.4 | 1.3 | PID CDC42 PATHWAY | CDC42 signaling events |
0.4 | 19.3 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.4 | 13.7 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.4 | 6.2 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.4 | 2.0 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.4 | 2.8 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.4 | 6.3 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.4 | 13.8 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.4 | 5.4 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.4 | 3.8 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.4 | 0.7 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.4 | 18.8 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.4 | 8.3 | PID PLK1 PATHWAY | PLK1 signaling events |
0.4 | 2.2 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.4 | 0.7 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.4 | 2.5 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.4 | 1.4 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.3 | 5.6 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.3 | 3.5 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.3 | 4.4 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.3 | 8.4 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.3 | 3.9 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
0.3 | 0.6 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.3 | 0.3 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
0.3 | 3.1 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.3 | 1.8 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.3 | 2.7 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.3 | 1.5 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.3 | 2.9 | PID RAS PATHWAY | Regulation of Ras family activation |
0.3 | 1.2 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.3 | 0.6 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
0.3 | 1.7 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
0.3 | 2.3 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.3 | 1.4 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.3 | 3.3 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.3 | 1.1 | PID IFNG PATHWAY | IFN-gamma pathway |
0.3 | 5.8 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.3 | 0.3 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.3 | 3.9 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.3 | 3.3 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.3 | 3.9 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.3 | 2.8 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.3 | 33.9 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.3 | 2.5 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.3 | 1.3 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.3 | 1.5 | ST GAQ PATHWAY | G alpha q Pathway |
0.2 | 2.0 | PID ATM PATHWAY | ATM pathway |
0.2 | 4.4 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.2 | 5.5 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.2 | 1.2 | PID EPO PATHWAY | EPO signaling pathway |
0.2 | 0.9 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.2 | 0.5 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.2 | 7.6 | NABA COLLAGENS | Genes encoding collagen proteins |
0.2 | 2.9 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.2 | 3.5 | ST FAS SIGNALING PATHWAY | Fas Signaling Pathway |
0.2 | 46.7 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.2 | 2.0 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.2 | 0.2 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.2 | 0.6 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.2 | 2.5 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.2 | 0.2 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.2 | 3.2 | PID P53 REGULATION PATHWAY | p53 pathway |
0.2 | 1.9 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.2 | 1.8 | PID ARF 3PATHWAY | Arf1 pathway |
0.2 | 25.5 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.2 | 3.1 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.2 | 0.8 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.2 | 2.6 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
0.2 | 1.6 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.2 | 2.8 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.2 | 1.1 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.2 | 2.2 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.2 | 1.8 | PID BMP PATHWAY | BMP receptor signaling |
0.2 | 0.9 | PID FOXO PATHWAY | FoxO family signaling |
0.1 | 1.6 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.1 | 0.1 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.1 | 0.4 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.1 | 1.4 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.1 | 1.5 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.1 | 23.3 | NABA MATRISOME ASSOCIATED | Ensemble of genes encoding ECM-associated proteins including ECM-affilaited proteins, ECM regulators and secreted factors |
0.1 | 0.6 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.1 | 0.3 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.1 | 0.7 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.1 | 0.2 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.1 | 0.7 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.1 | 0.1 | ST GA13 PATHWAY | G alpha 13 Pathway |
0.1 | 1.8 | PID P73PATHWAY | p73 transcription factor network |
0.1 | 2.2 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.1 | 0.1 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.1 | 0.1 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.1 | 0.2 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.1 | 0.6 | PID ENDOTHELIN PATHWAY | Endothelins |
0.1 | 0.6 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.1 | 0.2 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.1 | 2.8 | NABA CORE MATRISOME | Ensemble of genes encoding core extracellular matrix including ECM glycoproteins, collagens and proteoglycans |
0.1 | 0.7 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.1 | 1.5 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.1 | 0.1 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.1 | 0.4 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.1 | 0.7 | PID BCR 5PATHWAY | BCR signaling pathway |
0.1 | 1.0 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.1 | 0.7 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
0.1 | 0.3 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.1 | 0.1 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.1 | 0.1 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.1 | 0.5 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.1 | 0.2 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.0 | 0.2 | PID ATR PATHWAY | ATR signaling pathway |
0.0 | 0.0 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.0 | 0.0 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.0 | 0.0 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.0 | 0.2 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.0 | 0.1 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.0 | 0.6 | PID NOTCH PATHWAY | Notch signaling pathway |
0.0 | 0.1 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.0 | 0.0 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.0 | 0.0 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.0 | 0.1 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.0 | 0.0 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.8 | 3.8 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
2.7 | 26.8 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
2.0 | 31.6 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
1.7 | 5.1 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
1.7 | 18.5 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
1.6 | 14.2 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
1.6 | 15.8 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
1.6 | 17.3 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
1.4 | 27.0 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
1.4 | 16.8 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
1.3 | 17.5 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
1.3 | 20.9 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
1.3 | 27.0 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
1.3 | 8.9 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
1.2 | 20.1 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
1.2 | 8.1 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
1.1 | 26.1 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
1.1 | 4.4 | REACTOME DESTABILIZATION OF MRNA BY KSRP | Genes involved in Destabilization of mRNA by KSRP |
1.1 | 20.8 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
1.0 | 10.5 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
1.0 | 13.3 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
1.0 | 9.9 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
1.0 | 20.6 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
1.0 | 1.0 | REACTOME ABORTIVE ELONGATION OF HIV1 TRANSCRIPT IN THE ABSENCE OF TAT | Genes involved in Abortive elongation of HIV-1 transcript in the absence of Tat |
0.9 | 11.0 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.9 | 11.7 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.9 | 11.3 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
0.9 | 24.3 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.8 | 22.4 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.8 | 22.4 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.8 | 7.2 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.8 | 17.6 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.8 | 21.5 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.8 | 14.3 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.8 | 7.1 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.8 | 18.0 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
0.8 | 0.8 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.8 | 7.0 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.8 | 9.3 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.8 | 10.1 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.8 | 1.5 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
0.8 | 3.0 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.7 | 9.7 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.7 | 8.2 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.7 | 5.9 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.7 | 2.2 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.7 | 3.6 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.7 | 16.5 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.7 | 6.4 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.7 | 5.6 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.7 | 7.6 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.7 | 6.6 | REACTOME ARMS MEDIATED ACTIVATION | Genes involved in ARMS-mediated activation |
0.6 | 22.0 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.6 | 45.8 | REACTOME L1CAM INTERACTIONS | Genes involved in L1CAM interactions |
0.6 | 15.9 | REACTOME PYRUVATE METABOLISM AND CITRIC ACID TCA CYCLE | Genes involved in Pyruvate metabolism and Citric Acid (TCA) cycle |
0.6 | 35.2 | REACTOME GLYCEROPHOSPHOLIPID BIOSYNTHESIS | Genes involved in Glycerophospholipid biosynthesis |
0.6 | 13.0 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.6 | 5.2 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
0.6 | 0.6 | REACTOME SCF BETA TRCP MEDIATED DEGRADATION OF EMI1 | Genes involved in SCF-beta-TrCP mediated degradation of Emi1 |
0.6 | 5.8 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.6 | 0.6 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
0.6 | 0.6 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.6 | 5.0 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.6 | 3.9 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.6 | 6.1 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.5 | 3.2 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.5 | 11.9 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.5 | 7.0 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.5 | 6.9 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
0.5 | 12.7 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.5 | 2.1 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
0.5 | 16.1 | REACTOME MRNA 3 END PROCESSING | Genes involved in mRNA 3'-end processing |
0.5 | 8.3 | REACTOME FATTY ACYL COA BIOSYNTHESIS | Genes involved in Fatty Acyl-CoA Biosynthesis |
0.5 | 7.2 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.5 | 5.1 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.5 | 8.1 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.5 | 3.5 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.5 | 25.7 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.5 | 3.0 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.5 | 0.5 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
0.5 | 11.4 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.5 | 7.9 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.5 | 1.5 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
0.5 | 2.5 | REACTOME REGULATION OF AMPK ACTIVITY VIA LKB1 | Genes involved in Regulation of AMPK activity via LKB1 |
0.5 | 4.4 | REACTOME MRNA PROCESSING | Genes involved in mRNA Processing |
0.5 | 31.4 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.5 | 3.3 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.5 | 15.2 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.5 | 0.9 | REACTOME PROLONGED ERK ACTIVATION EVENTS | Genes involved in Prolonged ERK activation events |
0.5 | 20.7 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.5 | 7.5 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
0.5 | 2.3 | REACTOME METABOLISM OF RNA | Genes involved in Metabolism of RNA |
0.5 | 2.8 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.5 | 4.2 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.5 | 36.5 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.5 | 4.1 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.4 | 14.6 | REACTOME LATE PHASE OF HIV LIFE CYCLE | Genes involved in Late Phase of HIV Life Cycle |
0.4 | 6.1 | REACTOME APC CDC20 MEDIATED DEGRADATION OF NEK2A | Genes involved in APC-Cdc20 mediated degradation of Nek2A |
0.4 | 3.1 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.4 | 1.7 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.4 | 17.7 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
0.4 | 3.5 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.4 | 6.9 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.4 | 14.4 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.4 | 0.4 | REACTOME GLUCAGON SIGNALING IN METABOLIC REGULATION | Genes involved in Glucagon signaling in metabolic regulation |
0.4 | 3.4 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
0.4 | 2.1 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.4 | 4.6 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.4 | 2.9 | REACTOME PEPTIDE HORMONE BIOSYNTHESIS | Genes involved in Peptide hormone biosynthesis |
0.4 | 8.7 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.4 | 12.4 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.4 | 4.5 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.4 | 1.6 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.4 | 19.6 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.4 | 2.0 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.4 | 0.8 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.4 | 14.6 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
0.4 | 18.5 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.4 | 2.4 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.4 | 36.5 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.4 | 14.4 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.4 | 11.3 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.4 | 3.0 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.4 | 1.1 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.4 | 3.6 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.4 | 7.3 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
0.4 | 0.7 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
0.4 | 1.1 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.3 | 5.2 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.3 | 3.5 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.3 | 4.1 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.3 | 0.3 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.3 | 3.8 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.3 | 2.0 | REACTOME THROMBOXANE SIGNALLING THROUGH TP RECEPTOR | Genes involved in Thromboxane signalling through TP receptor |
0.3 | 5.0 | REACTOME GAP JUNCTION TRAFFICKING | Genes involved in Gap junction trafficking |
0.3 | 13.4 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
0.3 | 3.6 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.3 | 5.6 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.3 | 7.5 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.3 | 5.5 | REACTOME TRNA AMINOACYLATION | Genes involved in tRNA Aminoacylation |
0.3 | 1.9 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.3 | 4.7 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.3 | 4.6 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.3 | 5.0 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.3 | 6.5 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.3 | 7.0 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.3 | 6.1 | REACTOME MEIOSIS | Genes involved in Meiosis |
0.3 | 1.2 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.3 | 3.2 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
0.3 | 2.6 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.3 | 2.0 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.3 | 2.6 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.3 | 0.9 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
0.3 | 5.4 | REACTOME SIGNALING BY NOTCH1 | Genes involved in Signaling by NOTCH1 |
0.3 | 0.3 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
0.3 | 0.8 | REACTOME CELL DEATH SIGNALLING VIA NRAGE NRIF AND NADE | Genes involved in Cell death signalling via NRAGE, NRIF and NADE |
0.3 | 1.9 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
0.3 | 2.5 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.3 | 2.5 | REACTOME PERK REGULATED GENE EXPRESSION | Genes involved in PERK regulated gene expression |
0.3 | 1.0 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
0.3 | 0.8 | REACTOME SHC RELATED EVENTS | Genes involved in SHC-related events |
0.3 | 0.5 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.3 | 0.5 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.3 | 2.0 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.3 | 33.0 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.2 | 28.8 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.2 | 1.0 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.2 | 0.5 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.2 | 4.1 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.2 | 6.9 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.2 | 33.3 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.2 | 3.3 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.2 | 3.3 | REACTOME ANTIGEN PROCESSING CROSS PRESENTATION | Genes involved in Antigen processing-Cross presentation |
0.2 | 1.6 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
0.2 | 8.0 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.2 | 1.4 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.2 | 5.6 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.2 | 13.2 | REACTOME GENERIC TRANSCRIPTION PATHWAY | Genes involved in Generic Transcription Pathway |
0.2 | 2.2 | REACTOME RESOLUTION OF AP SITES VIA THE MULTIPLE NUCLEOTIDE PATCH REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the multiple-nucleotide patch replacement pathway |
0.2 | 3.1 | REACTOME BOTULINUM NEUROTOXICITY | Genes involved in Botulinum neurotoxicity |
0.2 | 8.1 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.2 | 3.0 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.2 | 1.9 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.2 | 2.7 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.2 | 0.4 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.2 | 0.2 | REACTOME RIG I MDA5 MEDIATED INDUCTION OF IFN ALPHA BETA PATHWAYS | Genes involved in RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways |
0.2 | 0.6 | REACTOME FGFR1 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR1 ligand binding and activation |
0.2 | 0.8 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.2 | 0.2 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.2 | 2.2 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.2 | 5.3 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.2 | 0.6 | REACTOME UNFOLDED PROTEIN RESPONSE | Genes involved in Unfolded Protein Response |
0.2 | 0.4 | REACTOME PKB MEDIATED EVENTS | Genes involved in PKB-mediated events |
0.2 | 1.1 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.2 | 6.4 | REACTOME MITOTIC G2 G2 M PHASES | Genes involved in Mitotic G2-G2/M phases |
0.2 | 3.6 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.2 | 1.3 | REACTOME PROTEIN FOLDING | Genes involved in Protein folding |
0.2 | 0.9 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.2 | 1.2 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.2 | 0.8 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.2 | 0.5 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.2 | 0.3 | REACTOME HEMOSTASIS | Genes involved in Hemostasis |
0.2 | 0.6 | REACTOME SIGNALING BY NOTCH | Genes involved in Signaling by NOTCH |
0.2 | 0.2 | REACTOME SIGNALING BY ERBB2 | Genes involved in Signaling by ERBB2 |
0.2 | 1.2 | REACTOME IMMUNE SYSTEM | Genes involved in Immune System |
0.2 | 0.2 | REACTOME TRIGLYCERIDE BIOSYNTHESIS | Genes involved in Triglyceride Biosynthesis |
0.2 | 5.1 | REACTOME INTEGRATION OF ENERGY METABOLISM | Genes involved in Integration of energy metabolism |
0.2 | 0.3 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
0.2 | 1.7 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.1 | 0.6 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.1 | 3.3 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.1 | 0.7 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.1 | 0.8 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.1 | 0.3 | REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
0.1 | 0.5 | REACTOME SIGNALING BY WNT | Genes involved in Signaling by Wnt |
0.1 | 2.0 | REACTOME G2 M CHECKPOINTS | Genes involved in G2/M Checkpoints |
0.1 | 0.2 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.1 | 6.3 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.1 | 0.2 | REACTOME CDT1 ASSOCIATION WITH THE CDC6 ORC ORIGIN COMPLEX | Genes involved in CDT1 association with the CDC6:ORC:origin complex |
0.1 | 3.3 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.1 | 0.9 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.1 | 2.0 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.1 | 0.1 | REACTOME G BETA GAMMA SIGNALLING THROUGH PI3KGAMMA | Genes involved in G beta:gamma signalling through PI3Kgamma |
0.1 | 0.7 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.1 | 0.6 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.1 | 0.7 | REACTOME SIGNALING BY FGFR1 MUTANTS | Genes involved in Signaling by FGFR1 mutants |
0.1 | 0.5 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.1 | 2.3 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.1 | 5.8 | REACTOME TCA CYCLE AND RESPIRATORY ELECTRON TRANSPORT | Genes involved in The citric acid (TCA) cycle and respiratory electron transport |
0.1 | 4.3 | REACTOME METABOLISM OF CARBOHYDRATES | Genes involved in Metabolism of carbohydrates |
0.1 | 0.7 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
0.1 | 0.8 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.1 | 1.5 | REACTOME SPHINGOLIPID METABOLISM | Genes involved in Sphingolipid metabolism |
0.1 | 0.7 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.1 | 0.1 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
0.1 | 1.0 | REACTOME ACETYLCHOLINE BINDING AND DOWNSTREAM EVENTS | Genes involved in Acetylcholine Binding And Downstream Events |
0.1 | 0.1 | REACTOME P75NTR RECRUITS SIGNALLING COMPLEXES | Genes involved in p75NTR recruits signalling complexes |
0.1 | 0.1 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
0.1 | 0.1 | REACTOME 3 UTR MEDIATED TRANSLATIONAL REGULATION | Genes involved in 3' -UTR-mediated translational regulation |
0.1 | 0.6 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.1 | 0.1 | REACTOME REGULATION OF MITOTIC CELL CYCLE | Genes involved in Regulation of mitotic cell cycle |
0.1 | 0.9 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.1 | 1.1 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.1 | 1.6 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.1 | 0.1 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.1 | 2.9 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.1 | 0.5 | REACTOME RNA POL I TRANSCRIPTION | Genes involved in RNA Polymerase I Transcription |
0.1 | 0.1 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.0 | 0.3 | REACTOME DOWNSTREAM SIGNAL TRANSDUCTION | Genes involved in Downstream signal transduction |
0.0 | 1.0 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.0 | 1.2 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.0 | 0.1 | REACTOME NEF MEDIATES DOWN MODULATION OF CELL SURFACE RECEPTORS BY RECRUITING THEM TO CLATHRIN ADAPTERS | Genes involved in Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters |
0.0 | 0.6 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.0 | 0.4 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.0 | 0.1 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.0 | 0.3 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.0 | 0.4 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
0.0 | 0.6 | REACTOME TRANSLATION | Genes involved in Translation |
0.0 | 0.0 | REACTOME CELL CYCLE CHECKPOINTS | Genes involved in Cell Cycle Checkpoints |
0.0 | 0.0 | REACTOME SIGNALING BY FGFR | Genes involved in Signaling by FGFR |
0.0 | 0.1 | REACTOME DEFENSINS | Genes involved in Defensins |
0.0 | 0.1 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.0 | 0.1 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |